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Introduction

Neuromuscular Junction
Function
The transmission of signals from a neuron to its target is mediated by a specialized

structure called the synapse. The neuromuscular junction is the synapse between a cholinergic
motoneuron axon and a skeletal muscle cell (Adams et al., 1997). It is the best-studied synapse

because it is readily accessible and relatively simple. It consists of one motor nerve ending and
one skeletal muscle cell. The studies about the function, structure, and synaptogenesis of the
neuromuscular junction actually build the foundation for all of our current knowledge about the
synapse. Although intemeuronal synapses differ from neuromuscular junctions in important
ways, similar principles are applicable to both. The neuromuscular junction and intemeuronal

synapses are both chemical synapses. Functionally, the signal transmission through these

chemical synapses follows the same basic steps. A nerve impulse delivered from the presynaptic
axon results in the depolarization of the presynaptic membrane and causes voltage-gated calcium
channels in the presynaptic membrane to open, leading to calcium influx. Elevated intracellular

calcium then triggers release of the neurotransmitter out of the nerve ending by exocytosis. The
released transmitter diffuses across the synaptic cleft and binds to corresponding receptors in the

postsynaptic membrane, which changes the electrical activity of the postsynaptic cell membrane
by opening or closing ion channels. Finally the transmitter dissociates from the receptors and is

removed by diffusion, uptake, and/or enzymatic inactivation. Vesicle membrane is then retrieved
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from the presynaptic surface and utilized to make new vesicles. Synaptic vesicles are replenished
within the nerve terminal by axonal transport or a local cycle of endocytosis, so that transmission
can recur.

Acetylcholine Receptor (AChR)
Before differentiation, skeletal muscle cells are mononucleated myoblasts; after

differentiation, the myoblasts fuse to form multinucleated myotubes. Before neuromuscular
junctions are formed, these myotubes express basal levels of the embryonic acetylcholine

receptor, and the AChRs evenly distribute on the muscle cell membrane. Each myotube forms a
neuromuscular junction with a terminal branch of motoneuron axons. After the neuromuscular
junctions are mature, these muscle cells make high levels of the adult AChRs which cluster in the

post-synaptic membrane at a density 1000 times higher than on the extrasynaptic membrane
region (Salpeter and Harris, 1983; Salpeter et al., 1988).

Acetylcholine receptors are pentamers of a, P, y, 6, and 8 subunits. The embryonic AChR

consists of two a subunits and one each of the p, y, and 6 subunits (a2Py6). During postnatal
maturation of synapse, embryonic AChRs switch to the adult AChR, a2Pe6 (Mishina et al.,

1986; Gu et al., 1988). The y subunit in embryonic AChR is replaced by the £ subunit. Since this
change occurs only after the neuromuscular junction is formed, the postnatal y-*£ switch is

synapse-dependent (Chu et al., 1995). The ion channel properties of the two types of AChR are
different. The single-channel conductance of the embryonic AChR is smaller but its opening time
is longer than that of the adult AChR (Moss and Schuetze, 1987; Brehm and Henderson, 1988).

The y AChRs are thought to be more effective in depolarizing the smaller muscle fibers of
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embryonic muscle than e AChRs (Jaramillo et al., 1988).

Structure of the Neuromuscular Junction
Skeletal muscles are innervated by motoneurons which locate in the spinal cord and brain

stem. An axon extended from each motoneuron reaches a single muscle through a plexus of

peripheral nerves. In the muscle, the axon branches to innervate dozens to hundreds of muscle
fibers. Each muscle fiber is innervated at a single synaptic site by a single axon. Processes of

Schwann cells form the myelin sheath surrounding each motoneuron axon. Near the

neuromuscular junction the motor nerve loses its myelin sheath and divides into fine terminal
branches. Synaptic vesicles at the axon terminals, which contain the neurotransmitter

acetylcholine, are concentrated near “active zones” in the nerve terminals. The active zones refer
to the specialized dense areas on the presynaptic membrane, which are formed by accumulations
of proteins (Bear et al., 1996). One of the proteins identified in active zones is a calcium channel

(Robitalle et al., 1990; Cohen et al., 1991). It is now known that the active zones are the places

where the synaptic vesicles fuse with the presynaptic membrane to release neurotransmitter into

synaptic clefts (Bear et al., 1996). The terminal branches of the motoneuron axons lie in synaptic
troughs on the surfaces of the muscle cells. The specialized plasma membrane of the muscle cell

lining the trough forms numerous junctional folds. The AChRs on the thickened postsynaptic

membrane are concentrated at the mouths of the junctional folds which are precisely aligned with
the presynaptic active zones. Underneath the postsynaptic membrane are well-organized

cytoskeletal proteins and clusters of nuclei. Both the nerve ending and the skeletal muscle cells
are surrounded by a layer of extracellular matrix (ECM) called the basal lamina (BL). Although
the synaptic BL is morphologically indistinguishable from the extrasynaptic BL, the components
3
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of the BL in the synaptic cleft are different from those in the extrasynaptic region. Some
molecules, such as acetylcholinesterase (AChE) which inactivates the transmitter ACh,

specifically appear in the synaptic region but not outside of synapses (Sanes et ah, 1990). The
specific distribution of AChRs on the postsynaptic membrane and the precise alignment of the

junctional folds with the presynaptic active zones strongly indicate that the neuromuscular

junction is a highly differentiated structure that spans two cells and links their interiors. The

synaptogenesis of the neuromuscular junction is not fully understood. It is now known that the
development of the neuromuscular junction is regulated by the complex series of inductive

interactions between nerve and muscle. These interactions are mediated by extracellular matrix,
pre- and postsynaptic membrane, and soluble molecules synthesized by the motoneurons and

muscle cells.

Extracellular Matrix
The ECM is the substance which surrounds all the connective tissue cells and underlines

all epithelia and endothelia (Hay et al., 1991). This matrix is composed of a variety of proteins

and polysaccharides that are secreted locally and assembled into an organized meshwork in close

association with the surface of the cell that produced them. The ECM should not be viewed as
merely providing strength and physical support for tissues and organs. It is now quite clear
that this matrix exerts profound influence on both the behavior (e.g., adherence, spreading and
migration) and the pattern of gene expression of the cells in contact with it. Basal laminae are

flexible thin mats of specialized ECM that underlie all epithelial cell sheets and tubes; they also
surround individual muscle cells, fat cells, and Schwann cells which wrap around peripheral
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nerve cell axons to form the myelin sheath. The basal lamina thus separates these cells and cell
sheets from the underlying or surrounding connective tissue. In other locations, such as the

kidney glomerulus and lung alveolus, a basal lamina lies between two cell sheets and functions
as a highly selective filter. BLs have more than simple structural and filtering roles, however.

They are able to determine cell polarity, influence cell metabolism, organize the proteins in

adjacent plasma membranes, induce cell differentiation, and serve as specific highways for cell

migration. Although its precise composition varies from tissue to tissue and even from region to
region in the same tissue, most mature BL contains type IV collagen, heparan sulfate

proteoglycan, laminin and entactin. Type IV collagen molecules assemble into a felt-like sheet or

meshwork that constitutes a major part of mature BL (Alberts et al., 1994).

BL and Regeneration of Neuromuscular Junction
Motor nerve axons can spontaneously reinnervate muscle after nerve damage (Tello,
1907). Miledi and Slater pointed out that regenerated motor nerve axons formed neuromuscular
junctions at the original endplate regions of the muscle cells (Miledi and Slater, 1960). By using

a cholinesterase staining technique combined with light and electron microscopy to trace the

regeneration of injured motor nerve axons during the three months after the injury, it was found

that more than 95% of the original postsynaptic membrane was precisely reinnervated by the
original nerve terminals after crushing the motor nerve (Letinsky et al., 1976).

In the early 1970s, it was found that the junctional basal lamina plays a central role in
reconstructing a synapse after nerve or muscle injury. The evidence comes mainly from

experiments in frogs. One study established a method by which the cutaneous pectoris muscle of
5

the frogs was damaged and denervated, but the orientation of the basal lamina sheaths of the
damaged muscle cells were preserved and could be identified after both the myofiber and nerve
terminal were removed. Synaptic sites on BL also could be recognized by several histological

criteria after nerve terminals and muscle cells have been completely removed. After
degeneration and phagocytosis of myofibers were induced, the damaged muscle was given X-ray
irradiation at 1600 or 2000 rad doses. This dosage of irradiation inhibited muscle regeneration

almost completely, but the sheath of BL that surrounds each myofiber survived these treatments.
Regeneration of the nerve terminal was not interrupted because both BL and nerve tissue could
tolerate a much higher dosage of irradiation than muscle cells (Marshall et al., 1977). It was

found that when the motor nerve, but not the muscle cell, was allowed to regenerate, the nerve
axons still could find the original synaptic sites on the empty BL and differentiate there to form

normal-looking nerve terminals as judged by morphological, immunocytochemical, and
physiological criteria (Glicksman and Sanes, 1983). Thus, the neuromuscular junction basal

lamina by itself could guide the regeneration of motor nerve terminals. Some of the site-specific

factors that influence regenerating axons are tightly associated with synaptic BL (Sanes et al.,
1978). If the muscle and nerve were both destroyed, but now the muscle was allowed to
regenerate while the nerve was prevented from doing so, the AChRs synthesized by the
regenerated muscle would 1'localize predominantly in the region of the old junctions even

though the nerve was absent (Burden et al., 1979; McMahan et al., 1984). This indicates that the
basal lamina also controls the localization of the acetylcholine receptors to the post-synaptic

membrane at neuromuscular junctions. Thus, the junctional basal lamina apparently coordinates

the local spatial organization of the components in each of the two cells that form a
6

neuromuscular junction. This information led to efforts in the following decades to find the

proteins in the BL of the neuromuscular junction having these functions and to discover how they
work.

Identification of Laminin P2
In an effort to identify those synaptic BL proteins, antisera were raised against an alkali

digest of lens capsule, which is a particularly thick and easily isolated BL. These sera,

subsequently named junction-specific-1 (JS-1), stained synaptic BL more intensely than
extrasynaptic BL in adult rat muscle (Sanes and Hall, 1979). In order to further characterize the

JS-1 antigen, a group of monoclonal antibodies were generated using the same immunogen
(mAbs C4, D5, and D7) or using muscle BL as the immunogen (mAb Cl). These mAbs also

stained synaptic BL selectively (Sanes and Chiu, 1983; Hunter, 1987). When tissue sections were
preincubatcd with JS-1, immunostaining using these mAbs was blocked. This indicated that all

of these mAbs stained the same subset of BLs and recognized the same antigen. However, the
antibodies differed in species cross-reactivity and in their ability to recognize fixed or denatured

antigen, indicating that they recognized distinct epitopes. The selective staining of synaptic sites
by this group of antibodies indicated the restricted distribution of the JS-1 antigen.

Besides being concentrated at synaptic sites in muscle, JS-1 antigen was abundant in
other tissue BLs. In peripheral nerve, all four mAbs stained perineurial BL, which surrounds each

of fascicles of axon-Schwann units, more intensely than endoneurial BL, which ensheathes each
of a single axon-Schwann cell unit. In the kidney, these mAbs stained glomerular BL, which is

adjacent to capillary endothelia and podocytes on both of its sides, more intensely than tubular
7

BL, which is beneath the tubular epithelial cells. Within muscle, arterial BL was stained more
strongly than venous or capillary BL. Because glomeruli are more abundant in kidney than

synaptic sites are in muscle, glomerular extracts were first used to identify the antigen. A 190-kD

protein in glomerular extracts was specifically recognized on immunoprecipitations and western
blots using this group of mAbs. The solubility properties of the antigen and its sensitivity to a

variety of hydrolases indicated that it was a non-collagenous glycoprotein tightly associated with
the matrix by a combination of hydrophobic and disulfide bonds. These properties suggested that

the JS-1 antigen was an integral component of the BL.

Partially purified antigen from rat kidney was used to raise a new group of mAbs, and the
complete set was used to screen a Agtl 1 cDNA library from rat kidney. A cDNA encoding a
mAb D5-reactive fusion protein used as a probe recognized a single mRNA of about 5.7 kb on

northern blot analysis. These were used to isolate longer clones, and the process was repeated
until the entire mRNA was cloned. Subsequently, cDNAs encoding JS-1 antigen were isolated
from muscle-derived libraries and found to be identical in sequence to the kidney-derived

cDNAs. These results suggest that the form of JS-1 in muscle is identical in primary structure to
that in the kidney (Hunter et al., 1989a).
The most striking feature of the JS-1 sequence was its homology with the subunits of
laminin.

The characterized prototype of laminin purified from Engelbreth-Holm-Swarm (EHS)

tumor cells consists of three chains-a, P, and y« The chains form a cruciform trimer consisting of
three short arms and one long arm (Timpl, 1989). The three chains are assembled into a

heterotrimer by specific sequences at the C-terminal portions of the al, pi and yl chain (Utani et
8

al., 1994). After deducing the secondary structure of the proteins based on the analysis of cDNA

sequences of the individual laminin chains, each chain was divided into six domains, I-VI. For
the p chain, an additional a domain was designated between domain I and II (Sasaki et al., 1987;

Sasaki and Yamada, 1987; Sasaki et al., 1988) (Fig. 1).
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Fig. 1. Laminin-1 Trimeric Structure. Parentheses indicate
laminin B2 replaces laminin B1 chain in the trimer.
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Other laminin variants with a similar structure have been identified in the last two
decades and were shown to possess novel isoforms of the constituent chains. Analysis of
placental laminins supports the idea that subunits can combine to form several distinct
heterotrimers (Engvall et al., 1990). The first laminin identified from the

Engelbreth-Holm-Swarm tumor is laminin-1, with the chain composition al, P1, and yl

(Burgeson et al., 1994). At present, eleven laminin isoforms are known. Five alpha chains (ala5; Pierce et al., 1998), three p and two y chains have been described (Lentz et al., 1997). Genes

encoding the a4 and a5 chains have been cloned, but little is known about their expression, and
their protein products have not been identified (Miner et al., 1997).

In both primary sequence and predicted secondary structure, the closest relative of the JS-1
antigen is the laminin pi chain. The major difference in the amino acid sequence between JS-

1 antigen and laminin pi chain is in domain 1. Because of this homology and the restriction of

JS-1 antigen to a subset of BLs including synaptic BL, JS-1 antigen was renamed s-laminin
(Hunter et al., 1989a). The s-laminin gene (Lams) of mouse was mapped to chromosome 9

(Porter et al., 1993). The human s-laminin cDNA was cloned in 1994 and the gene encoding
human s-laminin was mapped to chromosome 3p21 by in situ hybridization. The amino acid
sequence of human s-laminin chain showed 86% sequence identity to the rat s-laminin chain

(Wewer et al., 1994). Because of the homology with laminin pi chain, s-laminin is now called

laminin P2 in the new nomenclature for laminin (Burgeson et al., 1994).
The native trimeric structure of laminin P2 was determined based on derived information

from the following studies. Immunohistochemistry revealed that laminin P2 and a laminin a

11

chain are greatly concentrated in synaptic BL, that laminin pl is apparently absent from synaptic

BL, and that the laminin y 1 chain is present at similar levels synaptically and extrasynaptically.
When intramuscular nerve was stained by the same group of anti-laminin chain antibodies, anti

laminin P2 stained perineurial BL more intensely than endoneurial BL. In contrast, antibodies to
laminin pi stained endoneurial BL but not perineurial BL. Antibodies to laminin yl and a
chains stained both endoneurial and perineurial BL with similar intensity. In the kidney of

rabbits, guinea pigs, rats, and humans, antibodies to laminin p2 stained glomerular BL far more
intensely than tubular BL. In contrast, antibodies to laminin pl stained tubular BL but did not
react detectably with glomerular BL, and antibodies to laminin y 1 stained both glomerular and

tubular BL. Finally anti-laminin al stained both glomerular and tubular BL (Sanes et al., 1990;
Sollberg et al., 1992; Wewer et al., 1992; Glukhova et al., 1993; Porter et al., 1993; Wewer et al.,
1994b). These data suggested that laminin P2 co-exists with an a-like chain and a y-like chain,

but not laminin pi, in all the tested tissue and species. Finally, this observation was confirmed by

immunoprecipitation using laminin chain-specific antibodies. Immunoprecipitation of
metabolically labeled material from the rat muscle cell line RMo revealed the presence of

specific oligomers. Anti-yl mAb coprecipitated P1, p2, and an a-like chain, whereas anti-P2
mAb coprecipitated laminin yl and an a-like chain but not the pi chain. The results confirmed
that laminin p2 associates with the a- and the y- chains to form a heterotrimer in the cells.
Laminin pi and laminin P2 both appear in the laminin trimer, but the two laminin p chains do

not assemble in the same trimeric molecule. Differential assembling and tissue distribution of

laminin P2 strongly suggests that it may have novel functions (Green et al., 1992).

12

Function of Laminin P2
Laminin is a potent promoter of neurite out-growth (Sanes et al., 1989). Since laminin P2
is concentrated in a subset of basal laminae, including those of the skeletal neuromuscular

junction, it might play a role in the differentiation of motor nerve endings during synaptogenesis
at neuromuscular junctions. If that is the case, laminin P2 should recognize and bind to

motoneurons selectively. Functional studies of laminin P2 were initiated using a neuron adhesion
assay. Cholinergic motoneurons from embryonic chick ciliary ganglia were tested in this

experiment. These ciliary neurons innervate striated muscle in vivo and form conventional
neuromuscular junctions. In addition, ciliary neurons also recognize original synaptic sites on

fragments of adult skeletal muscle in vitro (Covault et al., 1987). Ciliary neurons are somatic
motoneurons, but they are much easier to isolate than spinal motoneurons. Dissociated ciliary

neurons were incubated for 1-2 hours on dishes that had been coated with either recombinant

laminin P2 or purified laminin 1. In this assay, neurons adhered to a recombinant protein
comprising the carboxyl-terminal 80 kD (40%) of laminin P2. This adhesion was specific in that
it was blocked by antibodies to laminin p2 and was not mimicked by other proteins such as
bovine serum albumin (Hunter et al., 1989b). These results indicate that at least one adhesive site

for motoneurons is present in the carboxyl-terminal 40% of laminin P2.
In another series of neuron adhesion assays, several types of neurons (e.g., tectal, sensory,

and ciliary neurons), neuron-like cells (e.g., PC 12, B35, and Bl04 cells), and non-neuronal cells

(e.g., fibroblasts, myoblasts, and glomerular epithelial cells) adhered well to laminin-1
(containing laminin pi but not P2). In contrast, only ciliary motoneurons attached significantly
to the laminin P2 fusion protein. Deletion studies of the recombinant laminin p2 finally
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pinpointed a tripeptide Leucine-Arginine-Glutamate (LRE), which competitively inhibited

adhesion of ciliary neurons to recombinant laminin 02 fragments. The potency of LRE in molar

terms is approximately equal to that of the longer fragment, indicating that LRE defines a crucial
determinant of a motoneuron-selective adhesive site. The observation that LRE-dependent
adhesion is important for synapse formation or maintenance receives further support from the
sequences of other molecules concentrated in synaptic BL: laminin 02, laminin al, laminin yl,

agrin, acetylcholinesterase, and collagens #3(IV) and a4(IV) (McMahan and Wallace, 1989;

Sanes et al., 1989 and 1990). The LRE tripeptide sequence is present in all of these molecules.
There are three in rat laminin 02, two in mouse, human, and Drosophila laminin yl as well as in

rat agrin, one in mouse laminin al, and one in acetylcholinesterase from both Torpedo and
human (Hunter et al., 1989b). In contrast, proteins that are concentrated at synaptic sites in

innervated muscle but appear extrasynaptically following denervation lack LRE; these include NCAM, N-cadherin, and the subunits of the acetylcholine receptor. The laminin 01 chain, to which

laminin 02 is most closely related, does not contain any LRE sequence. The LRE in laminin al
and one of the LREs in laminin y 1 correspond precisely in position to two of the three LREs in

laminin 02 (Hunter et al., 1989).
A number of cell lines (tectal and sensory neurons, neuron-like PC 12, B35, Bl 04 and
NSC-34 cells, and non-neuronal cells such as fibroblasts, myoblasts, and glomerular epithelial

cells) were screened for their ability to recognize the laminin 02-derived fusion protein and/or
LRE-protein conjugates. Only one cell line was found to be capable of LRE-dependent adhesion.
This line, NSC-34, is derived from a fusion of rat spinal cord cells to a neuroblastoma line. It
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resembles spinal motoneurons by several neurochemical and functional criteria. (1) It expresses
high levels of acetyl CoA : choline O-acetyltransferase (ChAT), the synthetic enzyme for ACh.
(2) It synthesizes and stores ACh, the only classical transmitter at the neuromuscular junction. (3)

It releases ACh in response to depolarization. (4) It expresses cell surface antigens that are also

present on cultured primary motoneurons. (5) It forms morphologically stable contacts with and
induces contractile activity in coculturcd myotubes. (6) It induces acetylcholine receptor clusters

at synapses on cocultured myotubes (Schnaar and Schaffner, 1981; Cashman et al., 1992).
Motoneurons are believed to have a receptor specific for the LRE tripeptide in laminin p2
(Hunter et al., 1989b).

To begin to determine the properties of this putative LRE-receptor on motoneurons, a

simple diagnostic approach was taken. Adhesion of many different types of cells to extracellular
matrix molecules is mediated by cell-surface receptors called integrins. In many cases integrins
recognize short peptide sequences within their substrates; for example, the Arg-Gly-Asp (RGD)
sequence in fibronectin (Ruoslahti et al., 1987). If the LRE receptor was an integrin on the cell

membrane of the motoneurons, its activity would be strictly dependent on divalent cations,
particularly magnesium. The divalent cation dependence of NSC-34 cells was used as a

diagnostic test to check whether the LRE receptor is an integrin. Adhesion of NSC-34 cells to
laminin-1 was entirely dependent on extracellular magnesium ions, but was unaffected by
calcium ions, indicating adhesion of laminin-1 was mediated by an integrin. However, adhesion

of NSC-34 cells to the laminin P2 fragment was robust in the presence of chelating agents,
unaffected by extracellular magnesium, and inhibited by the presence of extracellular calcium.

Moreover, an antibody to the chick integrin pi subunit, JG22, inhibited adhesion of chick ciliary
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neurons to laminin-1 but not to recombinant laminin p2 fusion protein. This was strong evidence

that the LRE receptor is not an integrin (Hunter et al., 1991). This putative non-integrin LRE
receptor has not been identified yet.

To determine the influence of the LRE-dependent adhesive interaction on motoneurons,
the short-term adhesion assay was extended to longer incubation times and the behavior of ciliary

neurons and NSC-34 motoneuron-like cells on substrata coated with laminin-1, laminin p2, or
LRE-protein conjugates was observed. NSC-34 cells soon extended neurites on laminin-1 but not
on LRE-protein conjugates, though similar numbers of cells adhered to both substrata. The result

indicated that the LRE-conjugate did not merely fail to support the process outgrowth but, in fact,

inhibited the process outgrowth on laminin. These data led to the hypothesis that, whereas
laminin-1 promotes the outgrowth of regenerating axons back to and along the muscle fiber

surface, laminin p2 causes axons to stop growing at original synaptic sites and possibly to initiate

their differentiation into nerve terminals at these sites (Porter et al., 1995). In further experiments
ciliary neurons were plated on substrates coated with alternating strips of laminin-1 and a

mixture of laminin-1 plus laminin p2. On these patterned substrates, cells seldom crossed from

laminin p2-free to laminin p2-containing regions. Mutation of the tripeptide LRE in a
recombinant laminin p2 fusion protein abolished the ability of laminin P2 to block border

crossing of the cells. However, overall rates of migration were similar on the two substrates. It
was proposed that laminin P2 blocks cell migration through a “gating” mechanism that acts

primarily at borders (Porter and Sanes, 1995). In embryonic muscle, laminin [32-like
immunoreactivity was detectable predominantly at synaptic sites, but not in non-synaptic areas.

Laminin P2 appeared only after acetylcholine receptors clustered in the postsynaptic membrane,
16

and a rudimentary BL formed in the synaptic cleft. These data imply that laminin p2 (and/or
other components of synaptic BL) could promote the maturation of synapses once they have

formed (Chiu and Sanes, 1984).
If these hypotheses are true, then it is important to know how laminin p2 molecules exert

their function in vivo. In skeletal muscle, the basal lamina ensheaths each muscle fiber. Synaptic

and extrasynaptic portions of the basal lamina contain different laminin p chains-P2 at synaptic

clefts and pi extrasynaptically. Laminin p2 is also confined to synapse-like patches on myotube

surfaces in vitro, whereas pi is present throughout the extracellular matrix ( Patton et al., 1997).
This differential localization of laminin p chains was analyzed by expression of chimeric p 1 -p2
molecules in cultured mouse myotubes. A 16-amino acid carboxyl-terminal sequence in P2 was

found to cause synaptic localization, and an amino-terminal domain in pi promoted association

with extracellular fibrils. The synaptic targeting sequence of laminin p2 contains the LRE site
previously shown to be adhesive for motor neurons. Although this experiment found that the
short carboxyl-terminal sequence in laminin P2 is necessary for synaptic localization of the
molecules, the mechanism with which the laminin P2 is targeted to the synaptic clefts is still not

known. Laminin p2 molecules are targeted to the neuromuscular junction either directly by this

so-called synaptic localization sequence or by some unknown proteins along with this synaptic

localization sequence (Martin et al., 1995).
However, the results from motoneuron adhesion assays have been refuted recently by

other studies. Using native laminin-2 (a2plyl) and laminin-4 (a2p2yl) coated culture substrata,
these studies demonstrated that neurite outgrowth by chick motor neurons was promoted rather

than inhibited, and chick sympathetic and sensory neurons also interacted with these laminin
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isoforms by showing neurite outgrowth. Although a recombinant randomly coiled LRE peptide
indeed inhibited outgrowth by chick motoneurons, the LRE tripeptide sequences in laminin p2
were found to be masked in a triple coiled-coil region in native laminin trimer so that they were
not available for interacting with motoneurons (Brandenberger et al., 1996). In addition, a new
study investigated the distribution of the 10 known laminin chains in muscle and assayed the

ability of several heterotrimers to affect the outgrowth of motor axons. The results made the
situation much more complicated than ever before. It was found that cultured muscle cells

express four different a chains (al, a2, a4, and a5), and that developing muscles incorporate all
four into BLs. The synaptic BL of the muscle contains at least three a chains and two P chains,

and each was regulated differently. In addition to p2 being restricted to synaptic BL from its first
appearance, the a2, a4, a5, and pl chains are present both extrasynaptically and synaptically.

As development proceeds, a2 remains broadly distributed, whereas a4 and a5 are lost from

extrasynaptic BL and pi from synaptic BL. The adult extrasynaptic BL is rich in laminin 2
(a2ply 1), and synaptic BL contains laminins 4 (a2p2y 1), 9 (a4p2y 1), and 11 (a5p2yl).

Mutation of the laminin a2 or p2 genes in mice not only leads to loss of the respective chains in

both nerve and muscle, but also to coordinate loss and compensatory upregulation of other
chains. Loss of P2 from synaptic BL in P2(-/-) "knockout" mice is accompanied by loss of a5,

and decreased levels of a2 in dystrophic a2(dy/dy) mice are accompanied by compensatory
retention of a4. The motor axons respond in distinct ways to different laminin heterotrimers.

They grow freely between laminin 1 (aipiy 1) and laminin 2 (a2piyl), fail to cross from
laminin 4 (a2p2yl) to laminin 1, and stop upon contacting laminin 11 (a5p2yl) (Patton et al.,
1997). The LRE tripeptide sequence in laminin P2 seems critical for its function; however,
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human laminin P2 doesn’t contain any LRE. As opposed to mouse and rat laminin p2 which are
strictly concentrated at the synaptic BL, human laminin P2 also is distributed in extrasynaptic BL

and plays an important role in myogenesis. The differences among these studies have not been

resolved yet.
In contrast to the BL in the peripheral neuromuscular junction, laminin p2 is not
detectable in synapse-rich areas in central nervous system (CNS) of rats. Instead, laminin p2 is

present in discrete subsets of three laminin-containing structures- developing cerebral cortex, the

pia of spinal cord, and capillary walls (Letourneau et al., 1988; Liesi and Silver, 1988). The

expression of the laminin P2 chain is regulated developmentally. Besides being present in
certain portions of the central nervous system, laminin p2 also is more readily detected at El 5

than at El3 or El7 in embryonic rat brain (Gordon-Weeks et al., 1989; Hunter et al., 1992). In
contrast to skeletal muscle, cellular sources of laminin p2 in brain are astrocytes with/without

other glial cells. Therefore, some researchers wondered if laminin P2 plays a role in the

formation of blood-brain-barrier (Chiu et al., 1991). The spatial and temporal patterns of laminin

P2 expression in the CNS suggest it may have some function there, but there is only limited
information available at present.

A large number of studies about laminin P2 have been conducted on rats and mice, and

all of these studies have confirmed that laminin P2 is concentrated in the synaptic BL in rodent
skeletal muscle (Hunter et al., 1989a). Until recently, little attention has been paid to the presence

and potential role of the laminin 02 chain in the extrasynaptic skeletal muscle basement
membrane. Recent studies investigated the distribution of the laminin p2 chain in human fetal

and adult skeletal muscle by immunoblotting and immunohistochemistry using a group of new
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mAbs to laminin p2. Laminin P2 was first detected in 15 to 22-week-old fetal skeletal muscle as
distinct focal immunoreactivity in the sarcolemmal basement membrane area of some myofibers.

In the human adult skeletal muscle, laminin p2 immunoreactivity was found in the sarcolemmal

BL around the entire surface of each muscle fiber in all muscles studied, in addition to strong
immunoreactivity of the neuromuscular junction consistent with previous observation. Laminin
P2 present in the sarcolemmal BLs of Duchenne/Baker muscular dystrophy patients was similar

to that in normal adult skeletal muscle (Wewer et al., 1997). An extrasynaptic localization of the
laminin P2 chain also was found in chicken skeletal muscle (Maier and Mayne, 1995). There has

been some evidence showing that changes in the distribution pattern of laminin p2 are associated
with pathogenesis of some types of muscular dystrophy. The expression of laminin subunits al,

a2, pi, p2, and yl in skeletal muscle biopsy specimens of eight severe childhood autosomal

recessive muscular dystrophy (SCARMD) patients from various human populations were
investigated by using immunohistochemistry and confocal laser scanning microscopy. A

reduction of the laminin pi chain and the overexpression of the P2 chain in the extrajunctional

basal lamina were observed in five patients who had advanced clinical symptoms and
histopathologic changes. Disturbance of the sarcolemma-basal lamina interaction may play an

important role in the molecular pathogenesis of muscle fiber necrosis in SCARMD (Yamada et
al., 1995). SCARMD is similar to Duchenne muscular dystrophy in phenotype but is
characterized by the deficiency of adhalin, which is one of two major dystrophin-associated

integral membrane proteins of the muscular plasma membrane. At present, the relationship

between the dystrophin-glycoprotein complex and laminin is unclear in SCARMD (Sunada and
Campbell, 1995). Muscular dystrophy may be caused by disturbances in a number of muscle
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proteins that appear to be part of a chain of interacting molecules that includes cytoskeletal, cell

membrane, and basement membrane components. In contrast to SCARMD patients, the skeletal

muscle from patients with Walker-Warburg syndrome (cerebro-ocular dysplasia-muscular
dystrophy) was found severely deficient in the both laminin p2 chain and adhalin. The findings

indicate that these two proteins are key molecules in the interactive protein complex conferring

muscle stability and cell survival (Wewer et al., 1995). It is already known that the complete lack
of laminin a2 expression in skeletal muscle due to mutations in the LAMA2 gene, which
encodes for the a2 chain, is the hallmark of one form of congenital muscular dystrophy. It is

characterized by dysmyelination of the central nervous system (CNS). This type of congenital
muscular dystrophy is linked to chromosome 6q2 and is common among Caucasians (Voit et al.,

1995; Haltia, 1997). However, the fact that laminin P2 chain is related to human congenital
muscular dystrophy is a relatively new discovery. The pathological role of laminin P2 in these

diseases remains unknown.
Laminin-4 (a2p2y) is a more abundant component of the human striated muscle
basement membrane than previously thought. The prominent expression in normal muscle and
changes in expression in certain muscle diseases suggest a distinct role for p2-containing laminin

isoforms in muscle function (Wewer et al., 1997). In rodent skeletal muscle, laminin p2 is
confined to the neuromuscular junction (Hunter et al., 1989a). Why laminin P2 is distributed to
both synaptic and extrysynaptic BL in the human skeletal muscle is not understood. Structurally,

rodent laminin P2 contains the LRE sequence but human P2 does not. Whether the LRE
sequence results in this difference needs further investigation.
In the study of laminin function, gene knock out experiments have the potential to be
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most informative (Noakes et al., 1995a). Homozygote animals bearing nonfunctional laminin P2
genes die between 15 and 30 days after birth. Two abnormalities were found to account for their
failure to thrive. First, mutant mice developed massive proteinuria due to failure of the
glomerular filtration barrier. This defect results from alterations in the kidney glomerular BL,

which is rich in laminin P2. In the mutants that lack laminin P2, the glomerular basement
membrane (GBM) is rich in laminin pi, in contrast to the glomerular basement membrane of

wild type animals. Despite the molecular compensation by laminin pl, it can not prevent

nephrosis in the renal glomerulus of mice lacking laminin P2. In fact, normally immature GBM
bears laminin pi, which is replaced by the P2 chain as development proceeds. These results in
mutant mice suggest there is a feedback mechanism that normally regulates GBM maturation.

Laminin P2 plays an important role in this process. This is also strong evidence that laminin P
chains are functionally distinct although they assemble to form similar structures (Noakes et al.,

1995b).
These transgenic animals also showed obvious defects in the structure and function of the
neuromuscular junctions. First, active zones were common in normal nerve terminals but were

rarely seen in mutant terminals. Second, synaptic vesicles were evenly spread throughout the
mutant terminals, whereas about two-thirds of the synaptic vesicles are normally concentrated in

the half of the terminal that abut the muscle fibers. Third, Schwann cell processes frequently
penetrated the synaptic cleft separating the nerve terminals from BL and muscle fibers in mutant

neuromuscular junctions. In normal neuromuscular junctions, the Schwann cell processes only
surround the nerve terminals. Four, mutant postsynaptic membranes were almost devoid of
junctional folds. All of these defects were seen in continuously active respiratory muscles.
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Neurophysiological tests indicated that both amplitude and frequency of miniature endplate
potentials (m.e.p.ps) in muscle cells were lower than normal mice; the freqeuncy of m.e.p.ps. in
mutants was 15-fold lower than in controls. The m.e.p.ps. are believed to reflect spontaneous
release of neurotransmitter by individual synaptic vesicles. Lower amplitude and frequency of

m.e.p.ps in mutant muscle cells suggested either the density of AChRs in the postsynaptic

membrane was slightly affected by laminin P2 deficiency or subnormal amounts of transmitter

reach the postsynaptic membrane (Noakes et al., 1995a).
In summary, these results indicated that laminin p2 plays an important role in the process
of formation of the glomerular filtration barrier, synaptogenesis of the neuromuscular junction

and development as well as maintenance of skeletal muscle. However, the mechanism of how

laminin p2 works still is not known.

Neuromuscular Junction Development
The postsynaptic accumulation of AChR during neuromuscular junction development is

mediated by transcriptional regulation. The investigation of distribution and turnover rate of
acetylcholine receptors found that the receptor site density was approximately 10 times greater

on the top region of the postjunctional folds than on the bottom folds for both total and newly
inserted receptors. This ratio does not change significantly during a six day period after labeling

the new receptors. Calculated values for turnover time of receptors indicated that the different

densities of both total and newly inserted receptors at both regions of the junctional folds could
not be simply explained by different turnover times (Salpeter and Harris, 1983). However, AChR
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messenger RNA is more abundant near to than far from synapses in adult muscle fibers. These
results demonstrated that AChRs are preferentially synthesized near synapses and that

innervation can influence not only where AChRs are inserted or accumulate but also where they
are synthesized (Merlie et al., 1985).

It has been found that two different signaling pathways regulate neuromuscular junction
formation. One is the Agrin-MuSK(for muscle specific kinase) pathway. The other is the
NRG/ARIA-erbB receptor pathway.

Agrin is a component of the synaptic basal lamina at the adult neuromuscular junction. It

has been confirmed that neurally-derived agrin is responsible for the initial clustering of AChRs
at developing synapses. During development, agrin is expressed by embryonic motoneurons and

is transported to the nerve terminals, where it is released at sites of contact with developing

muscle fibers. Agrin becomes stably incorporated into the basal lamina and appears to act

through specific receptors in the cytoplasmic membrane of the muscle cell, which trigger

aggregation of pre-existing AChRs in the postsynaptic membrane (Godfrey et al., 1984; Tsim et

al., 1992). Agrin also induces the accumulation of other components at the synapse, including the

43 kD protein rapsyn, acetylcholinesterase, and a heparan sulfate proteoglycan (Wallace, 1989).

Agrin-induced clustering of AChRs in the postsynaptic membrane is a key step in synaptogenesis
at the neuromuscular junction. The receptors for agrin have not been completely identified. The

first candidate for the agrin receptor was a-dystroglycan (Gee et al., 1994), which is one of two
dystrophin-associated glycoproteins encoded by a single messenger RNA. Dystroglycan-a and P
subunits provide a linkage between the cytoskeleton of muscle cells and the ECM

(Ibraghimov-Beskrovnaya et al., 1992). Despite the findings that agrin can bind directly to a24

dystroglycan and that the dystroglycan complex is coupled to AChRs via rapsyn (Apel et al.,
1995), a-dystroglycan is now believed to be only a part of the agrin receptor. One reason for this

view is that antibodies against a-dystroglycan blocked agrin binding to a-dystroglycan but failed

to block the clustering of AChRs induced by neural agrin (Sealock and Froehner, 1994;

Sugiyama et al., 1994). Agrin has been shown to stimulate tyrosine phosphorylation of a
muscle-specific receptor tyrosine kinase (MuSK), and tyrosine kinase inhibitors and a tyrosine
kinase-deficient mutant of MuSK prevent AChR aggregation (Valenzuela et al., 1995). The

receptor tyrosine kinase MuSK is only a component of the agrin receptor because MuSK

becomes phosphorylated upon incubation with agrin, but it does not bind to agrin on its own.
Agrin-triggered MuSK phosphorylation and AChR aggregation are correlated. Picomolar
concentrations of agrin are sufficient to induce MuSK phosphorylation. Similar amounts are
necessary for the aggregation of AChRs as well as their phosphorylation on a tyrosine residue.

The complete overlap of specificities for MuSK phosphorylation and AChR aggregation suggests
that only binding of agrin to a MuSK-containing receptor complex is responsible for the
initiation of AChR aggregation (Hopf and Hoch, 1998).
The activation of MuSK leads to the tyrosine phosphorylation of p subunits of AChR.

Treating chick myotubes with agrin caused an increase in phosphorylation of the AChR P, y, and
6 subunits. Experiments with anti-phosphotyrosine antibodies demonstrated that agrin caused the
AChR p subunit to be phosphorylated on tyrosine residues (Wallace et al., 1991). To evaluate the

role of tyrosine phosphorylation of the AChR p subunit in receptor aggregation, all three putative
cytoplasmic tyrosine residues of the subunit were replaced with phenylalanine residues. The
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mutant receptors were expressed in cultured myotubes. After treating with agrin, transfected
myotubes formed AChR aggregates that contained receptors with mutant p subunits. Thus,
AChRs can be recruited into agrin-induced specializations by protein-protein interactions that do

not depend on tyrosine phosphorylation of the AChR p subunit (Meyer and Wallace, 1998).
Activation of MuSK kinase domain is necessary and sufficient to mediate

phosphorylation of AChRs. However, MuSK kinase domain activation and the resulting AChR
phosphorylation are not sufficient to trigger AChR clustering. It has been demonstrated that the

MuSK ectodomain plays a required role. In addition to simply mediating ligand binding and
receptor dimerization, the ectodomain of the MuSK may help to recruit components of the
neuromuscular junction to a MuSK-based scaffold (Glass et al., 1997). The 43 kD cytoplasmic

protein rapsyn is necessary for the clustering of AChRs and all other postsynaptic membrane

components studied to date (Frail et al., 1987; Froehner, 1990; Apel et al., 1997). AChR-rapsyn
clusters colocalize with dystroglycan when these proteins are coexpressed in the cells. In the

electric organ of Torpedo, AChRs and 43K proteins are present in approximately equimolar

amounts (LaRochelle and Froehner, 1986), and precisely coexist on the crests of the folds
(Sealock et al., 1984; Flucher and Daniels, 1989). It is currently thought that rapsyn is a

molecular link connecting the AChR to the dystrophin-glycoprotein complex (DGC). At the

neuromuscular synapse, rapsyn-mediated linkage of the AChR to the cytoskeleton-anchored
DGC may underlie AChR cluster stabilization (Apel et al., 1995). In cultured C2 myotubes,

MuSK phosphorylation increased on the same time course as phosphorylation of the P subunit of
the AChR. There are still some different opinions about the role played by MuSK in this
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signaling pathway. Based on the observation that agrin-induced AChR phosphorylation was
blocked by both tyrosine kinase inhibitors herbimycin and staurosporine, but the phosphorylation

of MuSK was inhibited only by herbimycin, Fuhrer et al. (1997) think that although agrin

activates MuSK that is associated with the AChRs, MuSK is not directly responsible for AChR
phosphorylation but acts through other kinases. Overall, there are still some steps in this

signaling pathway that are not very clear. The agrin-MuSK pathway regulates neuromuscular

junction formation on the post-translational level; it doesn’t affect gene expression of AChRs
(Glass et al., 1996).

The NRG/ARIA-erbB receptor pathway regulates synaptogenesis on the genetranscriptional level. ARIA (Acetylcholine Receptor Inducing Activity) was initially

characterized as an activity present in chicken brain and spinal cord extracts capable of

increasing the rate of AChR synthesis in myotube cultures. Purification of this activity

subsequently defined a 42 RD glycoprotein (Harris et al., 1988). NRG (neuregulin) was purified
on the basis of its ability to stimulate phosphorylation of erbB2/neu (described below) and was

initially termed neu differentiation factor (NDF). Subsequently, it became clear that NRG and
ARIA are a family of protein molecules encoded by a single gene (Mudge, 1993). Alternative
splicing of the gene encoding NRG/ARIA results in a great heterogeneity of predicted translation
products (Carraway and Burden, 1995). At least 15 iso forms have been reported so far. These

NRG/ARIA iso forms were given names such as heregulin (HRG), neu differentiation factor

(NDF), and glial growth factor (GGF) (Fischbach and Rosen, 1997).
The structure of the NRGs includes an EGF-like motif, an Ig-like loop, a glycosylation
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domain, and a transmembrane domain. The presence or absence of the latter domain determines
whether the precursor is made as a transmembrane protein or as a secreted polypeptide (Loeb et
al., 1988). Secreted NRG retains the EGF-like domain, which alone is sufficient to cause tyrosine

phosphorylation of NRG receptors and to stimulate cellular responses. According to a new

nomenclature, the various isoforms are grouped into three types. Type I includes variants with an
Ig loop and a glycosylation domain (e. g., isoforms NDF and ARIA); NRGs with an Ig loop but

no glycosylation domain are termed type II (e.g., the NRG isoform originally called GGF-II);

sensory and motor neuron-derived factor (SMDF) is now termed type III NRG (Burden and

Yarden, 1997).
Recent studies have shown that the function of NRG/ARIA is mediated by members of

erbB receptor family (Fischbach and Rosen, 1997). The erbB receptor family has four members-

erbBl, erbB2, erbB3, and erbB4. The erbB receptors are receptor tyrosine kinases and can form

homodimers or heterodimers following the binding of ligands. ErbBl is the epidermal growth
factor (EGF) receptor. It binds six mammalian EGF-like molecules: EGF, transforming growth

factor a (TGF-a), heparin-binding EGF-like growth factor (HB-EGF), amphiregulin, epiregulin,
and betacellulin. The erbB2 receptor has no known direct ligand so far. The kinase activity of

erbB3 has degenerated during evolution. Therefore, it has to form dimers with other erbB family
members. Because the function of the erbB receptors overlaps with other receptor tyrosine
kinases, the situation is extremely complicated. The downstream events of the pathway are not
clear. NRG isoforms bind directly to erbB-3 and to erbB-4, but they recruit erbBl and erbB2 as

coreceptors (Burden and Yarden, 1997). Originally, erbB2 was thought to be the receptor for
NRGs because NRGs stimulate tyrosine phosphorylation of the erbB2 RTK (Lupu et al., 1990).
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Several lines of evidence indicate that the interaction between NRG and erbB2 involves another

molecule. In ovarian cells which overexpress erbB2 receptors, NRG had no effect on the tyrosine
phosphorylation of the erbB2 receptors. In ligand binding assays of both ovarian and fibroblastic
cell lines, which overexpressed erbB2 receptors, there was no protein covalently cross-linked

with radiolabeled NRG (Peles et al., 1993). In addition, a group of anti-erbB2 mAbs failed to
inhibit NRG binding to the target cells (Tzahar et al., 1994). It has been known that EGF
specifically binds to EGFR but not to erbB2. However, in SKBR-3 human breast carcinoma
cells, chemically cross-linked l25I-labeled EGF and EGFR coimmunoprecipitate with the erbB2

receptors. EGF binding to these cells results in a self-phosphorylation of both EGFR and erbB2

(Goldman et al., 1990; Tzahar et al., 1994). Now it is known that erbB2 can form heterodimers

with all other erbB receptor family members (Graus-Porta et al., 1997).
NRGs have different functions in different tissues. In cardiac development, loss of

functional NRG, erbB2, and erbB4 genes in mice resulted in almost identical cardiac
malformations. NRGs also play a role in Schwann cell and oligodendrocyte differentiation and
in epithelial morphogenesis (Levi et al., 1995; Meyer et al., 1995).
Many studies have demonstrated that NRG/ARIA plays an important role in the

synaptogenesis of neuromuscular junctions (Harris et al., 1991; Jo et al., 1995). Neurally-derived
NRGs are believed to act as signals that stimulate transcription of the genes encoding AChR
subunits (Fall et al., 1993). These proteins are secreted from motor nerve endings (Sandrock et

al., 1995) and are deposited in the synaptic membrane of the neuromuscular junctions (Goodearl
et al., 1995). NRGs activate AChR gene expression in the nuclei of muscle cells near the

neuromuscular junctions (Harris, 1989). NRG/ARIA is also responsible for the AChR subtype-
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switch from embryonic a2Pyd to a2pe5 (Chu et al., 1995; Si et al., 1997). The first in vivo
evidence supporting the role of NRG/ARIA in the neuromuscular junction formation was

presented by Sandrock et al. (1997). In NRG gene knockout mice, homozygotes die in the
embryonic stage. Heterozygotes are mildly myasthenic (fluctuating muscle weakness and

fatigue). In these heterozygous mice, AChRs at the neuromuscular synapses are 50% of normal
level, supporting the idea that NRG has a role in stimulating AChR synthesis in synaptic nuclei.

Tetanic stimulation (frequency = 30-Hz) of their motor nerves in vitro showed that synaptic
transmission fails more readily in these heterozygous mice, further indicating that NRG has a

role in neuromuscular function (Fischbach and Rosen, 1997). In skeletal muscle, it has been
reported that the NRG receptors erbB3 and erbB4 are localized at the neuromuscular junction

area (Zhu et al., 1995). But most studies have indicated that erbB2 and erbB3 are the
NRG/ARIA receptors in skeletal muscle, and that these receptors are concentrated at the synaptic

basement membrane of the neuromuscular junctions (Altiok et al., 1995; Jo et al., 1995; Carroll
et al., 1997). It has been shown by RNase protection assays that in NRG/ARIA responsive-

myotubes, muscle cells express both erbB2 and erbB3, but little EGFR or erbB4 (Moscoso et al.,

1995).
The downstream events of the NRG/ARIA-erbB pathway are not very clear. A few
studies reported that NRG/ARIA works through activation of the PIP2/IP3 and Ras/MAPK

pathways (Marte et al., 1995; Tansey et al., 1996).

As is the case for other receptor tyrosine kinases, ligand-induced autophosphorylation of

erbB proteins on specific tyrosine residues establishes docking sites for cytoplasmic signaling
proteins sharing a phosphotyrosine binding motif (SH2 or PTB domains). Due to differences in
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the amino acid sequences surrounding phosphorylation sites of each receptor, different sets of
signaling proteins become associated with each of the 10 possible erbB complexes (Burden et al.,

1997). One exception is Eps8, which originally was identified as a substrate of the EGF receptor.

Eps8
Eps8 stands for epidermal growth factor receptor pathway substrate clone 8; it is a
recently described substrate for receptor tyrosine kinases (Fazioli et al., 1993). It is tyrosine-

phosphorylated in vivo following EGF stimulation and associates with the EGF receptor, despite

the lack of a functional SH2 domain. The SH2 domains of the signaling proteins mediate the

binding of these proteins to tyrosine-phosphorylated polypeptides. Tyrosine phosphorylation of
RTKs acts as a switch to induce the binding of SH2 domains (Koch et al., 1991). However, Eps8

binds directly to the EGFR at a region just underneath the cell membrane by a unknown
mechanism that requires neither the presence of phosphotyrosine residues nor the SH2 domain

(Castagnino et al., 1995). Thus, the physical association between EGFR and Eps8 represents a
novel interaction between RTKs and their substrates.
The amino acid sequence of Eps8 contains a putative nuclear targeting site ArginineLysine-Lysine-Serine-Lysine-Lysine (RKKSKK). Overexpression of Eps8 in both fibroblasts

and hematopoietic cells results in an increased mitogenic response to EGF, but downstream

events of this signaling pathway are not known. Antibodies specific to the Eps8 gene product

recognize a major protein of 97 kD and a minor 68 kD component, which is believed to be the
product of alternative mRNA splicing.
The most striking feature of the Eps8 gene product is the presence of a SH3 domain

31

homologous to the SH3 domains present in several known substrates for RTKs and other
proteins. A structure study using X-ray crystallography revealed that Eps8 exists as a homodimer

by the binding of its SH3 domains. Such a dimer structure in SH3 domain-containing proteins is
novel. In addition, co-immunoprecipitation experiments showed that intact Eps8 is multimeric in

vivo (Kishan et al., 1997). The functions of SH3 domains are not well understood. Such

sequences are present in several proteins bearing an SH2 domain (Koch et al., 1991), but are also
observed in a number of other proteins, such as cytoskeletal proteins (Drubin et al., 1990). In

addition, mutations in the SH3 domain of v-src attenuate its ability to depolymerize actin
filaments (Hoch et al., 1991). Thus, this domain may direct protein-protein interactions in the
cytoskeleton (Dearborn et al., 1999). SH3-containing proteins are involved in signal transduction

by a number of growth factor receptors and in the organization of the cytoskeleton (Gallo et al.,

1997).
To investigate the potential functions of Eps8, the subcellular localization of Eps8 was

first investigated by immunocytochemistry in Swiss 3T3 fibroblasts, since growth factors
markedly alter the architecture of the actin cytoskeleton in these cells. In proliferating
fibroblasts, Eps8 showed a prominent perinuclear punctate cloud of staining. A conspicuous
staining for Eps8 was also found at the cell periphery, particularly at membrane ruffles and at

cell-cell junctions. In these specialized subcellular regions Eps8 showed a good co-localization
with cortactin, which is an actin-binding protein known to associate with cortical F-actin and to

concentrate at ruffles. An accumulation of Eps8 to membrane ruffles is observed in cells treated
with phorbol esters, which also induce marked changes of the F-actin cytoskeleton. The

localization of Eps8 at the cell cortex is largely independent from the binding of Eps8 to an
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EGFR/ErbB-2 chimeric receptor. In the cells transformed by the oncogenic tyrosine kinase v-Src,

Eps8 associates with newly formed F-actin and is recruited to newly formed specialized regions
of the cytoskeleton, indicating that the subcellular distribution of Eps8 is dependent on the

structural rearrangement of the cytoskeleton induced by v-Src. Extraction with Triton X-100

leaves the majority of the v-Src tyrosine-phosphorylated Eps8 in the detergent-resistant fraction.

The observed recruitment of Eps8 to highly dynamic cytoskeletal structures of normal and
transformed cells suggests that Eps8 may play a role in the reorganization of the cytoskeleton,
perhaps acting as a docking site for other signaling molecules (Provenzano et al., 1998).
Eps8 is expressed at low levels in resting fibroblasts, but its expression is strongly

induced during activation by serum, phorbol esters and the v-src oncogene. Conversely,

expression of Eps8, but not of other EGFR substrates such as She or Epsl5, is virtually

extinguished in non-proliferating, terminally differentiated murine myogenic cells. In murine
fibroblasts and in quail myogenic cells expressing a temperature-sensitive variant of the tyrosine

kinase v-Src, tyrosine phosphorylation of Eps8 was detected only at the permissive temperature.

These findings indicate that Eps8 may be a critical substrate of v-Src (Gallo et al., 1997). It has
been reported that the tyrosine kinase Src specifically binds to AChRs purified from C2 muscle
cells and tyrosine-phosphorylates p subunits of AChRs. In transfected C2 cells, Src also binds

and phosphorylates glutathione S-transferase fusion proteins containing the N-terminal half of
the cytoplasmic loop of the AChR P subunit. This suggests that Src may play a role in
construction of the specialized postsynaptic membrane during synaptogenesis (Fuhrer and Hall,
1996). Whether Eps8 is involved in this process is not known. Further studies establish Eps8 as
an example of a signal transducer whose expression senses the balance between growth and

33

differentiation and might, therefore, be involved in the determination of the growth and
differentiation of the cells (Gallo ct al., 1997).

A full-length cDNA clone of 3.2 kb was identified from a human fibroblast M426
expression library screened with the SH3 domain of Eps8. This clone was designated e3Bl for
Eps8 SH3 domain binding protein 1. Northern analysis revealed that expression of e3Bl mRNA

was ubiquitous in human tissues. The e3Bl gene encodes an SH3 domain containing protein.
E3B1 binds to the SH3 domain of Eps8 and Abl in vitro, and associates with Eps8 in vivo.
Overexpressing e3Bl in EGFR-transfected NIH/EGFR fibroblasts inhibited the growth of the

cells (Biesova et al., 1997).
Activation of EGFR can lead to tyrosine phosphorylation of phospholipase C-y, but the
stoichiometry of tyrosine phosphorylation (< 1% of the total pools) of PLC-y by EGFR is low.

The interaction between Eps8 and the EGFR was estimated to be 10-20-fold weaker than that of
the SH2 domains of PLC-y with the same receptor. Several other RTKs are also able to
phosphorylate Eps8, such as PDGF (platelet-derived growth factor-BB), aFGF (acidic fibroblast
growth factor), IL-3 (interleukin-3), and CSF-1 (colony stimulating factor-1). As described
above, the non-receptor tyrosine kinase v-Src can phosphorylate Eps8, too. In NIH-3T3 cells

transfected with an EGFR/erbB-2 chimera, in which the erbB-2 receptor kinase is inducible by
EGF stimulation, activation of erbB-2 resulted in greatly increased tyrosine-phosphorylation of

Eps8, compared with untreated controls. In summary, it is now believed that Eps8 gene products
are good substrates for a wide spectrum of RTKs instead of just a substrate of EGFR.
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Desmin
In the cytosol of the animal cells, arrays of protein filaments form cytoskeleton networks

that give the cell its shape and provide a basis of its coordinated and directed movements. It also
provides the machinery for intracellular movements, such as the transport of organelles from one
place to another in the cytoplasm and the segregation of chromosomes at mitosis. Three main

kinds of cytoskeletal filaments are 1) microtubules, 2) actin filaments, and 3) intermediate
filaments. Each type of filament is formed from a different protein subunit: actin for actin
filaments, tubulin for microtubules, and a family of related fibrous proteins (keratin, vimentin,
vimentin-related proteins, neurofilament proteins) for intermediate filaments. Each of the three

principal types of protein filaments that make up the cytoskeleton has a different arrangement in

the cell and a distinct function (Mitchison et al., 1994).

Intermediate filaments are tough and durable protein fibers found in the cytoplasm of
most animal cells. They are called “intermediate” because their diameter is between that of the

thin actin filaments and the thick myosin filaments of muscle cells; they are also intermediate in
diameter between actin filaments and microtubules. In most animal cells an extensive network of

intermediate filaments surrounds the nucleus and extends out to the cell periphery, where it

interacts with the plasma membrane.
The cytoplasmic intermediate filaments in vertebrate cells can be grouped into three

classes: (1) keratin filaments, (2) neurofilaments, and (3) vimentin and vimentin-related
filaments, each formed by polymerization of their corresponding subunit proteins. Keratins

primarily are the intermediate filament proteins in epithelial cells and epithelia-derived organs
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such as liver and kidney. Neurofilament protein forms neurofilaments in neuron cells. Many nonepithelial cells contain their own distinctive cytoplasmic intermediate filaments which belong to

the vimentin and vimentin-rclated family. In muscle cells, the intermediate filament protein is
desmin. Desmin is distributed throughout the cytoplasm of smooth muscle cells. In skeletal and

heart muscle cells, desmin links together adjacent myofibrils (Albers and Fuchs, 1992).
In the traditional view, the role of intermediate filaments would be to contribute to spatial

organization and structural stability of the cell. However, desmin has been identified by

immunochemical methods from preparations of acetylcholine receptor-rich postsynaptic

membranes from the electric tissue of electric rays, suggesting that desmin may play a role in the
neuromuscular junction formation. This result was supported by immunohistochemistry of both

electric tissue of electric rays and rat skeletal muscle. Images of immunoelectron microscopy

showed that desmin is found near the AChR-rich crests of the junctional folds and is particularly

concentrated among and around the ends of the folds. These results suggest that desmin

intermediate filaments may have an important role in organization of the postsynaptic cytoplasm
in rat muscle (Sealock et al., 1989). Desmin is highly concentrated at the neuromuscular
junction of human skeletal muscle (Askanas et al., 1990). Abnormal levels of desmin in muscle
cells have been related to the pathogenesis of some developmental myopathies (Samat, 1992). A
desmin gene mutation has been identified from a human patient with severe generalized

myopathy. Skeletal, cardiac, and smooth muscle biopsies showed abnormal aggregation of
desmin in the patient’s muscle cells. A homozygous deletion of 21 bp within exon I of the
desmin gene at nucleotides 679-699 was identified. This mutation resulted in a seven amino acid

deletion within the coiled-coil segment of the desmin protein. Further study demonstrated that
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recombinant desmin harboring this deletion can’t form proper desmin intermediate filament

networks in cultured cells, nor is it able to assemble into 10-nm filaments in vitro. These
findings provide direct evidence that a mutation in desmin can cause human myopathies (MunozMarmol et al., 1998).

Yeast Two-Hybrid System
To understand the function of a particular protein, it is useful to identify other proteins

that associate with it. One approach to do this is the yeast two-hybrid system. This technique was

developed by Fields and colleagues to detect protein-protein interactions in vivo using a yeast
based genetic assay (Fields and Song, 1989). The design of the yeast two-hybrid system is based
on the fact that many eukaryotic transcriptional activation factors consist of two physically

separable domains, a DNA binding domain and a transcription activation domain (Keegan et al.,

1986). In the original yeast two-hybrid system from Clontech (Palo Alto, CA), DNA fragments
encoding the two functional domains of the GAL4 transcriptional activator have been cloned into

two different expression vectors, pGBT9 and pGAD424. In cells cotransfected with only these
two plasmids, the expressed GAL4 DNA binding domain and activation domain do not interact
with each other. The two vectors have multiple cloning sites which allow genes of interest to be

subcloned into the vectors in the reading frame of the GAL4 domain genes. The pGBT9 is used

to generate a fusion of the GAL4 DNA-binding domain with a target protein (X). The pGAD 424
vector is used to generate a fusion of the GAU activation domain with a potentially interacting

protein (Y) or with a collection of random proteins in a fusion library. The plasmids encoding the
two hybrid proteins are co-transformed into a HF7c yeast host strain. The HF7c yeast are
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auxotrophic for tryptophan and leucine and have two reporter genes under the control of GAL4

responsive promotor; one is the IcicZ gene and the other one is HIS3 gene. The co-transformants
can be selected on the appropriate synthetic minimal medium. When the bait protein X fused
with GAL4 DNA binding domain interacts with protein Y fused with activation domain in co-

transfomed cells, the DNA-binding domain and transcriptional activation domain of GAL4 are

brought together by the interacting proteins. This reconstitutes a functional GAL4 transcriptional
activation factor, which turns on transcription of the lacZ reporter gene encoding for the enzyme

P-galactosidase (Fig 2). The positive colonies are identified by assaying p-galactosidase activity

of the cells, which turn blue on X-gal plates to indicate interaction between the two proteins (Fig.
3). The plasmid DNA can be isolated from these positive clones and analyzed by DNA

sequencing. Since this powerful research tool was created, many protein-protein interactions in

cells have been successfully identified, such as tumor suppressor p53 with SV40 antigen, vitamin
D receptor with transcription factor IIB, and Protein Al, one of the heterogeneous nuclear

ribonucleoproteins (hnRNPs), with other RNA splicing factors (Li et al., 1993; MacDonald et al.,

1995; Cartegni et al., 1996).
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C. Interaction between the X and Y portions of the two hybrid proteins in vivo
reconstitutes GAL4 function and results in expression of the reporter gene.

Fig. 2. Schematic diagram demonstrating the basis of the two-hybrid system.
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Research Goal
As described above, laminin p2 is a unique laminin chain which is concentrated in a

subset of BL including that of the neuromuscular junction in skeletal muscle and the glomeruli in
the kidney. Previous studies indicate that laminin 02 is involved in the synaptogenesis of the

neuromuscular junction, the myogenesis of the skeletal muscle, and in the formation of the
glomerular filtration barrier. However, the mechanism by which laminin 02 functions in the cells
generally is not known. As far as we know, most of the physiological functions of the cells are
accomplished by protein-protein interactions either in the cytoplasm, in the nucleus, or in the

ECM. In order to understand the function of this protein molecule in muscle cells, this study

takes novel approaches to search for other proteins which normally interact with laminin 02 in
muscle cells. The first approach was to screen a mouse kidney cDNA library with the
recombinant domain I of laminin 02 using the yeast two-hybrid system. Then the proteins

interacting with laminin 02 in the two-hybrid assays were verified by immunoprecipitation and
other experiments. A functional study of these protein-protein interactions was also initiated. The

information gathered from looking at this protein-protein interaction in muscle cells should
contribute to the knowledge of the function of laminin 02 in synaptogenesis of the

neuromuscular junction and myogenesis of skeletal muscle. Understanding these protein-protein

interactions will further provide useful information for research in treating laminin 02-related
neuromuscular disorders.
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Materials and Methods

Plasmid Constructs

1. Construction of domain I of laminin 02 in pGBT9
In order to find proteins encoded by the mouse kidney cDNA library which interact with
laminin 02, a fusion of the DNA sequences encoding domain I of rat laminin 02 and the GAL4
DNA-binding domain was constructed in the expression vector pGBT9. The full length cDNA

encoding rat laminin 02 has been cloned and sequenced (Hunter et al., 1989). A fragment
corresponding to the domain I of rat laminin 02 and containing an EcoR I restriction site upstream

and a Sal I restriction site downstream was generated by PCR (polymerase chain reaction). The
nucleotide sequence of the upper primer used in this PCR was 5'-gaattctgcagtggagcagcagccaca-3'

and the lower primer was 5’-gtcgacagccaagagctctttaatgtc-3'. (The bold letters in the primer

sequences represent the EcoR I (upper) and Sal I (lower) restriction sites introduced into the
amplified DNA fragment). The PCR reaction was 20 cycles of 94°C for 1 minute, 61 °C for 1
minute, and 72°C for 2 minutes. This 1,149 base pair fragment corresponds to nucleotides 4401-

5550 of laminin 02. The PCR fragment was gel purified and cloned into the pGEM-T vector
(Promega; Madison, WI). The DNAs were cut out of the vector with EcoR I and Sal I and ligated

into EcoR I-Sal I digested pGBT9 expression vector. This construct was named S/pGBT9 (Fig. 4).
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Fig. 4. The recombinant plasmid constructs used in the Two-Hybrid Assay.
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2. Antisense laminin P2 construct in pcDNA3
To study the function of a protein of interest, antisense RNA has been used. The antisense
RNA is complementary to the endogenous sense mRNA. The binding of antisense RNA to its
complementary mRNA in the cells should block the translation of the sense RNA and cause its
rapid degradation, which reduces the production of the protein of interest (Eguchi et al., 1991).

The full length rat laminin p2 cDNA was cut out of the original construct p7-4/Bluescript with the
restriction enzyme EcoR I. It was ligated into the EcoR I site of the expression vector pcDNA3,
which was linearized with EcoR I and treated with calf intestinal alkaline phosphatase to remove

the phosphate groups on the 5’ ends. Both ends of the insert DNA of the antisense construct were

sequenced bidirectionally to confirm that the DNA was in the antisense orientation. This construct

was called antisense-S/pcDNA3 (Fig. 5).

3. Construction of Eps8-EGFP/pcDNA3
pCRIH-Eps8myc, the full length mouse Eps8 cDNA cloned into the BamH I-Xho I sites of
the pCRIH expression vector (Invitrogen; San Diego, CA), was a gift from Dr. Pier Paolo Di Fiore,

International Institute of Genetics and Biophysics, CNR, Naples, Italy.

The Eps8-EGFP construct was made as follows.
1) A N-terminal fragment of Eps8 cDNA was cut out of the pCRIIl-Eps8myc plasmid with

restriction enzyme BamH I and Pst I and ligated into BamH I-Pst I sites of the SK+ vector. This
fragment included the nucleotides 1-2446 of Eps8 cDNA, and the construct was designated
Eps8/SK+.
2) A 270 base pair fragment corresponding to the C terminal portion of Eps8 cDNA
(nucleotides 2436-2708) was amplified by PCR using the upper primer
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degradation. This results in reduced laminin B2 protein levels in transfected RMo
muscle cells.

Fig. 5. Antisense laminin B2 construct in transfected RMo cells
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5'(acttggctgcagtcaaagggat)3' and the lower primer 5’(atatatggtaccccgtggctgctcccttca)3’. The bold
letters in the sequences of the primers indicate the Pst I (upper) and Kpn I (lower) restriction sites
introduced into the PCR product. The upper primer was positioned at the nucleotide 2436 of Eps8
cDNA sequence and the lower primer bound to the nucleotide 2708, next to the stop codon. Each

reaction cycle consisted of 94°C for 1 minute, 57°C for 1 minute, and 72°C for 2 minutes. PCR was
conducted for 25 cycles. In this PCR product, the stop codon (TGA) of the Eps8 cDNA was
deleted and a Kpn I restriction site was added to the 3' end.

3) The PCR fragment was ligated into Pst I-Kpn I sites of Eps8/SK+. This construct was
called Eps8 minus stop codon/SK+.

4) The Eps8 cDNA without the stop codon was cut with the restriction enzymes Bam HI

and Kpn I, then subcloned into the Bam HI-Kpn I sites of the pEGFP vector (Clontech; Palo Alto,
CA). This construct is Eps8-minus stop codon/pEGFP.

5) The Eps8-EGFP fusion cDNA was removed from the recombinant pEGFP plasmid with

the restriction enzymes Bam HI and Not I, then subcloned into the Bam HI-Not I sites of the
expression vector pcDNAI/Amp and pcDNA3 (Invitrogen; San Diego, CA) (Fig. 6).

4. Construction of desmin cDNA in pcDNAI/Amp
The construct MD102/KSII, carrying the full length mouse desmin cDNA, was a gift from
Dr. Yassemi Capetanaki (Baylor College of Medicine, Houston, TX). The size of the cDNA was
1490 nucleotides and it was cloned into the EcoR I site of the vector. The full length desmin

cDNA was cut with the restriction enzymes Bam HI and Xba I and subcloned into the Bam HI-

Xba I sites of the expression vector pcDNAI/Amp. This construct was named

MD102/pcDNAI/Amp (Fig. 7).
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All of the above subclonings were performed using standard molecular biology techniques.
The template cDNA was either digested with the proper restriction endonuclease enzymes, if
compatible restriction sites were available, or otherwise modified and amplified by PCR using the
designated primers. Gel-purified cDNA fragments were ligated into the plasmid vectors. The

recombinant plasmids were amplified in competent bacteria. To transform competent bacteria, the
entire ligation reaction (approximately 200 ng of DNA) was mixed with 200 pl of competent XL-1

Blue bacteria (Stratagene; La Jolla, CA) in microcentrifuge tubes and incubated on ice for 30
minutes. Then 800 pl of LB medium (10 g /L Bacto® peptone, 5 g/L yeast extract, 85.5 mM NaCl,

pH 7.4) were added to each of the tubes, and the tubes were incubated at 37°C with vigorous
shaking (200 rpm) for one hour. After the incubation, 250 pl of each transformation reaction was

spread onto a LB agar plate containing 50 pg/ml of ampicillin (LB-amp plate). Since all of the
plasmids used contained an ampicillin resistance selection marker, only those competent bacteria
carrying the plasmids survived and formed colonies on the selective plates after overnight

incubation at 37°C. Usually 4 to 8 well-isolated colonies were each inoculated into 4 ml of LBamp broth in 15 ml tubes and incubated at 37°C overnight with shaking. On the next morning, the

plasmid DNA was purified using the Wizard® miniprep columns (Promega; Madison, WI)
following the manufacturer’s instructions. These plasmids were used either for identification of
true positive clones by conducting diagnostic restriction digestions to check for the existence of

the DNA inserts and their orientation, or for DNA sequencing. To prepare enough DNA (on a
larger scale) for further experiments, a single colony from the plate was grown up in 25-50 ml LB-

amp medium. The plasmids were isolated from the cell culture using the QIAGEN midiprep kit
(Chatsworth, CA), following the manufacturer’s instructions.
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DNA Sequencing
All of the constructs in expression vectors described above and the plasmids of the positive

clones in the yeast two-hybrid assays were subjected to DNA sequence analysis to confirm that the
insert DNAs were ligated in the correct reading frame. Nucleotide sequences were determined by
the dideoxy chain termination method (Sanger et al., 1977) using the Sequenase 2.0 sequencing kit

(Amersham; Arlington Hts, IL) following manufacturer’s instructions.

Yeast Two-hybrid Assays
The materials for the yeast two-hybrid assay, including the expression vector pGBT9, a

mouse kidney cDNA library in the pGADlO vector, HF7c and SFY526 yeast host strains, positive

control plasmids, and DNA sequencing primers were purchased from Clontech Laboratories, Inc.
(Palo Alto, CA). The mouse kidney cDNA library was screened with recombinant rat laminin p2
domain I using yeast two-hybrid assays following the manufacturer’s instructions.

1. Preparation of mouse kidney library DNA
The mouse kidney cDNA library (4.9 X 108 cfu/ml) in the pGADlO expression vector was

amplified to generate enough of each cDNA for the yeast transformations. To have a representative

sample of each cDNA, 4 X 106 colonies were screened. The bacteria were plated at 2 X 104

colonies on each of one hundred ninety one 15 cm LB-amp plates. The cells were scraped from the

plates into 2 L of LB-amp medium, and the plasmid DNA was isolated using a GIGA-prep column
(QIAGEN; Chatsworth, CA), following manufacturer’s instructions.

50

I
2. Transformation of yeast
Two HF7c colonies of 2-3 mm in diameter were inoculated into 100 ml YPD medium (20
g/L Difco peptone, 10 g/L yeast extract, 2% dextrose). The yeast culture was incubated at 30°C

overnight (16-18 hours) with vigorous shaking (200 rpm) to reach stationary phase. Sixty-five ml
of the yeast culture were transferred to one liter of fresh YPD medium and split into two one-liter
flasks. The culture was incubated at 30°C for 3 hours with shaking to produce an OD,'soo of 0.2-0.3.

This culture was centrifuged at 1,120 X g for 5 minutes at room temperature to remove the
medium. The pellet was resuspended in 500 ml sterile H2O and centrifuged again at 1,120 Xg for
5 minutes at room temperature. After removal of the supernatant, the yeast cells were resuspended
in 45 ml sterile H2O and pelleted at 1,120 X g for 5 minutes. The supernatant was discarded and

the pellet was resuspended in 8 ml 1 X TE/LiAc (0.01 M Tris-HCl, 1.0 mM EDTA, pH 7.5, 0.1 M
lithium acetate). These were the competent cells.

To cotransform these HF7c competent cells, 800 pg of S/pGBT9, 500 pg ofpGADlO

(mouse kidney cDNA library) and 20 mg of herring testis carrier DNA (Clontech; Palo Alto, CA)
were mixed in a microcentrifuge tube. The mixture of DNA was added to the competent yeast and

mixed well by vortexing. Next, 60 ml of PEG/LiAc (40% polyethylene glycol [M. W. 3,350] in 1
X TE/LiAc) were added to the competent cells and mixed by vortexing. The transformation

reaction was incubated at 30°C for 30 minutes with shaking at 200 rpm. After the incubation, 7.0
ml DMSO (final concentration 10%) were added and mixed with the yeast suspension. The cells
were incubated at 42°C for 15 minutes and then briefly chilled in ice for 10 seconds. The

transformed cells were pelleted at 1,120 X g for 5 minutes to remove the supernatant. The cells

were resuspended in 10 ml 1 X TE (0.1 M Tris, 10 mM EDTA, pH 7.5). Two hundred pl of the
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transformed yeast suspension were plated onto each of fifty 150 mm and sixteen 100 mm culture
plates containing synthetic dextrose (SD) medium [6.7 g/L Difco yeast nitrogen base without

amino acids, 2% dextrose, 30mg/L L-isoleucine, 150 mg/L L-valine, 20 mg/L adenine hemisulfate
salt, 20 mg/L L-arginine HC1, 30 mg/L L-lysine HC1, 20 mg/L L-methionine, 50 mg/L L-

phenylalanine, 200 mg/L L-threonine, 30 mg/L L-tyrosine, 20 mg/L L-uracil] lacking leucine,

tryptophan, and histidine (Leu-, Trp-, His-). The plates were incubated at 30°C for 8-10 days to
select cotransfonnants.

3. Colony lift filter assays
Colony lift filter assays for p-galactosidase expression were performed using Z buffer/X-

gal solution (16.1 g Na2HPO4-7H2O/L, 5.5 g NaH2PO4-H2O/L, 0.75 g KC1/L, 0.246 g MgSO4-7H2O

/L, pH 7.0, 2.7pl/ ml p-mercaptoethanol, 100 pg/ml X-gal [5-bromo-4chloro-3-indolyl-P-Dgalactopyranoside] in N, N-dimethylformamide). A volume of 1.75 ml of Z buffer/X-gal solution

was added to a 100 mm plate and a 75 mm sterile VWR 410 filter was presoaked in this solution.
For a 150 mm plate, 1.75 ml of Z buffer/X-gal solution and a 125 mm filter were used. One filter

was prepared for each plate of transformants to be assayed. A sterile VWR filter was placed over
the surface of the agar plate containing the transformant colonies. Each of the filters was marked

by poking holes into the agar in three asymmetric locations to orient the filter on the agar. The
filters were carefully lifted off the agar plate with forceps and transferred, colonies facing up, to a

pool of liquid nitrogen. The filters were completely submerged into liquid nitrogen. After they

were frozen completely (~10 sec), the filters were removed from the liquid nitrogen and allowed

to thaw at room temperature. This freeze/thaw treatment permeabilized the cells. Then each of the
filters was placed colony side up on the filter presoaked in Z buffer/X-gal solution. The filters
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were incubated at 30°C and checked periodically for the appearance of blue colonies. The blue

colonies were taken off from both the filters and corresponding plates, restreaked onto new
selective SD plates and retested two times with colony lift filter assays. Twenty three colonies
were positive for LacZ induction after the lift assays.

4. Elimination of false positives
To eliminate mouse library cDNAs that encode transcriptional activators and thus do not
require P2 for lacZ function, Trp auxotrophs were generated. The positive colonies from the initial
SD-Trp/Leu plates were cultured in 5 ml of SD-Leu medium overnight. The AD/library plasmid,
which contains the LEU2 gene, is maintained, but the BD/p2 plasmid is lost from about 10-20% of

the yeast. The culture was diluted either 1:10 or 1: 100 (to get from 10-50 colonies) and plated on

SD-Leu medium. The plates were incubated at 30°C until colonies appeared. Twenty-three
colonies were transferred using sterile toothpicks in a grid pattern to both a SD-Leu/-Trp and a

SD-Leu plate. Those colonies that grew on the SD-Leu but not the -Leu/-Trp plate are Trp
auxotrophs. These colonies were tested in the lift assay. Those that were negative are not

transcriptional activators and were kept; those that were positive likely contained a transcription
activator and were discarded. By this method, eight false positive colonies were discarded.

5. Preparation of yeast miniprep DNA
The plasmid DNAs from verified positive clones of the yeast cells were isolated based on
the method of Hoffman and Winston (1987) and Kaiser and Auser (1993). Single yeast

transformant colonies were inoculated each into 3 ml of YPD liquid medium in 15 ml conical
tubes and incubated at 30°C overnight. The yeast culture was centrifuged at 1120 X g for 5

minutes to remove the supernatant. Pellets were resuspended in residual liquid by vortexing and
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transferee! to microcentrifuge tubes. 0.2 ml of yeast lysis solution (2% Triton X-100, 1% SDS, 0.1
M NaCl, 1 mM EDTA, 10 mM Tris pH 8.0), 0.2 ml phenol:chloroform:isoamyl alcohol (25:24:1)

and 0.3 g of acid-washed glass beads (425-600 pm in diameter, Sigma, St. Louis, MO) were
sequentially added to each of the samples. The samples were vortexed for 2 minutes, and spun at

12,000 rpm for 5 minutes at room temperature. The supernatant was transferred to a new
microcentrifuge tube and the DNA was ethanol-precipitated by adding 1/10 volume of 3 M
NaOAc (pH 5.2) and 2.5 volumes of ethanol. The tube was incubated for 30 minutes at -20°C and

spun at 12,000 X g to remove the supernatant. The DNA pellet was washed with 70% ethanol, air

dried in a speed vacuum dryer, and resuspended in 20 pl of TE buffer. The plasmid DNA isolated

in this way was not suitable for restriction analysis or sequencing because of contamination by
yeast genomic DNA. Therefore, 3 pl of the plasmid DNA from the yeast minipreps was
transformed into competent XL-1 blue bacteria. The plasmid DNAs were re-isolated from the
transfected bacteria using a standard mini-prep procedure.

6. Identification of candidate proteins interacting with domain I of laminin [32
The plasmid DNAs purified from the positive clones identified from the yeast two-hybrid
assay were partially and bidirectionally sequenced using GAL4 activation domain (AD) junction

primers. The AD upper primer was 5’(ctattcgatgatgaagataccccacca)3' and the AD lower primer

was 5'(gtgaacttgcggggtttttcagtatct)3 ’. The DNA sequencing information was sent to the GenBank
for a database search using BLAST Sequencing Similarity.

Transfection of Skeletal Muscle Cells
Mouse C2C12 (also called C2) skeletal muscle cells (ATCC; Rockville, MD) were
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transfected with the full length rat laminin P2 cDNA as previously described (Green et al., 1992).
C2 cells were also transfected either with the full length mouse Eps8 cDNA (in the pCRIII-

Eps8myc construct) or with the Eps8-EGFP fusion cDNA both in the pcDNAI/Amp (for transient

transfection) and pcDNA3 (for stable transfection) expression vectors. RMo (Merrill, 1989) rat
skeletal muscle cells were transfected with full length mouse desmin in the MD102/pcDNAI/Amp

construct. Antisense laminin P2 RMo cells were made by transfecting cells with the construct

antisense-S/pcDNA3 so that the antisense RNA of the laminin P2 would be transcribed.
For both stable and transient transfections, LipofectAMINE (Life Technologies;
Gaithersburg, MD) was used following the manufacturer’s directions. Generally, 3-5 X 105 cells

were plated into 35 mm culture dishes (for stable) or 60 mm dishes (for transient) one day prior to

transfection. Plasmid DNAs used in the transfections were purified with the QIAGEN Plasmid

MidiPrep kits (Chatsworth, CA), following manufacturer’s instructions. Each transfection was set
up in two 7.5 ml sterile tubes. One hundred pl of pre-warmed Opti-MEM® medium (Life
Technologies) was added to each of the tubes. Three pg of plasmid DNA were added to one of the

tubes and 12-15 pl of LipofectAMINE reagent were added to the second tube. Then the contents
of the two tubes were mixed by transferring the solution from one tube into the other one and

gently tapping the side of the tube. This mixture was then allowed to incubate for 45 minutes at
room temperature. If the construct plasmids did not contain a neomycin resistance gene, the SV2-

Neo plasmid, which conferred neomycin resistance, was added to the transfection reaction in a 1:5
molar ratio to the applied DNA. The conditioned medium was removed from the culture dish, and
the cells were washed once with 0.5 ml Opti-MEM® medium. At the end of the incubation, 0.8 ml

of pre-warmed Opti-MEM® was pipetted into the tube containing the transfection reaction
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mixture, and the entire contents were transferred to the culture dish. The cells were incubated in
the transfection medium in a 37°C incubator overnight, then the medium was replaced with growth
medium. For transient transfections, cells usually were lysed for immunoblot analysis or observed

using a fluorescence microscope 48 hours after switching back to growth medium. For stable

transfections, 500 pg/ml G418 was added to the transfected cells 48 hours after switching back to

growth medium, and the cells were incubated for two or three more days. The cells were then
transferred to a 150 mm culture plate using trypsin-EDTA solution and cultured in growth medium
supplemented with 500 pg/ml G418 to select neo gene-expressing clones. The medium was

changed once a week for the next two to three weeks. When the clones contained enough cells

(approximately several hundred cells), they were isolated. To pick up single clones from the

culture plate, small pieces of sterile filter paper (diameter 5 mm) were soaked in 0.05%
trypsin-0.53 mM EDTA solution (Life Technologies), the medium was removed from the plate,

one piece of the filter paper was carefully put on top of each marked clone, the plate was put back
to 37°C incubator for 5 minutes, and then the filter papers were each transferred to one well of a

24-well culture plate with cell side facing down. One ml of growth medium containing 500 pg/ml
G418 was added to each well. Usually 24-48 candidate clones were isolated. After the cells
attached to the plate and began to proliferate, the filter papers were removed from the cell culture.

It took about two weeks for the cells to grow up. Cells from each well were trypsinized and split to

separate 60 mm culture plates. After reaching confluence, the cells on 60 mm dishes were lysed
with RIPA buffer and analyzed by Western blot to identify positive clones.
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Cell Culture
C2C12 and Sol8 mouse skeletal muscle cells were grown in Dulbecco’s Modified Eagle’s
Medium (DMEM, Life Technologies) supplemented with 10% fetal calf serum. The human
embryonic kidney cell line HEK293 (ATCC) was cultured in DMEM containing 10% heat-

inactivated horse serum. RMo rat skeletal muscle cells were cultured in F10 medium (Life

Technologies) containing 15% fetal calf serum and 1% chick embryonic extract (CEE, Life
Technologies). For transfected cells, 200 pg/ ml G 418 was added to the medium. Hybridoma
cells 42-10-H7-F5 (producing D5), 48-10-D6-B9 (producing D19), 49-5-B8-H10 (producing D27),

42-7-G12-F4 (producing D7) were cultured in RPMI-1640 (Mediatech, Inc.; Herndon, VA)
supplemented with 15% fetal calf serum and 10 mM HEPES (pH 7.2), lOOu/ml penicillin, and 100

pg/ml streptomycin. Cells were cultured at 37°C in 5% CO2 and at 95% humidity. Cells were fed
every two to three days.

Preparation of Cell Lysates
Cell culture medium was removed from the culture plates, and the cells were washed three

times at room temperature with 1 X PBS (8.0 g NaCl/L, 0.2 g KC1/L, 1.44 g Na2HPO4/L, 0.24 g

KH2PO4/L, pH 7.4) . Cells were lysed on ice with RIPA lysis buffer [150 mM NaCl, 1% NP-40,
0.5% DOC (Sodium Desoxycholate), 0.1% SDS (Sodium Dodecyl Sulfate), 50 mM Tris pH 8.0,
10 mM EDTA, pH 8.0] (Harlow and Lane, 1988), containing the protease inhibitors PMSF (100

pg/ml), aprotinin (2 pg/ml), and leupeptin (4 pg/ml), plus 10 pg/ml NaF (phosphatase inhibitor)].

All the protease inhibitors were added to the lysis buffer just before use. During the 30 minute

incubation on ice, the culture plates were swirled occasionally. Lysed cells were removed from the
57

plates using plastic Falcon® cell scrapers (Becton-Dickinson; Lincoln Park, NJ), and the lysate was

transferred to a 1.5 ml centrifuge tube. The cell lysates were passed several times through a 21G

needle. The debris and nuclei contained in each lysate were pelleted by a 10 minute centrifugation
at 8,800 X g at 4°C. The supernatant was either used immediately for immunoprecipitation or
stored at -20°C for subsequent western blots. To prepare intracellular protein for

immunoprecipitation (IP), the rat laminin p2 transfected C2 cells and RMo cells were cultured to

confluency and allowed to differentiate by reducing serum concentration to 2% for two days. The
protein secretion from the cells was blocked with 1 pg/ml tunicamycin (a gift from Dr. R. Davis,

Lilly Research Laboratories) for 24 hours, and the extracellular matrix protein of the cell culture

was removed by adding 1.5 ml 0.05% trypsin-0.53 mM EDTA solution per 10 cm plate and
incubating at 37°C for 10 minutes followed by three washes with 1 X PBS. Then the pelleted cells
were lysed with RIPA lysis buffer as described above.

Antibodies Used in This Study
Monoclonal antibodies (mAbs) D5 (Hunter et al., 1989), DI 9 and D27 (Green et al., 1992),

DI 8 (Sanes et al., 1990a), and C21 (Sanes and Chiu, 1983) have been described previously. D5,
DI9 and D27 specifically recognize rat laminin p2 and do not cross-react with the mouse protein.
D5 only recognizes denatured laminin P2; both DI9 and D27 only recognize the native antigen.

Both mAbs C21 (against laminin pi) and DI8 (against laminin yl) are specific for the native
antigens from rats but not mice. Polyclonal antibody R49 recognizes both rat and mouse native

and denatured laminin P2. All of mAbs mentioned above were used as ascites generated in mice
from the corresponding hybridoma cells except D5, which was used as a cell culture supernatant.
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Anti-Eps8 polyclonal antibody was a gift from Dr. Pier Paolo Di Fiore (International Institute of
Genetics and Biophysics; CNR, Naples, Italy), and a mAb to Eps8 was purchased from

Transduction Laboratories (Lexington, KY). Polyclonal antibody YY13, which recognized the
mouse laminin yl chain, was a gift from Dr. Hynda Kleinman (NIH). Anti-desmin mAb D3,

which was purchased from Developmental Studies Hybridoma Bank (Iowa City, IA), recognizes
desmin from both rats and mice. Polyclonal antibodies to erbB2, erbB3, and c-fos were purchased

from Santa Cruz Biotechnologies (Santa Cruz, CA). The mAb PY20 to phosphotyrosine was from

Transduction Labs (Lexington, KY). A rabbit polyclonal antibody to laminin purified from mouse

EHS sarcoma was purchased from Polysciences, Inc. (Warrington, PA). Anti-actin mAb, mouse
anti-rat Ig kappa light chains (la+lb) clone RT-39 mAb, and FITC- and TRITC-conjugated

secondary antibodies were purchased from Sigma (St. Louis, MO). Rat anti-mouse laminin pi
mAb and an anti-desmin polyclonal antibody were purchased from Chemicon International, Inc.

(Temecula, CA). Horseradish peroxidase (HRP)-linked anti-mouse Ig G and anti-rabbit Ig G were
purchased from Amersham Pharmacia Biotech (Arlington Heights, IL). A polyclonal antibody to

both rat and mouse collagen IV was donated by Dr. George Kamphaus (Harvard University School

of Medicine).

Immunoprecipitation
Immunoprecipitations were carried out essentially as described by Green et al. (1992) with

some modifications. (A schematic mechanism of immunoprecipitation is shown in Fig. 8). Fresh
cell lysates were incubated with normal mouse serum (NMS, 5 pl/ml cell lysate) and 20 pl Protein

A/G-conjugated agarose (Santa Cruz Biotechnologies; Santa Cruz, CA) for one hour at 4°C with
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shaking. They were then centrifuged at 8,800 X g for 10 minutes at 4°C to remove any components
of the cell lysate nonspecifically bound to immunoglobulin (Ig). The pre-cleared supernatant (500
pl, ~1 mg of total protein) was dispensed to a microcentrifuge tube and incubated with the

appropriate primary antibody for two hours with gentle shaking at 4°C. The amount of primary
antibody varied based on its activity. On average, the dilution factor for our monoclonal antibodies

was 1:250 and for our polyclonal antibodies 1:100. Tachisorb-M or Tachisorb-R immunosorbent
precipitation reagent (Calbiochem Co.; San Diego, CA) was used to immunoprecipitate antigen

antibody complexes. Before the end of the primary antibody incubation, 500 pl of Tachisorb-M (if

the primary antibody was mouse Ig G) or Tachisorb-R (if the primary antibody was rabbit Ig G) per
immunoprecipitation reaction was washed twice with R1PA buffer. The cell lysate-primary antibody

reactions were transferred to the washed Tachisorb pellets. The Tachisorb pellets were resuspended
by briefly vortexing or tapping. The cell lysate-primary antibody-Tachisorb mixture was incubated

at 4°C with gentle agitation for one hour. The antigen-primary antibody-Tachisorb complex was

pelleted by centrifugation at 8,800 X g for 10 minutes at 4°C. The supernatant of the reaction was
removed, and the precipitates were washed three times with RIPA buffer. After the final wash, the
wash buffer was removed completely from the immunoprecipitates. Each pellet was resuspended in
80 pl of 1 X protein gel loading buffer (50 mM Tris, pH 6.8, 2% SDS, 0.1% bromophenol blue, and

10% glycerol) and 10 pl of 1.0 M DTT (dithiotheitol) and incubated at room temperature for at least
20 minutes but no more than 2 hours, based on the manufacturer’s (Calbiochem) instructions to

dissociate antigen-antibody complexes. Then the immunoprecipitates were heated at 100°C for 10
minutes and spun at 12,000 X g in a table-top microcentrifuge for 15 minutes. The supernatants

were separated on SDS-PAGE. The proteins in the immune complexes were transferred to a
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nitrocellulose membrane and analyzed by Western blotting and ECL (Enhanced

Chemiluminescence; Amersham, Arlington Heights, IL).

Western Blot Analysis
Western analysis was performed according to the method of Towbin et al. (1979) and
Burnette (1981). Protein concentrations of the cell extracts were determined using the Bradford
reagent (Bio-Rad Laboratories; Richmond, CA). First, 10 pl of 0.1 M NaOH were aliquoted to

microcentrifuge tubes, and 0, 1,2, 5, 8, 10, 15, and 20 pg of bovine Ig G protein (concentration

5pg/pl; Sigma) were added to eight of the tubes to establish a standard curve. 4 pl of each of the
cell lysates was added to the NaOH. All the tubes were allowed to stand at room temperature for 5

min. Then 790 pl of double distilled H2O and 200 pl of Bradford reagent were added to each tube.
The full contents of each tube were transferred to separate disposable spectrophotometric cuvettes.
The OD595 values were measured using a computer-assisted Beckman DU650 spectrophotometer. A
standard curve and the protein concentration of the samples were calculated and displayed with the

pre-loaded software.

Amounts of lysates needed for analysis depended upon the availability of the samples,

abundance of the individual proteins in the lysates, and the quality of antibodies specific for the
proteins. On average, 100-200 pg total protein in each of the samples were loaded on the gel in a

volume of 40-90 pl. To denature the proteins, 20 pl of 5x sample buffer (50% glycerol, 25% 2mercaptoethanol, 0.6 M Tris, 0.0IM SDS, 0.1% bromophenol blue) were added to 80 pl of lysate.

The samples were boiled for 10 minutes and briefly spun down in a bench-top microcentrifuge prior
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to loading.

Protein samples were separated by SDS-containing polyacrylamide gel electrophoresis
(SDS-PAGE). All acrylamide gels were made as described by David (1964), Omstein (1964), and
Laemmli (1970). The ratio of acrylamide to N, N-methylene bis-acrylamide in the SDS-PAGE was

29:1. The acrylamide concentration of resolving gel varied from 6% to 12%, based on the size of

the proteins examined. For all denaturing protein gels, a 5% stacking gel was poured on the top of
the resolving gel. The gel was run overnight (approximately 16 hours) at 60 volts in gel running
buffer (0.192 M glycine, 1% SDS, 25 mM Tris, pH 8.3). The next morning the voltage was raised to

100-140 volts, and the gel was run an additional hour after the bromophenol blue (BPB) tracking

dye ran out of the bottom of the gel.
After the protein lysates were separated by electrophoresis, the stacking gel was removed.

Both the nitrocellulose and the gel were soaked for 30 minutes in gel transfer buffer (12.5 mM Tris
base, 100 mM glycine, 20% methanol). A transfer sandwich of the nitrocellulose membrane and the

polyacrylamide gel between two layers of blotting paper was assembled and placed into the transfer
apparatus Tilled with the gel transfer buffer. The proteins were transferred from the gel to the

membrane for 1.4 hours at 0.4 amperes.
After the transfer, the molecular weight marker lane was cut off from the rest of the

membrane using a clean razor blade. This portion of the membrane was stained for 5 minutes in
0.5% Ponceau Red protein stain solution and destained with distilled H2O. The rest of the
membrane was incubated for 30 minutes in 5% non-fat dry milk dissolved in Tween-Tris-Saline [T-

T-S] (0.05% Tween-20, 150 mM NaCl, 10 mM Tris, 0.2 mM EDTA [pH 8.0]) to block non
specific binding. After the blocking step, the membrane was placed into a Seal-A-Meal plastic bag
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(Rival; Kansas City, MO), and the primary antibodies diluted in 2.5% non-fat dry milk in T-T-S
were added. The optimal dilution of primary antibodies ranged from 1:200 (anti-c-fos) to 1:5,000
(anti-Eps8). Since mAbs D3 and D5 were used as conditioned culture media, the optimal dilution

factors were 1:10 for D3 and 1:2 for D5. The optimal dilution factors of the polyclonal antisera

R49 (anti-laminin p2), YY13 (anti-mouse laminin yl), Polyscience anti-laminin, and anti-collagen
IV were 1:3,000, 1:3,000, 1:1,000, and 1:500 in 5% non-fat dry milk in T-T-S, respectively. The
membrane was incubated with primary antibody solution either for two hours at room temperature

or overnight at 4°C. Then the membrane was removed from the primary antibody solution and
washed three times with T-T-S for 10 minutes each. The blot was then incubated with secondary

antibody solution for two hours at room temperature and washed with T-T-S three times for 20
minutes each. Horseradish peroxidase (HRP) conjugated-secondary antibodies were used in the
Western analysis, which permitted detection of signals using a chemiluminescent substrate for the

HRP enzyme. Both secondary antibodies HRP-anti-Mouse Ig G (for primary antibody made in
mice) and HRP-anti-Rabbit Ig G (for primary antibody made in rabbits) were diluted 1:3,000 in

2.5% non-fat dry milk in T-T-S.
The detection of secondary antibody was utilized the ECL chemiluminescent system

following manufacturer’s instructions. After the final wash, the blot was placed on a piece of plastic

wrap and the protein side of the membrane was fully covered with 1:1 mixture of ECL solutions 1
and 2 for one minute. Then the membrane was wrapped in a piece of plastic wrap or enclosed in a

Seal-A-Meal® bag. The wrapped membrane was placed in a X-ray film cassette with the proteins
facing up. A piece of RX Fuji X-ray film (FUJI Medical System U.S.A. Inc.; Stanford, CT) was

firmly placed on the top of the membrane in the dark room, and the position of the film relative to
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the membrane was marked to help line up molecular weight marker later on. The first film was

exposed for one minute and developed immediately in an X-ray film developer. Based on the

intensity of the signals on the film, further films, if needed, were exposed for longer or shorter time

to get satisfactory results.

Bound antibodies could be stripped off each membrane, and the membrane could be
reprobed several times with different antibodies. To strip off bound primary and secondary

antibodies, the membrane was submerged in stripping buffer (100 mM P-mercaptoethanoI, 2% SDS,

62.5 mM Tris-HCl, pH 6.7) and incubated at 50°C for 30 minutes with occasional agitation. Then

the membrane was washed two times with T-T-S for 10 minutes each. The membrane was reprobed
starting at the blocking step. The membrane was stored wet in a sealed Seal-A-Meal® bag at 4°C

after each immunodetection.

Immunocytochemistry
Immunocytochemistry was based on a slightly modified method described by Osborn and
Weber (1982). To immunostain cultured skeletal muscle cells, 12 mm glass coverslips were treated
with AES (3-aminopropyl-triethoxysiliane; Sigma) following the manufacturer’s instructions. The

coverslips were submerged in 2% AES in acetone for 2 minutes, then transferred to an autoclaved
beaker, rinsed three times with sterile H2O in a tissue culture hood, then put into a 60 mm culture
dish. Wt or laminin p2-transfected C2 muscle cells were placed onto coverslips in the culture dish

and grown until nearly reaching confluence. Then the coverslips containing the cells were
transferred into each well of a 24-weIl culture plate and washed three times with PBS. The cells

were fixed in a solution of 1% paraformaldehyde and 0.3% Triton X-100 in 1 X PBS for 20
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minutes at room temperature, washed again in PBS for 10 minutes, and incubated in 1% bovine
serum albumin (BSA) in PBS (Blocking solution) for 30 minutes at room temperature. Diluted

primary antibodies (1:100 for m Ab D19, polyclonal Abs to Eps8 and myogenin; 1:500 for
polyclonal Ab R49) in blocking solution were incubated with the cells for 1.5 hours at room

temperature on a low speed shaker. Cells were washed three times in PBS containing 0.1% Tween20 for 5 minutes with shaking. Then, either FITC- or TRITC-labeled secondary antibody (diluted 1:

200 in blocking solution) was applied to the cells for one hour at room temperature. From this stage
the cells were covered with a piece of aluminum foil to prevent photobleaching of the fluorochrome
labels. Cells were washed three times in PBS containing 0.1% Tween-20 for 5 minutes each. For

controls, cells were stained with only the fluorochrome-labeled secondary antibody. TRITC-labeled

phalloidin (1 pg/ml) was used to specifically stain the cytoplasmic protein actin. Double
immunostaining was sequentially performed as two independent immunostainings. The stained
coverslips were sealed onto glass microslides with GelMount (Biomeda Corp.; Foster City, CA) cell

side down. The preparations were mounted on a Nikon Diaphot microscope, and confocal
microscopy was performed with a BioRad Model 1024 using a krypton/argon laser. Three
dimension images built from serial Z-plane images were combined and analyzed using Lasersharp

and Confocal Assistant software, also from BioRad.

Functional Study of The NRG-erbB Pathway in Muscle Cells
To observe the effect of EGF (epidermal growth factor) and NRG (neuregulin) on wt and

laminin p2-transfected skeletal muscle cells, equal numbers of cells were dispersed into 60 mm
culture plates and allowed to reach 90% confluence. The conditioned medium was replaced with
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fresh DMEM supplemented with or without 10% fetal calf serum, plus either 50pg/ml human EGF
(GIBCO BRL), 3 nM recombinant NRG, 3 nM NRG plus 15 nM of both erbB2 and erbB3

polyclonal antibodies, or 1 nM insulin (Sigma). Recombinant NRG (yHRG-pl 177-244, Mr
7884) was a gift from Dr. Mark Sliwkowski (Genentech, Inc.; South San Francisco, CA). Cells
were cultured at 37°C for two more days. After 48 hours, the cells were treated again for 30 more

minutes, then lysed with RIPA buffer. Equal amounts of proteins were analyzed by Western blot

for Eps8, laminin p2, erbB2, and erbB3.

Isolation of Nuclei from Muscle Cells
Nuclei from cells were isolated by three different protocols. In the first protocol (Greenberg

and Bender, 1997), the cell culture medium was removed from the plates and the cells were placed
on ice. The culture plates were rinsed three times with ice-cold PBS. Cells were scraped off and
collected in 15 ml centrifuge tubes. The cells were spun down at 500 X g for five minutes at 4°C

and the supernatant was removed. The pellets were gently vortexed for five seconds and
completely resuspended in 5-10 ml cold lysis buffer (10 mM Tris-HCI, pH 7.4, 3 mM CaCl2 2

mM MgCl2, chilled on ice). The preparations were transferred into 50 ml conical tubes. The
volume of the samples was brought to 40 ml with cold lysis buffer. The tubes were inverted

several times to distribute the cells. Cells were spun down at 500 X g at 4°C for 10 minutes. The
supernatant was removed and discarded. The pellet was resuspended in 1 ml cold lysis buffer and

vortexed gently to mix. To each tube, 1 ml NP-40 lysis buffer B (10 mM Tris-HCI, pH7.4, 3 mM
CaCl2, 2 mM MgCl2 1% (v/v) NP-40) was added and the contents were mixed gently by rocking
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the tube. The cells were transferred to a cold Dounce homogenizer and broken with 10 strokes of
the B pestle. Then the homogenate was transferred to a 50 ml conical tube and nuclei were pelleted
at 500 X g for five minutes at 4°C. The supernatant was removed. 0.2 ml RIP A buffer plus 2 pl

PMSF and 1 pl leupeptin were added to each pellet. The isolated nuclei were incubated on ice for
30 minutes and then spun at 8,800 X g in an Eppendorf 5413 centrifuge for 10 minutes at 4°C to
remove the debris. Finally the supernatant was transferred to a new tube and stored at -20°C.

The second protocol isolated nuclei by sucrose density ultracentrifugation. Cells cultured
on 10 cm plates were washed three times with 1 X PBS at room temperature and then frozen on

their individual culture plates at -100°C in a 100% ethanol-dry ice bath. Then the cells were
thawed on ice to detach them from the plates. The cells were harvested in 3 ml of Buffer A (20

mM Tris-HCl, pH 7.5 plus 1 mM MgCl2) and spun down at 600 X g at 4°C for 5 minutes. The cell

pellet was resuspended in 1 ml of Buffer A containing 1.3 M sucrose, 100 pg/ml PMSF, 2 pg/ml
aprotinin, 4 pg/ml leupeptin and 10 pg/ml NaF. The pellet was homogenized on ice with 70 - 80
strokes of a Dounce tissue grinder with Pestle B. One ml of the lysate was mixed with 4.5 ml of

buffer A containing 2.4 M sucrose, resulting in a 2.2 M sucrose solution. This homogenate was
centrifuged at 100,000 X g for 1 hour. Based on previous work (Gruber et al., 1995), the pellet

consists of highly purified nuclei as determined by DNA assays and acridine orange staining. It is

free of lactic acid dehydrogenase (a cytosolic marker) and 5' nucleotidase (a plasma membrane
marker) activities. The nuclear pellet from each culture plate was resuspended in 150 pl of RIPA

buffer with 2 pl PMSF, 1 pl aprotinin and 4 pl NaF. It was incubated on ice for 30 minutes, then
sonicated for 10 seconds in a CP50 High Intensity Ultrasonic Homogenizer (Cole-Parmer

Instrument Co.; Chicago, Illinois). Equal amounts of nuclear proteins were analyzed by Western
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blots.
In the third protocol, the nuclei were isolated with the cationic detergent cetylpyridinium
chloride (CPC) (Li et al., 1997). The conditioned medium was removed from confluent cells, and

the culture plates were rinsed three times with 1 X PBS. The cells were suspended by incubation

for 5 minutes at 37°C in 0.05% trypsin-0.53 mM EDTA solution. After addition of an equal
volume of the corresponding growth medium, the cells were sedimented at 500 X g for 4 minutes
at room temperature. The medium was discarded and the cell pellet was resuspended and washed

twice in 1 X PBS. The washed cells were pelleted at 500 X g for 4 minutes at room temperature
and lysed by incubation in the CPC lysis buffer (0.2% CPC containing 0.25 M sucrose, 1 mM

MgCl2, 10 mM Tris-HCl, pH 7.4) for 10 minutes at room temperature with gentle oscillation of the
mixture. The nuclei were pelleted at 600 X g for 5 minutes at 4°C and washed twice by

suspension in and sedimentation through a wash buffer (0.25 M sucrose, 1 mM MgCl2, pH
7.4), yielding the final nuclear pellet. Microscopic examination of nuclei isolated by this
method (Li et al., 1997) established that cell lysis occurred and that the nuclei appeared to remain

intact. Biochemical analyses of nuclei isolated with the CPC lysis buffer showed them to be
apparently free of cytosolic components. For each nuclear pellet from a 10 cm culture plate, 800 pl

of RIPA lysis buffer plus 8 pl PMSF, 2 pl aprotinin and 8 pl NaF were added. The pellet was
incubated on ice for 30 minutes, then sonicated for 10 seconds and stored at -20°C. Equal amounts

of nuclear proteins were analyzed by Western blots.
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Northern Blot Analysis

1. Isolation of RNA
Total RNAs ofwt C2, laminin p2-trans footed C2, RMo, desmin-transfocted RMo (dRMo), and Eps8-transfoctcd C2 muscle cells were isolated using RNAgents Total RNA Isolation

System (Promega Corporation; Madison, WI), following the manufacturer’s instructions. Phenol :

Chloroform : Isoamyl alcohol provided in the kit was warmed up to room temperature for 15 min
prior to isolation of RNA, ensuring that the phases of the solution were separated. The Denaturing

solution [26 mM sodium citrate (pH 6.8), 0.5% N-lauryl sarcosine, 0.125M P-mercaptoethanol,
4M guanidine thiocyanate] in the kit was pre-chilled on ice. Confluent cells were removed from
the incubator, the conditioned media were discarded, and the cells were washed three times with 1

X PBS. The PBS was completely removed from the plates . To isolate RNA from two 10 cm
culture plates, 4 ml of Denaturing solution was added to one of two culture plates, swirled to cover

the entire plate, then rocked by hand until the cells lysed and came off the plate. Then the lysate

was transferred to the second plate to lyse the cells in the same way. The lysate was collected into
a 10 ml syringe with 21 G needle. An additional 2 ml of Denaturing solution was added to the first
plate and swirled again. The Denaturing solution was transferred to the second plate and swirled

again. The remaining cell lysate was collected into the same syringe. The lysate was pushed
through the 21 G needle once into one dish to shear DNA, and the sample was transferred to a 15

ml Corex tube. 600 pl of 2 M sodium acetate [pH 4.0] was added to the tube and mixed

thoroughly by inverting the tube 4-5 times. Six ml of pre-warmed phenol: chloroform : isoamyl
alcohol was added to each sample. The tubes were carefully mixed by inverting 3-5 times, and
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then shaken vigorously for 10 seconds. The tubes were incubated on ice for 15 min, then
centrifuged at 10,000 X g for 20 min at 4°C. The top aqueous phase (containing RNA) was
carefully transferred to a new Corex tube, avoiding taking the material from the interface which

contains genomic DNA. An equal volume of isopropanol was added to the aqueous phase and
mixed, then the samples were incubated at -20°C for 30 min to precipitate the RNA. The RNA was

pelleted by centrifugation at 10,000 X g for 10 min at 4°C. The supernatant was carefully poured

off. The RNA pellet was resuspended in 2.5 ml of Denaturing solution and pipetted until the RNA

was dissolved. An equal volume of isopropanol was added and the RNA was precipitated again at

-20°C for 30 minutes. The RNA pellet was spun down by centrifugation at 10,000 X g for 10 min
at 4°C. The supernatant was removed from the tube. The RNA pellet was washed by adding 10 ml

of ice-cold 75% ethanol, broken up with a pipet, and centrifuged at 10,000 X g for 10 min at 4°C.

The supernatant was decanted, and the tube was put upside down on a piece of kimwipe for 5
minutes to air-dry the pellet. For each RNA pellet extracted from two 10 cm culture plates, 50 pl
RNA storage solution (1 mM Sodium Citrate [pH 6.4] in RNase free H2O; Ambion, Austin,

Texas) was added. The RNA samples were resuspended by pipetting and heating for 10 min at 55

- 60°C. Another 50 pl of RNA storage solution was added, and the RNA was pipetted repeatedly to
make sure that it was dissolved completely. The samples were stored at -70°C.

2. Determination of RNA yield and quality
RNA yield and quality were determined using a Beckman DU Series 650
spectrophotometer. Two pl of RNA sample and 598 pl double distilled water were mixed (dilution
factor 1:300), and the OD values at wavelength 260 and 280 nm were measured. Generally the

concentrations of RNA samples were between 2-5 pg/pl. The purity of RNA samples was judged
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by the [260/280] ratio, which was usually around 1.8.

3. RNA gel electrophoresis
Before performing denaturing gel electrophoresis, the RNA samples were checked by
native agarose gel electrophoresis to determine if they were degraded. First, the electrophoretic

chambers were soaked in 3% H2O2 for 30 minutes and rinsed with double distilled water three
times. Three pg of each of the RNA samples was briefly mixed with native gel loading buffer (50

mM EDTA [pH 8.0], 50 mM Tris-Cl [pH 8.0], 50% (v/v) glycerol, 0.25% (w/v) bromphenol blue)
on a piece of clean parafilm and separated on a 1% agarose gel in 1 X TBE buffer (0.09 M Tris
Borate, 0.001 M EDTA, pH 7.8), in the presence of 0.5 pg/ml ethidium bromide. The gel was run

at 47 V for 1.5 hours. After electrophoresis, the gel was photographed on a UV illuminator. If the

RNA was not degraded, the 28S and 18S rRNAs were clearly seen as two bands on the gel; the
intensity of the 28S rRNA signals was much stronger than that of the 18S rRNA. Based on this
result, the general integrity of total RNA could be determined. If the purity and integrity of RNA

samples were good, total RNA samples were separated by formaldehyde-denaturing agarose gel
electrophoresis.
Denaturing RNA gel electrophoresis was performed as follows. The gel tank, gel tray and
comb were treated by soaking with 3% H2O2 overnight, then rinsed twice with DEPC-H2O. One

gram of ultra pure DNA grade agarose (Bio-Rad Laboratories) was dissolved in 72 ml DEPCtreated H2O by heating in a microwave, then cooled to 60°C. The flask was placed in a fume hood

and 18 ml of 12.3 M formaldehyde and 10 ml 10 X MOPS running buffer (0.4 M MOPS, 0.1 M
sodium acetate, 0.01 M EDTA in DEPC-treated H2O, pH 7.0; sterilized by filtration through a

0.2-micron Millipore filter and stored at 4°C protected from light) were added. The gel was
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allowed to set at room temperature for one hour. In the meantime, one liter of 1 X MOPS gel

ninning buffer was prepared and kept at 4°C. About 800 ml of 1 X MOPS gel running buffer was

added to cover the gel to a depth of ~1 mm in the electrophoretic apparatus. 30 pg of total RNA

from each sample was dispensed into a microcentrifuge tube, then the volume was brought to 11
pl with DEPC-treated H2O. RNA samples were prepared as follows. To each tube, 39 pl RNA
denaturing buffer (25 pl formamide, 9 pl 12.3 M formaldehyde and 5 pl 10 X MOPS buffer,

prepared just before use), 10 pl formaldehyde gel loading buffer [0.25% (w/v) bromophenol blue,

0.25% (w/v) xylene cyanol, 50% (v/v) glycerol, and 1 mM EDTA, pH 8.0] and 2 pl of 0.5 pg/pl
ethidium bromide were added. The samples were mixed by tapping, briefly spun to collect the
liquid, incubated at 65°C for 15 min, then chilled on ice. The denatured RNA samples were loaded

on the gel, and the gel was run at 90 V for 3 hours. The bromophenol blue dye usually migrated
two-thirds the length of the gel. The running buffer in the two chambers of the electrophoretic

apparatus was mixed every hour to avoid the formation of pH gradients that could cause aberrant
migration. After electrophoresis, the gel was carefully transferred to a RNase-free container and
rinsed twice with DEPC-treated H2O for 20 minutes each. Then the DEPC-treated H2O was

replaced with 20 X SSC (3 M NaCl, 0.3 M sodium citrate, pH 7.0) and the gel was soaked for 40

minutes. The gel was photographed on a transilluminator prior to transfer. To avoid introducing
RNase contamination, the gel was transferred onto a piece of clean Saran wrap on a UVtransilluminator. The RNA was visualized with UV light and photographed. The position of

visualized 28S and 18S rRNA bands were used as molecular weight markers (corresponding to
4718 and 1874 nucleotides, respectively). To allow better transfer, the gel on the UV

transilluminator was exposed to UV light for one minute to nick larger RNAs.
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4. Transfer of separated RNA
The downward capillary transfer method was used (Ingelbrecht et al., 1998). Eight pieces
of Whatman 3 MM filter paper, one piece of Nytran® nylon membrane (Schleicher & Schuell;
Keene, NH), both the same size as the gel, and another piece of Whatman 3 MM paper slightly

wider than the gel and long enough to wick transfer buffer up from transfer buffer tray, were

prepared. The nylon membrane was soaked in 20 X SSC solution for 5 minutes. The stack tray of
the transfer device (Turboblotter™ rapid downward transfer system; Schleicher & Schuell) was
placed on the bench, making sure it was leveled. Paper towels of the same size of the gel were

prepared in a clean area. The blotting stack in the stack tray was set up as follows. From the
bottom to the top of the blotting stack were a one inch stack of paper towels, four sheets of dry 3
MM paper, one sheet of 3 MM paper pre-wetted in transfer buffer, the nylon membrane, the

agarose gel, three sheets of 3 MM paper pre-wetted in transfer buffer, the wick, the plastic wick

cover, and a 100 gram weight. Any trapped air bubbles between or under the gel and the
membrane were rolled out with a disposable pipet. Any extra wick area of the blotting stack was

covered with parafilm to ensure the transfer buffer could only go through the gel. Then the buffer

tray of the transfer device was attached to the stack tray. The buffer tray was filled with 150 ml of
20 X SSC as transfer buffer. The wick was placed across the blotting stack so that it completely

covered the blotting stack. Both ends extended into the buffer tray and were immersed in the
transfer buffer. The transfer went from three hours to overnight. The open area of the transfer
apparatus was covered with a piece of plastic membrane to prevent evaporation. After transfer, the
filter paper and the flattened gel on the top of the stack were removed, and one comer of the

membrane was cut to ensure that the up-down and back-front orientations of the membrane were
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recognizable. The membrane was removed with forceps and briefly rinsed in 2 X SSC buffer to

remove agarose fragments and excess salt. The membrane was placed on a sheet of filter paper and
allowed to dry. The RNA was immobilized RNA-side-up in a Model CL-1000 UVP Ultraviolet
crosslinker (UVP, Inc.; San Gabriel, CA) at the UV wavelength 254 nm and energy level 120,000
microjoules per cm2. The membrane was sealed in a plastic hybridization bag and kept at 4°C.

5. Preparation of probes
Three RNA probes were labeled using the Riboprobe® in vitro Transcription Systems from

Promega Corporation. PCR fragments of mouse EGFR, HER/erbB2, HER/erbB3 and HER/erbB4
subcloned into pSKII+ vector (Moscoso et al., 1995) were generous gifts from Dr. Joshua R. Sanes

(Washington University School of Medicine). DNA inserts in both the HER/erbB2 and
HER/erbB3 constructs are 350 base pairs long and subcloned into the Smal sites of the pSKII-r
vectors. The construct GAP/pSK+ contained a full length rat glyceraldehyde-3-phosphate-

dehydrogenase (GAPDH) cDNA (1233 nucleotide base pairs) cloned into the Pst I restriction site
of the pSK+ vector. DNA templates were prepared for in vitro transcription of [a-32P]-labeled

antisense RNA probes. Two pg each of the HER/erbB2/pSKII, HER/erbB3/pSKII, and GAP/pSK+

plasmid DNAs were digested with the restriction enzymes BamH I, Hind III, and Neo I,
respectively. The linearized DNAs were separated by agarose gel electrophoresis (1% agarose in 1
X TAE buffer [40 mM Tris-acetate, 2 mM Na2EDTA.2H2O, pH 8.3]). The agarose gel was stained

for 20 min in 0.5 pg/ml ethidium bromide. The DNA templates in the agarose gel were visualized

on a UV illuminator and excised out of the gel. Extraction of the DNA from the agarose gel was

performed using the QIAquick Gel Extraction Kit (QIAGEN Inc.), following manufacturer’s
instructions. To purify DNA extracted from the agarose gel, two volumes of
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phenol:chloroform:isoamyl alcohol (25:24:1) were added, and the samples were briefly vortexed
then spun in a bench top centrifuge at 11,000 X g for two minutes. The top aqueous phase of the

extraction was transferred to a new microcentrifuge tube. An equal volume of chloroform was
added, mixed by vortexing, and centrifuged again. The top phase was transferred to a new

centrifuge tube. 1/10 volume of 3.0 M NaoAc [pH 5.2] and two volumes of 100% ethanol were
added to the DNA. The samples were incubated at -20°C for /z hour, then centrifuged at 11,000 X
g for 15 minutes to pellet the DNA. The DNA pellets were washed once with 75% ethanol and

spun again. The DNA pellets were resuspended in 10 pl RNase-free H2O, and the volume was
reduced to 2-4 pl using a speed vacuum dryer. 5'[a- 32P]UTP was purchased from Amersham Life
Science (Arlington Heights, IL). The transcription reactions were prepared at room temperature

and the components were added in the following order to each tube: 4 pl Transcription Optimized
5 X Buffer, 2 pl 100 mM DTT, 0.5 pl Recombinant RNasiri® Ribonuclease inhibitor (20 units), 4

pl of ATP, GTP, and CTP mixture (2.5 mM each), 4.4 pl 100 pM UTP , 1 pl (~lpg) of erbB2 or
crbB3 or GAP DNA template, 3 pl [a-32P]UTP (60 pCi at 20 pCi/pl), and lpl T7 (for erbB2 &
GAP) or T3 (for erbB3) RNA polymerase (20 units) were added. The final volume of the

transcription reaction was 20 pl. The positive control reaction using pGEM® Express Positive
Control Template was done following manufacturer’s instructions. The transcription reactions
were incubated at 37°C for 1.5 hour. The DNA templates were removed from the reactions by a

15 minutes incubation at 37°C with 1 pl RQ1 RNase-Free Dnase per pg of template DNA.
In order to judge the quality of the labeled probes and calculate how much probe should be

used in the hybridization reaction, percent incorporation of [a-32P]UTP and probe specific activity

were determined. To do so, one pl probe solution from each of the three transcription reactions
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was removed and a 1:10 dilution of the labeled probes was prepared in DEPC-H2O. One pl of
these 1:10 dilutions was spotted onto duplicate Whatman® GF/A Filters and allowed to air-dry.

One of these duplicates was put into scintillation vials and counted directly to determine the total

cpm. The duplicate filters were washed twice with 5 ml of ice-cold 5% TCA (trichloroacetic acid
in double distilled H2O), rinsed with 2 ml of acetone to remove free nucleotides, and allowed to

air-dry. These filters were counted in scintillation vials to determine incorporated cpm. The
specific activity of the probe was expressed as the ratio of total incorporated cpm divided by total
micrograms of RNA synthesized based on the following equations.

1) % incorporation = incorporated cpm (TCA washed cpm) + total cpm X 100

2) Total cpm incorporated

incorporated cpm X dilution factor X reaction volume
volume counted

3) In order to calculate the total amount of RNA synthesized, the amount of UTP present in the
reaction, the maximum theoretical yield, and the percent incorporation need to be determined.
a. nmol of labeled UTP

pCi 5'[a- 32P]UTP in reaction
isotope concentration (pCi/nM)

b. nmol of cold UTP = pl of UTP X 100 pM X 103 nM X IL
pM X 10b pl

c. total nmol of UTP

nM of labeled UTP + nM of cold UTP

d. maximum theoretical RNA yield

total nM of UTP X 4 X 330 ng
nmol

e. total pg of RNA synthesized = % incorporation X maximum theoretical yield
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4) specific activity of the RNA probe

total incorporated cpm
total pg of RNA synthesized

Example: In the transcription reaction, the limiting rNTP was UTP; 4.4 pl of lOOpM UTP and 3

800pCi/nM) were used. One pl of a 1:10

pl of [a-32P]UTP (60 pCi at 20 pCi/pl, 800Ci/mM

dilution was used for TCA analysis.
The counts obtained for the erbB2 probe were:
incorporated cpm
total cpm

1). % incorporation

3.78 X 105

6.64 X 105

(3.78 X 105)- (6.64 X 105)

56.93%

2). Total cpm incorporated = 3.78 X 105 cpm X 10 X 20 ph- 1 pl = 7.57 X 107 cpm

3). nmol of labeled UTP = 60 pCi
4). nM of limiting cold UTP

800pCi/nM = 0.075 nM

4.4 pl X 100 pM X 103 nM X IL
1 pMX 106pl
”

5). total nmol of limiting UTP = 0.075nM + 0.44nM

0.44 nM

0.52 nM

6). maximum theoretical RNA yield = 0.52 nM X 4 X 330 ng/nM — 686.4 ng
7). total pg of RNA synthesized = 56.96% X 686.4 ng = 390.97 ng - 0.391 pg
8). The specific activity of the RNA probe

7.57 X 107 cmp
0.391pg

1.93 X 108 cpm/pg

In order to minimize the background in the Northern analysis, unincorporated nucleotides

from the synthesized RNA probes were removed by size exclusion chromatography using G-50
Sephadex® Columns (Boehringer Mannheim Corporation; Indianapolis, IN), following the
manufacturer’s instructions.
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6. Hybridization
The nylon membrane blots were sealed in microwavable plastic bags and the area of the
membranes was measured. 10 ml per 100 cm2 membrane of preheated Formamide
Prehybridization/Hybridization Solution (Ambion Co.) was added to the bags and incubated in

tubes in a hybridization oven. The optimum hybridization temperatures of the three probes,

determined by a series of pilot experiments, were 56°C for erbB2, 60°C for erbB3, and 72°C for
GAP. The membranes were prehybridized at the optimal hybridization temperatures for two hours.
Then the probes were added to each of the bags in the amounts of 1-5 X 106 cpm/ml of
Formamide Prehybridization/Hybridization Solution. Because the volume of probes needed was

very small (~2 pl for each blot), the probe was well mixed in 1 ml of
Prehybridization/Hybridization Solution before transferring to the corresponding hybridization

bags. The membrane blots were incubated with the probes for 24 hours at the appropriate
temperature. At the end of the hybridization, the Formamide Prehybridization/Hybridization

Solution containing the labeled probes were disposed. The membrane was washed twice for 10
minutes with agitation with Low Stringency Wash Solution #1 (2 X SSC; Ambion) in the amount

of 20 ml per 100 cm2 membrane at room temperature to remove hybridization solution and

unhybridized probe molecules. Then the membrane was washed twice with preheated (to
corresponding hybridization temperature) High Stringency Wash Solution #2 (0.1 X SSC;

Ambion) at 20 ml per 100 cm2 membrane. Each of two washes was conducted for 15 minutes with

gentle agitation.
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7. Autoradiography
After the final wash, the blots were transferred to new plastic bags and sealed. The blots

were exposed to RX Fuji X-ray film at -70°C for autoradiography. The first film was developed at

2 hours after exposure to the membrane, and the proper exposure time was adjusted based on the
result of the first film in order to get a satisfactory image.

After satisfactory images were captured, the probe was stripped off the membrane by

incubating in 0.1 x SSC containing 0.5% SDS in a 95°C water bath for five minutes, then rinsing
twice with 2 X SSC for 10 minutes each. The blots were cross-linked with UV light and reblocked

with Prehybridization/Hybridization Solution before reprobing.

Statistical analysis
To compare differences of relative abundance of some protein signals from SDS-PAGE,
protein bands on X-ray films were scanned with a Personal Densitometer (Molecular Dynamics

Inc.; Sunnyvale, CA). The intensity of the signals was quantified using version 3.3 of the

ImageQuant software (Molecular Dynamics Inc.). Statistical analyses were performed using either
unpaired student’s t-test or One Way ANOVA in SigmaStat™ statistical software (Jandel

Scientific; San Rafael, CA). Statistical significance was judged at the p<0.05 level.
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Results
Eps8 and intermediate filament protein keratin interact with laminin p2 in two-hybrid

screen.
A rich source of laminin p2 is the BL of glomeruli in the kidney (Hunter et al., 1989a). As

the first step to search for proteins which interact with laminin P2 in skeletal muscle, we screened
a mouse kidney cDNA library for laminin p2 partners with domain I of rat laminin P2 using the

yeast two-hybrid system. Out of 4 X 106 cDNA clones, 15 possible positive clones were isolated
(Table 1). These cDNAs were partially sequenced. Based on the sequence information, four groups

of candidate proteins were found to interact with domain I of laminin P2. The first two groups
were Eps8 and the intermediate filament protein keratin 10, each of which had three cDNAs of the

15 which matched. The third candidate protein in this kidney library was G9a, which is a protein
encoded by one of 36 genes in the class III region of the major histocompatibility complex in

human cells. Since the function of the G9a protein is unknown (Milner and Campbell, 1993) and
only one cDNA of positive clones matched this protein, further investigation into this protein was

not pursued. The fourth candidate consisted of three cDNAs which contained overlapped
sequences. Sequencing of the these three cDNAs revealed a novel open reading frame. These

cDNAs did not match any known gene in the data base. The investigation of the interaction of the
novel protein with laminin p2 is in progress and is not included in this study. In rest five cDNAs,

one matched a mitochondrial protein, three did not match any sequence in Genbank and they did
not have any related sequence, and last one matched mouse laminin P2 which was a false positive

clone. Because no enough information about these clones could be utilized, no further experiment
was performed on these clones.
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Table 1. Results of the two-hybrid screen of mouse kidney cDNA library

Totally
Screened

cDNA
clones 4X10

Genes matched by sequenced cDNAs

Positive

15

Eps8 Keratin 10 Ln B2 G9a novel mitochondrial others
*
ORF#
protein$

3

3

1

1

3

* Mouse laminin B2.
# ORF-open reading frame. Three cDNAs have overlapping sequences
and are not in the Genbank database.
$ cDNAs from these clones do not match any sequences in database
and are not related to each other.
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I

Intracellular laminin P2 associates with Eps8 in laminin p2 transfected C2 muscle cells.

The yeast two-hybrid assay is a useful system for investigating protein-protein interactions
in vivo. However, interactions identified by the two-hybrid approach need to be verified by an

independent method. The yeast two-hybrid assay is an artificial system, so interactions between
different proteins detected by this approach may not indicate an in vivo interaction in the cells in
which these proteins are normally found (Fields and Stemglanz, 1994). In order to verify the

results from the yeast two-hybrid system, immunoprecipitation (IP) was utilized to study these
protein-protein interactions. Based on our interest in detecting the function of laminin P2 in the

process of synaptogenesis of neuromuscular junction in skeletal muscle, IPs were initially

performed with full-length rat laminin p2-transfected mouse muscle C2 cells (S-C2 cells).
Laminin p2 is an extracellular matrix protein while Eps8 and intermediate filament proteins are
intracellular proteins; however, these proteins are synthesized by the same muscle cells (Albers

and Fuchs, 1992; Green et al., 1992; Gallo et al., 1997; our data). If these proteins can interact with
each other, it is reasonable to predict that intracellular laminin P2 might be binding to Eps8 and
intermediate filament proteins. It is also possible that these interactions may be transient and/or

occurring at low levels. Therefore, protein secretion from cells was blocked with tunicamycin so
that the secreting proteins were acumulated in the cells and the ECM proteins of the cell culture
were removed with trypsin digestion. The intracellular proteins of S-C2 cells were
immunoprecipitated with antibodies against either rat laminin P2 or Eps8, then the IP results were

analyzed by immunoblotting (Fig. 9). Laminin p2 was detected in the Eps8 IP (lane 3) and Eps8 in
the P2 IP (lane 6). The result indicated that intracellular laminin P2 and Eps8 form a complex in S-

C2 cells.
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Fig. 9. Intracellular laminin P2 co-precipitates with Eps8 in laminin p2-transfected mouse C2
muscle cells. Protein secretion from cells was blocked with tunicamycin (1 pg/ml) for 24 hrs and
extracellular matrix protein was removed by trypsin digestion followed by three washes with PBS.

The S-C2 cell lysates were immunoprecipitated with anti-laminin P2 antibody D27 (lanes 2 and 6),

anti-Eps8 antibody (lanes 3 and 7), and normal mouse serum (NMS, lanes 4 and 8). Lanes 1 and 5
(W.B.) are Western blot controls to confirm the presence of each protein. The IP proteins were
immunoblotted with anti-laminin P2 antibody D5 (lanes 1-4) and anti-Eps8 antibody (lanes 5-8).
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Desmin is involved in the interaction of laminin P2 and Eps8

The data from the yeast two-hybrid assays indicated that the intermediate filament protein
keratin could interact with laminin P2. Keratin is found primarily in epithelial cells, but in skeletal

muscle cells, the intermediate filament protein is desmin (Albers and Fuchs, 1992). Could desmin
interact with laminin p2 and Eps8? In the IPs (with desmin mAb D3) of tunicamycin and trypsin

treated S-C2 muscle cells, both laminin P2 (Fig. 10, lane 2) and Eps8 (Fig. 10, lane 5) could be
detected. The results indicated that desmin did coprecipitate with laminin P2 and Eps8. These
results demonstrate that laminin p2, Eps8 and desmin physically associate with each other in S-C2

cells.

The interaction of laminin p2 with Eps8 and desmin is not caused by tunicamycin treatment
In order to exclude the possibility that blocking protein secretion with tunicamycin could
cause laminin p2 to bind to Eps8 and desmin, the IP of the laminin p2-transfected C2 muscle was

performed without the tunicamycin-blocking and trypsin-digestion steps (Fig. 11). The result of
this IP indicated that Eps8, desmin, laminin P2, and yl still interacted with each other to form a
complex (lanes 3-6 in A and lanes 2, 3 and 6 in B). Therefore, interaction between laminin P2,
Eps8, and desmin is not an artifact.
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Fig. 10. Intermediate filament protein desmin is co-precipitated with laminin p2 and Eps8 in ratlaminin 02-transfected mouse C2 muscle cells. The tunicamycin and trypsin treated laminin 02

transfected C2 cell lysates were immunoprecipitated with anti-laminin p2 antibodies, DI9 (lane 1)

and D27 (lane 4), anti-desmin antibody D3 (lanes 2 and 5), anti-Eps8 antibody (lane 3), and NMS
(lane 6). The IP results were immunoblotted with anti-laminin P2 antibody D5 (lanes 1-2) and

anti-Eps8 antibody (lanes 3-7). Lane 7 (W.B.) is a regular Western blot control. Based on

migration on SDS-PAGE, the hyperphosphorylated (slower migrating) form of Eps8 preferentially
interacts with laminin P2 and desmin.
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Fig. 11. Interaction of laminin 02 with Eps8 and desmin in S-C2 cells without treatment with
tunicamycin and trypsin. The R1PA lysates of S-C2 muscle cells were immunoprecipitated with

either NMS (lane 1), or antibodies against Eps8 (lane 2), desmin ( D3, lane 3), laminin 02 (DI9
and D27, lanes 4 and 5) and mouse laminin yl (YY13, lane 6). The precipitated proteins were

immunoblotted with anti-Eps8 antibody (panel A), then reprobed with antibody D5 against laminin

02 (panel B). Lane 7 (W.B.) is a regular Western blot control. Eps8 was detected in the IPs of

desmin, laminin 02 and laminin yl (panel A) and laminin 02 was detected in the IPs of Eps8,
desmin, and laminin yl (panel B).
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Interaction of laminin 02 and Eps8 is not detectable in desmin-negative RMo cells.
After detecting laminin 02-Eps8 interaction in laminin 02-transfected C2 cells, these

experiments were performed in RMo rat skeletal muscle cells. Laminin 02-transfected C2 cells
may not represent the physiological interactions of the proteins since laminin 02 is overexpressed
in these cells. RMo rat skeletal muscle cells, first described by Merrill (1989), make endogenous

levels of laminin 02 (Green et al., 1992) and Eps8 (our data), but do not make desmin (Molnar et

al., 1996) (Fig. 12). Compared with laminin-transfected C2 cells, RMo cells make relatively lower
levels of Eps8 (see Fig. 22 a and b on page 109). In the IPs of RMo cell lysates with antibodies

against the laminin 01, 02, and yl chains, Eps8 was not detected (Fig. 13), suggesting these

proteins do not directly interact in RMo cells.
Abundance of Eps8 is not responsible for the lack of interaction of laminin 02 and Eps8 in

RMo cells. Desmin is necessary but not sufficient for the interaction between laminin 02 and
Eps8.
In order to determine why the association of laminin 02 and Eps8 could not be detected in

desmin-minus rat skeletal muscle RMo cells, two experiments were performed. Eps8 levels and
the ratio of phosphorylated versus unphosphorylated Eps8 are lower in RMo cells compared to S-

C2 cells (see Fig. 22 a and b). To increase the Eps8 level (Fig. 14B, lane 2), RMo cells were
treated with both recombinant neuregulin (NRG) and insulin for 24 hrs,, then the cell lysates were
immunoprecipitated. If the laminin 02 and Eps8 complex couldn’t be detected in RMo cells

because levels of Eps8 were too low, then addition of NRG and insulin, by increasing Eps8,
should increase levels of this complex. However, this treatment did not lead to the association of
laminin 02 and Eps8 in these cells (Fig. 14, lane 8 in A and lanes 4-6 in B). In other words, the
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Fig. 12. RMo cells do not make desmin. Lysates of wt C2, S-C2 (laminin-transfected C2) and
RMo cells were immunoblotted with anti-desmin mAb D3. Desmin was only detected in wt C2

and S-C2 cells but not in RMo cells. For unknown reasons, this antibody recognizes three bands

in S-C2 cells.
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low level of Eps8 in RMo cells was not the reason for the lack of interaction between laminin P2
and Eps8. It suggests that desmin may be necessary for the interaction of laminin 02 and Eps8 in

skeletal muscle cells. Therefore, RMo cells were stably transfected with a construct in which a
full-length desmin cDNA was cloned into an expression vector (Fig. 7). A desmin-positive RMo

cell line was identified; desmin levels were comparable in transfected RMo cells and C2 cells (Fig.

15). If desmin is required for the interaction between laminin 02 and Eps8, then the complex

would be seen in the transfected cells. However, the IP result of desmin transfected RMo cells
showed that the interaction was detectable only at a very low level, indicating the interaction of

laminin 02, Eps8 and desmin in the transfected RMo cells could only be partially recovered

(Fig. 16, lanes 7-8 in A and 4-5 in B). This experiment suggested that desmin is necessary but not
sufficient for interaction between laminin 02 and Eps8 in RMo cells. Other unknown proteins may

also be involved in this process.

The 68 kD component of Eps8 is not necessary for the interaction of laminin 02 and Eps8.
C2 cells make both 97 and 68 kD species of Eps8; whereas, RMo cells mainly make the 97

kD species (Fig. 13). The possibility that laminin 02 associates with the 68 kD species of Eps8 can
be excluded for the following reasons. 293 cells (human embryonic kidney cells) mainly express

the 97 kD Eps8 (our data). This observation is consistent with the previous study that in several

tested human cell lines, only the 97 kD component of Eps8 could be detected (Fazioli et al., 1993).
In the IP of rat laminin 02-transfected 293 cells (Kamphaus, 1998), laminin 02 coprecipitated with
Eps8 (Fig. 17). Therefore, the association of laminin 02 with Eps8 in muscle cells cannot be
attributed to 68 kD Eps8, though the relationship between the 68 kD and 97 kD species of Eps8 is
not certain.
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Fig. 13. Laminin P2 and Eps8 do not associate in desmin-minus rat skeletal muscle RMo cells.
Tunicamycin and trypsin-treated RMo cell lysates were immunoprecipitated with anti-rat laminin
yl antibody DI 8 (lane 3), anti-laminin P2 antibody D27 (lane 4), anti-laminin pi antibody C21

(lane 5), and NMS (lane 6). The proteins from this IP were immunoblotted with the anti-laminin
P2 antibody D5 (panel A), then reprobed with an anti-Eps8 antibody (panel B). Eps8 was not

detected in IPs with mAbs either to laminin P2 (panel B, lanes 3-4) or to pi (panel B, lane 5).

Lanes 1 and 2 (W.B.) are a regular Western blot of RMo cells treated without tunicamycin (norm)
or with tunicamycin (Tu). Non-equal amounts of proteins were loaded in lanes 1 and 2.
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Fig. 14. Increasing Eps8 levels in RMo cells does not lead to the association of laminin p2 and

Eps8. RMo cells were treated with 3 nM recombinant neuregulin (NRG) and 1 nM insulin for 24
hours. Treatment of NRG and insulin results in an increased level of Eps8 in muscle cells. The cell
lysates were immunoprecipitated with normal mouse serum (negative control, lane 3), anti-laminin

Y-l mAb DI8 (lane 4), anti-laminin mAbsD19 and D27 (lane 5 and 6), anti-laminin pi mAb C21

(lane 7), and anti-Eps8 mAb (lane 8). The immunoprecipitates were immunoblotted with anti
laminin P2 mAb D5 (panel A) and reprobed with anti-Eps8 mAb (panel B). Lanes 1 and 2 are
regular Western blots as positive controls. Equal amounts of protein were loaded in lanes 1 and 2.

Notice the low level of Eps8 in normal RMo cells (panel B, lane 1). Treatment with NRG and
insulin resulted in a dramatic increase of Eps8 (panel B, lane 2) but a decrease of laminin P2 in
RMo cells (panel A, lane 2). Laminin p2 could be detected in the IPs of laminin yl (lane 4),

laminin P2 (lanes 5 and 6), but not in laminin pi (lane 7), and Eps8 (panel A, lane 8). The Eps8

signals were only detected in the IPs of Eps8, but not in any IPs of laminin chains (panel B, lane 47). There was no interaction between laminin p2 and Eps8 detectable in NRG and insulin-treated

RMo cells.
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Fig. 15. The desmin level in d-RMo cells is comparable to that in C2 cells. Equal amounts of
RIP A lysates of wt C2 (control), RMo (control) and full-length desmin cDNA-transfected RMo
cells (d-RMo) were immunoblotted with mAb D3 to desmin.
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Fig. 16. Interaction of laminin P2, Eps8, and desmin in desmin-expressing RMo cells. Regular
Western blots of wt RMo (lane 1) and desmin-transfected RMo cells (d-RMo; lane 2) are positive

controls. The lysates of desmin-transfected RMo cell were immunoprecipitated with normal
mouse serum (negative control, lane 3), anti-laminin yl mAb DI8 (lane 4), anti-laminin mAbs

DI9 (lane 5), anti-laminin pi mAb C21 (lane 6), anti-Eps8 mAb (lane 7), and polyclonal anti
desmin antibody (lane 8). The immunoprecipitates were immunoblotted with anti-laminin P2 mAb

D5 (panel A). Strong laminin p2 signals were detected in the immunoprecipitates with the
antibodies against laminin yl (DI8; lane 4) and laminin P2 (DI9; lane 5). Weaker laminin P2
signals were detected in the immunoprecipitates with Eps8 and desmin antibodies (lane 7 and 8 in

panel A). The immunoprecipitates were reprobed with anti-Eps8 mAb (panel B). The strong Eps8

signals were detected in the immunoprecipitates with Esp8 antibody (lane 7). The much fainter

Eps8 signals were detected in the immunoprecipitates with antibodies against laminin y 1 (lane 4),
laminin P2 (lane 5), and desmin (lane 8). Notice that Eps8 was not detectable in laminin pi

immunoprecipitates (lane 6 in panel B). This experiment was conducted three times, and the
results were similar in each case. The results indicated that association of laminin P2, Eps8 and
desmin only was partially recovered in desmin-expressing RMo cells.
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Fig. 17. Laminin 02 coprecipitated with Eps8 in rat laminin 02-transfected 293 cells. The laminin
02-293 cell lysates were immunoprecipitated with NMS (negative control, lane 1), anti-laminin 02
mAh D27 (lane 2), and anti-Eps8 mAb (lane 3). The proteins were immunoblotted with anti-Eps8

mAb. Lane 4 is regular Western blot as a control.

99

Phosphorylated Eps8 associates with laminin p2 in mouse muscle cells.
Based on the migration rate of Eps8 on SDS-PAGE, it appeared both phosphorylated

(slower-migrating band) and unphosphorylated (faster-migrating band) Eps8 were present at
around 97 kD in the IPs of laminin p2-transfected C2 (Figs. 9 and 10). However, the intensity of

the slower-migrating Eps8 band detected in the IPs was much stronger than that of the faster-

migrating Eps8 component. This suggested phosphorylated Eps8 preferentially binds to laminin
p2. To test this hypothesis, phosphotyrosine levels in Eps8 were increased. Eps8 responds to

activation of the erbB2 receptor kinase by increased tyrosine-phosphorylation (Fazioli et al., 1993).
Neuregulin (NRG) uses erbB2 and erbB3 as its receptors in skeletal muscle cells (Altiok et al.,

1995; Jo et al., 1995; Carroll et al., 1997). Laminin p2-transfected C2 cells were incubated with
recombinant NRG, then the cell lysates were immunoprecipitated with antibodies against either

phosphotyrosine, rat laminin P2, Eps8 or desmin. This IP was sequentially immunoblotted with
antibodies against rat laminin P2 and Eps8. The results not only indicated that laminin P2, Eps8

and desmin were co-precipitated (Fig. 18A, lanes 2-5), but also that laminin P2 was detectable in
the anti-phosphotyrosine immunoprecipitates (Fig. 18B, lane 6). No evidence indicates that
laminin p2 is tyrosine-phosphorylated, but it could be co-precipitated by an anti-phosphotyrosine
antibody, PY20. Thus, PY20 precipitates both phosphorylated Eps8 and any protein associated

with Eps8, which included laminin P2. Since both slower- and faster-migrating components of
Eps8 were precipitated by anti-phosphotyrosine mAb PY20, it indicated both Eps8 components

were tyrosine-phosphorylated. The slower component is hyperphosphorylated and the faster

component is hypophosphorylated.
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Fig. 18. Phosphorylated Eps8 binds to laminin 02 in S-C2 muscle cells (laminin 02 transfected
C2). S-C2 cells were treated with NRG (3 nM) for 24 hours. NRG stimulation leads to the
phosphorylation of Eps8 in cells. The cell lysates were immunoprecipitated with normal mouse

serum (NMS, lane 1), anti-desmin antibody D3 (lane 2), anti-Eps8 antibody (lane 3), anti-mouselaminin yl antibody YY13 (lane 4), anti-rat laminin 02 antibody D27 (lane 5) and anti-

phosphotyrosine antibody PY20 (lane 6). Lanes 7 and 8 are regular Western blots. The
immunoprecipitates were immunoblotted with anti-Eps8 antibody (panel A). Eps8 could be

detected in the precipitates with D3, Eps8 mAb, YY13, D27, and anti-phosphotyrosine antibody
PY20. The mAb PY 20 precipitated more phosphorylated Eps8 than D3, YY13, and D27 (lane 6 in
panel A). The major component of Eps8 which appeared in immunoprecipitates was heavily

phosphorylated (the slower migrating band at 97 kD). The immunoprecipitates were reprobed with
anti-laminin 02 antibody D5 (panel B). Laminin 02 was detected in the PY20 immunoprecipitates

(lane 6 in panel B). After NRG stimulation, the Eps8 level was increased and most of Eps8 were
phosphorylated (lane 7 in panel A), but at the same time, the laminin 02 level was decreased in the
cells (lane 7 in panel B).
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Interaction of laminin p2 with Eps8 is laminin chain-specific.

The next question was whether Eps8 specifically binds to laminin p2 or whether it nonselectively associates with the other laminin chains, too. Several lines of evidence support the

notion that the interaction between laminin P2 and Eps8 is specific for the p2 chain. First, no
interaction was found between the laminin pi chain and the Eps8 clones in yeast two-hybrid

assays (data not shown). Second, lysates of tunicamycin- treated laminin p2-transfected C2 muscle

cells were immunoprecipitated with antibodies against laminin P2 and yl then immunoblotted
with antibodies against laminin P2, laminin pi and Eps8. The results indicated that laminin yl

was a part of this laminin p2-Eps8 complex as it could be detected in the IP of laminin P2
antibody. This is consistent with previous studies showing that laminin p2 binds with laminin yl,

but not with pl, to form a heterodimer (Green et al., 1992). Laminin pl was detected in the regular
Western blot lane but not in the IP lanes of laminin p2-transfected C2 cells (Fig. 19). There are

two possible explanations for this result. Either laminin pi does not interact with Eps8, or laminin
Pl complexed with laminin yl interacts with Eps8 and desmin but uncomplexed laminin pi

doesn’t. It is possible that overexpressed laminin P2 associates with most of the endogenous
laminin yl chain, so that uncomplexed laminin pi chains can not interact with laminin yl. This
might lead to laminin pi not being detected in the IP. In order to test this possibility, an IP of wt

C2 cell lysates was conducted with monoclonal antibodies specific against mouse laminin pi and

Eps8, then it was immunoblotted with antibodies against mouse laminin yl and Eps8. In wt C2
muscle cells, laminin yl forms a complex with either laminin pl or P2. In the immunoprecipitates
of laminin pi mAb, laminin yl was detectable, which is consistent with laminin yl forming a
complex with laminin pl. However, no Eps8 was detected in laminin pi IPs. In contrast, both
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laminin yl and Eps8 were detected in Eps8 IPs (Fig. 20). The data here strongly support that
laminin yl is a part of laminin P2-Eps8 complex, whereas laminin pi is not. Thus, the interaction

of laminin p2, Eps8 and desmin is specific for laminin p2.

Eps8 levels are directly related to the levels of laminin P2 in cultured muscle cells.
When equal amounts of protein were loaded on an SDS-PAGE gel, Eps8 levels in laminin

p2-transfected C2 cells are higher than those in wt C2 cells (Figs. 21 and 37). When the results of
the Western blot were quantified with a densitometer, the Eps8 level in laminin p2-transfected C2

muscle cells is about three fold higher than in wt C2 cells (Fig. 22a). If overexpression of laminin

P2 results in an increase of Eps8 in the muscle cells, then decreasing levels of laminin P2 should
result in decreased levels of Eps8. To test this possibility, antisense RNA was used to decrease

levels of P2 protein. RMo cells were stably transfected with plasmids in which the laminin P2
cDNA was subcloned in a opposite orientation so that the antisense RNA would be transcribed.

The antisense RNA should reduce laminin P2 levels in the transfected cells (Eguchi et al., 1991).

The Western blot of the antisense laminin p2-transfected RMo cell clearly showed that reducing
laminin P2 by about 75% also decreased total Eps8 levels by 60% in the cells (Fig. 21C, D, 23,

and 24). Therefore, laminin P2 abundance in transfected muscle cells is directly correlated with
the Eps8 levels. This experiment provided another line of evidence for the interrelationship

between laminin p2 and Eps8 in muscle cells.
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Fig. 19. Laminin y 1 is a part of the intracellular laminin 02-Eps8 complex. Tunicamycin and
trypsin-treated laminin 02-transfected C2 cell lysates were immunoprecipitated with anti-laminin
02 antibody D27 (panel A, lanes 1 and 5), anti-mouse laminin yl antibody YY13 (panel A, lanes 2
and 6 ) and NMS (panel A, lanes 3 and 7). Lanes 4 and 8 (W.B.) are regular Western blot positive

controls. Lanes 1 to 4 were immunoblotted with the anti-laminin 02 antibody D5. Lanes 5 to 8
were immunoblotted with the mAb against mouse laminin 01. Laminin 02 coprecipitated with

laminin yl (panel A, lane 1-2). Laminin 01 was detected in a Western blot (panel A, lane 8) but
was not detected in any immunoprecipitates from laminin 02-transfected C2 cells (panel A, lane 5-

7). Lanes 5 to 8 were reprobed with an anti-Eps8 antibody (panel B). Eps8 coprecipitated with
laminin 02 (panel B, lane 1) and laminin yl (panel B, lane 2).
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Fig. 20. Laminin (31 does not associate with Eps8 in wt C2 muscle cells. RIP A lysates of wt C2
mouse muscle cells were immunoprecipitated with normal rat serum (NRS; lane 3 and 6), rat anti
mouse laminin pi mAb (Bl; lane 4 and 7), and anti-Eps8 mAb (lane 5 and 8). Lane 1 (wt 293;

laminin yl negative), and lanes 2 and 9 (293D4, mouse laminin y 1-transfected 293 cells) were

regular Western blots as positive controls for the specificity of antibody YY13. Lanes 1 to 5 were

immunoblotted with anti-mouse laminin y 1 polyclonal antibody YY13. Lanes 6 to 9 were blotted

with an anti-Eps8 mAb. In laminin pl immunoprecipitates, laminin yl was detectable (lane 4), but
not Eps8 (lane 7). In Eps8 immunoprecipitates, both laminin yl and Eps8 were detected (lane 5

and 8).
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Fig. 21. Laminin p2 abundance in transfected muscle cells is directly correlated with Eps8 levels.
Western blots of laminin p2-transfected C2 (lane 1 in A and B), wild type C2 (lane 2 in A and B),

wild type RMo (lanes 1 and 3 in C and D), and antisense laminin p2-transfected RMo (Anti) (lanes
2 and 4 in C and D). Panels A and C were blotted with anti-laminin p2 antibody D5. Panels B and
D were reprobed with anti-Eps8 antibody. Equal amounts of protein were analyzed.
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Fig. 22a. Eps8 levels in wt C2, laminin P2-transfected C2 (S-C2) and RMo cells. Overexpression
of laminin p2 in S-C2 cells leads to increased Eps8 levels. The 68 kD Eps8 is not detectable in
RMo cells. The data shown represent average values from three (wt C2 and S-C2 cells) or six

(RMo cells) Western blots scanned with a densitometer. Error bars indicate standard error.
(*P<0.05 for 97 kD Eps8 in wt C2 vs. RMo, 68 kD Eps8 for wt C2 vs. RMo and S-C2 vs. RMo
cells).
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Fig. 22b. Phosphorylated vs. unphosphorylated Eps8 levels in wt C2, laminin p2-transfected C2
(S-C2) and RMo cells. The ratio of phosphorylated vs. unphosphorylated 97 kD Eps8 is different

in wt C2 (>2:1), S-C2 (=2:1) and RMo (<2:1) cells. The Eps8 levels represent average values
scanned with a densitometer from Western blots of wt C2 (N=3), S-C2 (N=3) and RMo (N=6)

cells. Error bars indicate the standard error. (* P<0.05)
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Fig. 23. Laminin P2 levels in RMo vs. antisense laminin P2-transfected RMo cells. Laminin p2
signals from Western blots of RMo and antisense laminin p2-transfected RMo cells were

quantified with a densitometer. The data shown represent average values from four samples. In
antisense laminin p2-transfected RMo cells, laminin P2 levels were reduced by about 75%. Error

bars indicate standard error. (* P<0.05)
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Fig. 24. Eps8 levels are reduced in antisense laminin p2-transfected RMo cells. Total,
phosphorylated (p-97 kD), and unphosphorylated (un-p-97kD) Eps8 signals from Western blots of

RMo and antisense laminin p2-transfected RMo (antisense-RMo) cells were quantified with a

densitometer. The Eps8 levels are average values from four samples. Total Eps8 levels in antisense
RMo cells were reduced about 60%. Error bars indicate the standard error. (* P<0.05)
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A portion of Eps8 colocalizes with laminin P2 in laminin p2-transfected C2 cells.

The immunoblotting data showed that in muscle cells laminin P2 interacts with Eps8, and
laminin P2 levels in transfected muscle cells are directly correlated with the Eps8 levels. In order

to know whether co-localization of laminin p2 and Eps8 can be visualized with microscopy, S-C2
cells cultured on coverslips were immunostained with antibodies against laminin P2 and Eps8 and

visualized with fluorochrome-labeled secondary antibodies. The confocal images of double
immunostained cell culture revealed that a part of laminin P2 and a part of Eps8 did colocalize in
cytoplasm of S-C2 cells, especially in the area close to the cell membrane (Fig. 25).

Laminin p2-Eps8-desmin complex is related to NRG/ARIA-erbB receptor pathway.
The evidence above indicates that laminin P2, Eps8 and desmin form a complex in C2

muscle cells. Previous studies demonstrated that Eps8 could be tyrosine-phosphorylated by the
activation of the receptor tyrosine kinases (RTKs) epidermal growth factor receptor (EGFR) and

erbB2 (Fazioli et al., 1993). ErbB2 and erbB3 are the receptors for NRG/ARIA in skeletal muscle
(Altiok et al., 1995). Both C2 and RMo muscle cells responded to the recombinant NRG treatment

by increasing Eps8 levels and decreasing laminin P2 levels (Figs. 14, 18, 26, and 29). These data

clearly indicate that laminin P2 is linked with the NRG/ARIA signaling pathway via Eps8. In order

to investigate the relationship among laminin P2, Eps8, erbB2, and erbB3, the effect of
recombinant NRG treatment on the protein levels of Eps8, erbB2 and erbB3 in wt C2 and laminin
P2-transfected C2 cells was examined with EGF and insulin as controls. Addition of EGF or NRG

to the culture medium in the absence/presence of serum resulted in an increase of Eps8 in both wt
C2 (Fig. 26a; lanes 2, 3 and 7) and laminin p2-transfected C2 cells (Fig. 29a; lanes 2, 3 and 7).

This is consistent with the previous studies that Eps8 could respond to the activation of EGFR and
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erbB2. Surprisingly, overexpression of laminin P2 in transfected C2 cells resulted in a dramatic

down-regulation of erbB3 receptors (Fig. 30 and 32). In contrast, erbB2 receptors in these cells
seem to be up-regulated when the cells were treated with the recombinant NRG (Fig. 31a; lanes 3
and 7). In wt C2 cells, addition of recombinant NRG led to the down-regulation of erbB2 receptors
(Fig. 28) but had no obvious effect on erbB3 receptors (Fig. 27). The only difference between wt

C2 and laminin p2-transfected C2 cells is the overexpression of laminin P2 in the latter. These
data provided strong evidence that laminin P2 may play a role in the regulation of erbB3 receptors
of the muscle cells.
Eps8, erbB2, erbB3 and erbB4 receptor levels were also checked in desmin-transfected

Rmo cells by Western blot analysis (Fig. 33). Expression of desmin, one of the components of the

laminin p2-Eps8-desmin complex, clearly resulted in an increase in the erbB3 receptor level and,

at the same time, a slight decrease in the Eps8 level in the transfected RMo cells, compared with

wt RMo cells. Consistent with previous studies (Moscoso et al., 1995), the erbB4 receptors were
not detectable in both wt and desmin-transfected RMo cells. These results suggest that one

function of the laminin p2-Eps8-desmin complex might be to regulate both the erbB2 and erbB3
receptor abundance in muscle cells and, therefore, regulate the response of the muscle cells to

NRG/ARIA signaling-pathway in the synaptogenesis of the neuromuscular junction of skeletal
muscle.
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Fig. 25.
A

B

C

D

E F
Laminin p2 and Eps8 are co-localized in S-C2 muscle cells. S-C2 cells cultured on cover-slips

were immunostained with anti-laminin P2 mAb DI 9 and FITC-conjugated secondary antibody

(green; A-D), and with anti-Eps8 polyclonal antibody followed by TRITC-conjugated secondary
antibody ( red; A-C). The cells were visualized using confocal microscopy. Some laminin p2 and

Eps8 co-localize in S-C2 cytoplasm, especially in the area close to the cell membrane (yellow, A-

C). S-C2 cells were stained with either FITC- (green, E) or TRITC- (red, F) conjugated secondary
antibody, without primary antibody, as a negative control. (Magnification 60 X)
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Fig. 26a. Effect of EGF and NRG treatment on Eps8 levels in wt C2 cells. Wt C2 muscle cells
were cultured to 100% confluence in regular growth medium. Then the medium was removed and
replaced with medium containing EGF (50 ng/ml), recombinant NRG (3 nM), insulin (1 nM)

and anti erbB2- and erbB3- antibodies (about 15 nM for both). The cells were continuously
cultured for 48 hrs. The compounds were added to the medium at 0 and 24 hr, except for the antierbB2- and erbB3- antibodies, which were only added at 0 hr. Equal amounts of RIP A lysates of

wt C2 cells were immunoblotted with anti-Eps8 mAb. In the absence of serum (FCS), addition of
EGF, NRG and insulin resulted in an increase in the levels and phosphorylation of Eps8 in wt C2
cells (lanes 2, 3, and 5). In the presence of serum, Eps8 levels increased only slightly with

treatment with NRG or insulin (lane 7 and 9). Addition of 15 nM antibodies against erbB2 and

erbB3 was not enough to completely block the effect of NRG (lanes 4 and 8).
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Fig. 26b. Eps8 levels in wt C2 muscle cells treated with EGF and recombinant NRG for 48 hours.
The data shown are from three Western blots, including Fig. 26a, scanned with a densitometer.
The labels in the figure indicate cells were cultured in DMEM medium only, or in DMEM
supplemented with EGF (D+EGF), NRG (D+NRG), NRG and anti-erbB2 plus erbB3 antibodies

(D+N+Abs), insulin (D+ insulin), fetal calf serum (D+FCS), FCS and NRG (D+F+N), FCS and
NRG in the presence of erbB2 and erbB3 antibodies (D+F+N+Abs), and FCS and insulin

(D+F+Insulin). The levels of Eps8 were increased in response to the treatment with EGF, NRG,
and FCS. (Error bars: standard error; *P<0.05). Since the role and significance of 68 kD Eps8 are
not clear, the changes of 68 kD Eps8 are not included in this figure.
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Fig. 27. Effect of EGF and NRG treatment on erbB3 levels in wt C2 cells. The experimental
procedure was the same as described in Fig. 26a. Equal amounts of wt C2 cell lysates were

immunoblotted with anti-erbB3 antibody. Wt C2 cells express high levels of erbB3 receptors.
There was no noticeable difference in erbB3 receptor levels in wt C2 cells treated with the

different agents either in the absence or presence of serum.
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Fig. 28a. Effect of EGF and NRG treatment on erbB2 levels in wt C2 cells. The experimental
procedure was the same as described in Fig. 26a. Equal amounts of wt C2 cell lysates were

immunoblotted with anti-erbB2 antibody, bi the absence of serum (FCS, lanes 1-5), addition of
EGF and NRG down-regulated the erbB2 receptor levels in the cells (lanes 2 and 3). In the
presence of serum (lanes 6-9), erbB2 levels were similar in wt C2 cells with different treatments

(lanes 6-9). Addition of 15 nM antibodies against erbB2 and erbB3 did not block the effect of
NRG (lanes 4 and 8).
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Fig. 28b. ErbB2 levels in wt C2 cells treated with EGF and NRG. The data shown are from three
Western blots, including Fig. 28a, scanned with a densitometer. The labels in the figure indicate

that the cells were cultured in DMEM medium only or in DMEM supplemented with EGF
(D+EGF), NRG (D+NRG), NRG in the presence of antibodies against the erbB2 and erbB3
receptors (D+N+Abs), insulin (D+Insulin), fetal calf serum (D+FCS), FCS and NRG (D+F+NRG),
FCS and NRG in the presence of erbB2 and erbB3 antibodies (D+F+N+Abs), and FCS and insulin

(D+F+Insulin). The general trend seems that erbB2 levels are down-regulated in the cells treated

with NRG.
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Fig. 29a. Effect of EGF and NRG treatment on Eps8 levels in rat laminin p2-transfected C2
cells. The experimental procedure was the same as described in Fig. 26a. Equal amounts of cell
lysates were immunoblotted with anti-Eps8 mAb. Addition of EGF and NRG resulted in an

increase in Eps8 levels in the absence (lanes 1-5), or presence (lanes 6-9), of serum. The effect of

NRG treatment was only partially blocked by anti-erbB2 and erbB3 antibodies (lanes 4 and 8).
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Fig. 29b. Eps8 levels in rat laminin p2-transfected C2 muscle cells treated with EGF and NRG for
48 hours. The data are from three Western blots, including Fig. 29a, scanned with a densitometer.

The labels in the figure have the same meaning as that in Fig. 28b. The results clearly showed that
the transfected cells responded to EGF and NRG treatment by increasing the Eps8 levels either in

the absence or presence of serum. In contrast to wt C2 cells (Fig. 26), the effect of NRG on the
transfected cells was almost completely blocked by the erbB2 and erbB3 antibodies. (* P<0.05).
As mentioned in figure 26b, the changes of 68 kD Eps8 are not included in this figure.
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Fig. 30. Effect of EGF and NRG treatment on erbB3 levels in laminin 02-transfected C2 cells.

The experimental procedure was the same as described in Fig. 26a. The blot from Fig. 29a was
reprobed with an anti-erbB3 receptor antibody. The erbB3 signals were undetectable in these cells.

Overexpression of laminin 02 in C2 muscle cells results in a dramatic down-regulation of erbB3
receptors.
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Fig. 31a. Effect of EGF and NRG treatment on erbB2 levels in laminin p2-transfected C2 cells.
The experimental procedure was the same as that in Fig. 26a. The blot from Fig. 30 was reprobed
with an antibody against erbB2 receptor to test if proteins were lost from the nitrocellulose.

Treatment with NRG led to a dramatic up-regulation of erbB2 receptor levels in the cells in the

absence (lane 3) and the presence (lane 7) of serum. The effect of NRG was partially blocked by
addition of anti-erbB2 and erbB3 antibodies to cell culture (lanes 4 and 8). EGF treatment led to a

decrease of erbB2 receptors in these cells (lane 2).
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Fig. 31b. ErbB2 levels in laminin p2-transfected C2 cells treated with EGF and NRG for 48 hours.
The results from three Western blots, including Fig. 31a, were scanned with a densitometer. The
labels in the figure indicate the culture condition and the treatment added in the cell culture, which
are the same as that in Fig. 28b. Notice that the response of the cells to the NRG treatment was

different from wt C2 cells. The erbB2 levels dramatically increased in response to the stimulation
ofNRG. (* P<0.05)
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Fig. 32. Comparison of erbB2 and erbB3 receptor abundance in wt C2, S-C2 (rat laminin P2-

transfected C2) and RMo (rat muscle) cells by Western blot analysis. Equal amounts of proteins
were immunoblotted with mAb D5 against rat laminin P2 (lanes 1-3), anti-erbB2 polyclonal
antibody (lanes 4-6), and anti-erbB3 polyclonal antibody (lanes 7-9). Lane 3 shows no laminin P2

signal because D5 only recognizes the rat antigen. The abundance of erbB2 receptors was the
highest in wt C2 and the lowest in RMo cells (lanes 4-6). RMo cells expressed very low levels of

erbB3 receptors (lane 7) compared with those in wt C2 cells (lane 9). Overexpression of laminin
P2 resulted in the down-regulation of ebrB3 receptors in S-C2 cells (lane 8).
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Fig. 33a. Comparison of erbB receptors and Eps8 in wt RMo (desmin-minus) versus desmin-

transfected RMo (d-R) cells. Both wt and transfected RMo cells were cultured in the same growth
medium to 100% confluence and allowed to differentiate for three days. Equal amounts of proteins

were immunoblotted with antibodies against erbB2 (lanes 1-2), erbB4 (lanes 3-4), and erbB3

(lanes 5-9) in panel A. In d-R cells, erbB2 receptor levels did not change. ErbB4 were not
detectable in both RMo and d-R cells. Expression of desmin in RMo cells resulted in a higher

level of erbB3 receptors (lanes 6 and 8) compared to wt RMo (lanes 5 and 7). Panel B is the panel

A reprobed with mAb to Eps8. The levels of Eps8 in d-R cells (lanes 2, 4, 6, and 8) were lower
compared to wt RMo cells (lanes 1, 3, 5 and 7). Lane 9 was wt C2 cells used as a control. This

suggests that desmin is involved in the regulation of erbB3 receptors in skeletal muscle cells and
that the expression of erbB3 receptor may be regulated by the laminin P2-Eps8-desmin complex.
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Fig. 33b. Expression of desmin in RMo cells affects Eps8 and erbB receptor levels. The data

shown are from Western blots of RMo (N=5), desmin-transfected RMo (d-RMo; N=5) and wt C2
(N=3), including Fig. 33a, scanned with a densitometer. Eps8 levels are lower, erbB2 levels
similar, and erbB3 levels higher in d-RMo cells than in wt RMo cells. In both wt and transfected
RMo cells erbB4 receptors were not detectable. (* P<0.05)
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Laminin P2 affects the expression of erbB2 and erbB3 receptors on the post-transcriptional

level.

To determine if the effect of overexpression of laminin p2 on the erbB2 and erbB3
receptors is at the transcriptional or post-transcriptional level, a Northern blot analysis of erbB2

and erbB3 receptor mRNA in different muscle cells was performed (Fig. 34). There was no
significant difference in the erbB2 and erbB3 mRNA levels among these cells. This suggests that
laminin p2-Eps8-desmin complex plays a role in regulation of erbB2 and erbB3 receptors at the
post-transcriptional level.

Distribution of EGFP-labeled Eps8 in muscle cells.

When this study was performed, there was no data about the distribution of Eps8 in muscle
cells. In order to look at the distribution of Eps8 in muscle cells, wt C2 cells were transiently
transfected with an Eps8-EGFP fusion cDNA in an expression vector. The images from the
confocal microscope revealed that the intracellular localization of Eps8 varied from cell to cell.

Either Eps8 was concentrated just underneath the cell membrane, or it was distributed evenly in
the cytoplasm, or it was distributed mainly in the perinuclear region (Fig. 35). This is consistent

with the newly published data about the distribution of Eps8 in Swiss 3T3 fibroblasts and in non

receptor tyrosine kinase v-Src-transfected quail myoblasts (Provenzano et al., 1998). In cycling
fibroblasts, Eps8 distributed within the perinuclear region in a punctate pattern, at membrane
ruffles, and at cell-cell junctions. The variation in localization of EGFP-labeled Eps8 may be due
to the cells being in different stages of the cell cycle.
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Fig. 34. Northern blot analysis of erbB2 and erbB3 mRNA of different skeletal muscle cells. 30 pg
of total RNA from wt C2, laminin p2-transfected C2 (S-C2), RMo, desmin-transfected RMo (dRMo) and Eps8-transfected C2 (Eps8-C2) cells were electrophoretically separated and hybridized

to 32P-labeled HER/erbB2, HER/erbB3 and full-length GAPDH RNA probes (control). Both
erbB2 and erbB3 mRNA are made in these muscle cells. When the mRNA signals were quantified
with a densitometer, there was no significant difference in erbB2 and erbB3 mRNA levels among

mouse cells (wt C2, S-C2 and Eps8-C2; N=4) or rat cells (RMo and d-RMo; N=4), respectively
(P>0.05). The results indicate that laminin P2-Eps8-desmin complex may regulate the expression

of erbB3 receptors on a post-transcriptional level.
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Fig. 35.
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Confocal images of Eps8 fused to GFP (green fluorescent protein) expressed in mouse C2 muscle

cells. Wt C2 muscle cells were cultured on glass coverslips and transiently transfected with a
GFP-Eps8 cDNA fusion cloned into the expression vector pcDNAI-Amp. The intracellular

localization of Eps8 varied from cell to cell. Eps8 was either concentrated just underneath the cell

membrane (b and d), or it was distributed evenly in the cytoplasm (a and d) or it was distributed

mainly in the perinuclear region (a and d). The expression levels of Eps8 was higher in some cells

than in others (a and c). Notice that a small portion of Eps8 also appeared in nuclei of the cells in a
punctate pattern (a, c, and d). (Magnification 60 X)
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Eps8 and laminin P2 can be translocated into the nuclei of muscle cells.

Eps8 contains the putative nuclear targeting site Arginine-Lysine-Lysine-Serine-Lysine-

Lysine (RKKSKK) (Fazioli et al., 1993), suggesting it may be targeted to the nucleus of the cell. In
the Eps8-EGFP transfected C2 cells, a small portion of Eps8 also appeared in the nuclei of the

cells in a punctate pattern (Fig. 35). After immunocytochemistry with antibodies to laminin p2 and
Eps8, the proteins appeared in the nuclei of the laminin p2-transfected C2 cells. The intensity of

the laminin P2 staining was much fainter than in either the ECM or cytoplasm (Fig. 36). Since
laminin p2 associates with Eps8 and desmin in muscle cells, whether these proteins could be

detected in muscle cell nuclei was investigated.
The nuclei of wt C2, laminin p2-transfected C2, RMo, and laminin p2-transfected 293

cells were isolated by Dounce homogenization (Greenberg and Bender, 1997), CPC detergent lysis

(Li et al., 1997), and sucrose ultracentrifugation (Gruber et al., 1995). The Western blot analyses
of nuclear preparations of these cells were consistent with the results from transfection with

EGFP-labeled Eps8 (Fig. 35) and immunocytochemistry (Fig. 36). A small portion of both laminin
02 and Eps8 were translocated into the nuclei of the muscle cells (Figs. 37, 38 and 39). When total

cell and nuclear lysates prepared from about equal numbers of laminin p2-transfected C2 cells,

were analyzed by Western blot and quantified with a densitometer, about 5% of the laminin P2 and

13% of the Eps8 proteins were translocated into the nuclei (Fig. 40). The purity of nuclear
preparations isolated with the different procedures was checked with antibodies against different
cellular marker proteins. The results indicated that the nuclear preparation isolated with sucrose

ultracentrifugation procedure was the cleanest, since little or no erbB2 receptors (cell membrane

protein; Fig. 41), actin (cytoplasmic protein; Fig. 42), other laminin chains (Fig. 43), collagen IV
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(the most abundant extracellular protein in BL; Fig. 44), or desmin (cytoplasmic protein; Fig. 45)
were detected. In contrast, c-Fos, a transcription factor expressed in a very low level in

differentiated muscle cells, was detected and enriched in the nuclear preparations (Fig. 46).

Moreover, nuclear translocation of laminin P2 and Eps8 is related to the state of cell
differentiation. Generally, higher concentrations of Eps8 (Fig. 47) and laminin P2 (Fig. 48) were

detected in differentiated, compared to undifferentiated, muscle cells. Nuclear translocation of
laminin P2 and Eps8 implies these proteins may play a role in the regulation of muscle cell

growth/differentiation-related gene expression, although it is not yet known which genes are

regulated by nuclear laminin P2 and Eps8.
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Fig. 36. Shown are confocal images of some laminin P2 and Eps8 translocated into nuclei of

skeletal muscle cells. Wt C2 cells cultured on glass coverslips and immuno-stained with anti-Eps8
polyclonal antibody and FITC-conjugated secondary antibody (green, left panel) or anti-laminin
P2 polyclonal antibody R49 and Rhodamine-conjugated secondary antibody (red, right panel; also

Fig. 14d). (Magnification 60 X)
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Fig. 37. Eps8 is detected in the nuclei of mouse muscle cells. Nuclei from wt C2 and wt Sol8
mouse skeletal muscle cells were isolated with the Dounce homogenizer procedure. Equal

amounts of proteins were immunoblotted with anti-Eps8 mAb. Eps8 could be detected in both
muscle cell lines (lanes 4 and 5). Lanes 1, 2, and 3 were regular cell lysates. Notice that C2 cells
make both the 97 and 68 kD components of Eps8 (lanes 1 and 2), whereas RMo cells mainly make
the 97 kD Eps8 (lane 3). In S-C2 cells (laminin p2 transfected C2, lane 2), the Eps8 level was
much higher than that in wt C2 cell (lane 1).
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Fig. 38. Laminin P2 is detected in nuclei of mouse muscle cells isolated with Dounce

homogenization procedure. The experimental procedure was the same as that in Fig. 37. Equal
amounts of proteins were immunoblotted with mAb D5 to rat laminin p2 (lanes 1-3) and

polyclonal antibody R49, which recognizes mouse laminin P2 (lanes 4 and 5). Lane 1 had no
signals because mAb D5 does not recognize the mouse antigen.
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Fig. 39. Laminin P2 was detected in nuclei isolated with either CPC (cetylpyridinium chloride)
detergent or with sucrose ultracentrifugation. Nuclei from S-C2 (rat laminin P2 transfected C2),

\vt C2, RMo, and S-293 (rat laminin p2-transfected human embryonic kidney cells; Kamphaus,
1998) were isolated with either the CPC detergent procedure (lanes 1- 4) or with the sucrose

ultracentrifugation procedure (lanes 7- 9). Equal amounts of proteins were immunoblotted with

mAb D5. Laminin P2 could be detected in nuclear preparations isolated with both methods.
Laminin P2 is not seen in lane 2 because D5 does not recognize the mouse antigen. Total cell

lysates of S-C2 and RMo were used as positive controls (lanes 5 and 6).
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Fig. 40. Relative quantity of laminin p2 and Eps8 proteins in total cell lysate and nuclear protein
from S-C2 cells. (A) Equal numbers of S-C2 cells were plated on two 100 mm dishes and cultured

to confluence. Cells on one of the plates were lysed with RIPA buffer. Nuclei were prepared from
the cells on the other plate using the sucrose ultracentrifugation procedure. Total cell lysates and
total nuclear proteins were loaded on an SDS-PAGE gel and immunoblotted with antibodies
against rat laminin P2 (upper panel) and Eps8 (bottom panel), respectively. (B) The levels of
laminin p2 and Eps8 in (A) were quantified with a densitometer. The percentage of each of the

two proteins translocated into nuclei of the cells were calculated using the intensity of the signals
of laminin P2 and Eps8 in total cell lysates as 100 %. The results indicated that about 5% of the

laminin P2 and 13% of the Eps8 in S-C2 cells are translocated into the nuclei.
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Fig. 41. Detection of erbB2 receptor from nuclei isolated with either CPC detergent or sucrose
ultracentrifugation. Nuclei were isolated with either CPC detergent (CPC nuclei) or with sucrose
ultracentrifugation (ultracentrifuged nuclei) and lysed with RIP A buffer. Equal amounts of

proteins were run on SDS-PAGE and immunoblotted with polyclonal antibody against the cell
surface receptor erbB2 (lanes 1-4). Very faint erbB2 signals were detectable in CPC-isolated
nuclei, but not in nuclei isolated with sucrose ultracentrifugation (lane 7- 9). Total cell lysates of

S-C2 and RMo (lane 5 and 6) were used as controls. This indicates that there was no

contamination of cell membrane proteins in the nuclear proteins isolated with the sucrose
ultracentrifugation procedure.
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Fig. 42. Detection of actin from nuclei isolated with either CPC detergent or sucrose
ultracentrifugation. The experimental procedures were the same as those in Fig.39. Equal amounts
of proteins were run on SDS-PAGE, and immunoblotted with a mAb against actin. There was no

actin detectable in the nuclear proteins isolated with sucrose ultracentrifugation procedure (lanes

7- 9), whereas it was detectable in nuclear proteins isolated with CPC detergent (lanes 1- 4). Total
cell lysates of S-C2 and RMo cells were used as controls (lanes 5 and 6).
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Fig. 43. Detection of laminin pi and y 1 in nuclei isolated with either CPC detergent or sucrose
density ultracentrifugation. Proteins from nuclei isolated with CPC detergent (lanes 1-4) and
isolated with sucrose density ultracentrifugation procedure (lanes 7- 9) were run on SDS-PAGE

and immunoblotted with a polyclonal antibody that recognizes the laminin al, pi and yl chains.
Equal amount proteins were loaded. Total cell lysates of wt C2 and 293D4 (mouse laminin yl144

transfected human embryonic kidney cells) were used as a control (lanes 5 and 6, respectively).

Laminin pl (MW 220 kD) and y 1 (MW 200 kD) are present in total cell lysate from wt C2 (lane
5), but only laminin y 1 is present in the 293D4 lysate (lane 6). In nuclear proteins isolated with

CPC detergent, faint laminin pl and yl signals could be detected in all three types of muscle cells

(lanes 1 to 3); neither laminin pl nor y 1 was detectable in laminin P2-transfected 293 cells
(293A2; lane 4). In contrast, in nuclear preparations isolated with the sucrose density
I

ultracentrifugation procedure, there were no laminin pi and y 1 signals detectable in the S-C2 and

RMo nuclear proteins (lanes 8 and 9); only wt C2 nuclear protein showed faint laminin pi and yl
signals (lane 7). Laminin a chain signals were not detected because of the size of the protein (MW

400 kD). This anti-laminin polyclonal antibody cross-reacted with proteins at around MW 150 kD
and 110 kD in all of the samples. The intensity of these protein bands were weaker in CPC nuclei

(lanes 1-4), but much stronger in nuclei isolated with sucrose density ultracentrifugation (lanes 7-

9), compared with those in the total cell lysate (lanes 5 and 6). However, the intensity of these
protein bands were similar in the nuclear samples isolated using the same methods (lanes 1 to 4

and lanes 7 to 9). It indicated that the amounts of proteins were loaded in each lane were similar.
The intensity of the 150/110 kD protein signals in the nuclear proteins isolated using sucrose
density ultracentrifugation was much stronger than those in the total cell lysates, but the laminin

Pl and yl signals were almost undetectable. If the nuclear preparations were contaminated with

proteins from other cellular compartments, the intensity of the laminin pi and yl signals should
parallel those of the 150/110 kD proteins. Since they did not, this result strongly suggests that the
presence of laminin P2 in the nucleus is not caused by the contamination with the ECM proteins.

145

r

cell lysate

CPC nuclei

Ultra nuclei

wt C2 S-C2 RMo 293A2 wtC2 293D4wtC2 S-C2 R Mo„

Collagen IV [2

116 kD—

1

2

3

4

146

5

6

7

8

9

Fig. 44. Detection of collagen IV in nuclei isolated with either CPC detergent (lanes 1-4) or
sucrose ultracentrifugation (lanes 7-9). The procedures were the same as those in Fig. 39. Equal
amounts of proteins were run on SDS-PAGE and immunoblotted with a polyclonal antibody

against type IV collagen, which is found exclusively in basement membrane. The MW of type IV
collagen is between 160-170 kD, depending upon the tissue origin. Type IV collagen molecules

are composed of three a chains selected from the translated products of six genetically distinct

genes (the COL4A1-COL4A6 genes giving rise to the al(IV)-a6(IV) chains, respectively). The

most abundant form of type IV collagen has the composition [al(IV)]2a2(rV). There was no
collagen IV detectable in the nuclei isolated with two different methods, except in wt C2 nuclear
proteins isolated with sucrose ultracentrifugation (lane 7), which showed trace amounts of the
protein. Total cell lysates are shown in lanes 5 and 6. Based on the strengths of the signal, it

indicates that the presence of laminin P2 in nuclear proteins of muscle cells is not due to

contamination by extracellular matrix proteins.
Note: The size of type IV collagen in human embryonic kidney cells is different from that in
rodent muscle cells.
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Fig. 45. Detection of desmin in nuclei isolated with either CPC detergent or sucrose
ultracentrifugation. The experimental procedures were the same as those in Fig. 39. Equal
amounts of proteins were run on SDS-PAGE and immunoblotted with mAb D3 against desmin.

Total cell lysates of wt C2 and 293D4 (mouse laminin yl-transfected homan embryonic kidney

cells) were used as controls (lanes 5 and 6). Desmin is found in muscle cells but not in kidney cells

(lanes 5 and 6). There is no desmin protein detectable in nuclei except in wt C2 nuclear protein
(lanes 1 and 7). The weak signal for desmin gives further evidence that the presence of laminin 02
in nuclei of muscle cells is not caused by contamination with cytoplasmic proteins.
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Fig. 46. Detection of c-Fos from nuclear preparations isolated with either CPC detergent or
sucrose ultracentrifugation procedures. The experimental procedures were same as those in Fig.
39. Equal amounts of proteins were loaded on SDS-PAGE, and immunoblotted with a polyclonal
antibody against the transcriptional factor c-Fos. The levels of c-Fos were much higher in nuclei

isolated with sucrose ultracentrifugation procedure (ultracentrifuged nuclei; lanes 7- 9) than in
nuclei isolated with the CPC procedure (lanes 1- 4). Lanes 5 and 6 are total cell lysates.
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Fig. 47a. Eps8 levels in nuclei from differentiated (D) and undifferentiated (N) muscle cells
isolated with sucrose ultracentrifugation. Wt C2, S-C2 and RMo cells were cultured on dishes to
about 50-60 % of confluence (undifferentiated) or to 100% confluence with some fusion into

myotubes (differentiated). Nuclei were isolated with the sucrose ultracentrifugation procedure.
Equal amounts of proteins were run on SDS-PAGE and immunoblotted with a mAb against Eps8.
The total cell lysates of differentiated S-C2 cells were used as a control (lane 7). The levels of
nuclear Eps8 in differentiated muscle cells (lanes 4 and 6) were much higher than that in

undifferentiated cells (lanes 3 and 5). In wt C2 cells, the Eps8 level was slightly higher in
undifferentiated nuclei (lane 1) than in differentiated nuclei (lane 2). This experiment was

conducted twice and the results were similar.
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Fig. 47b. Nuclear Eps8 levels in undifferentiated vs. differentiated muscle cells. The data shown
are the results of the Western blot in Fig. 41a scanned with a densitometer. Generally,

differentiated muscle cells tend to have higher levels of both 97 and 68 kD Eps8, compared to
undifferentiated cells.
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Fig. 48a. Laminin 02 levels in nuclei from differentiated (D) and undifferentiated (N) muscle cells
isolated with sucrose ultracentrifugation. The blot from Fig.47a was reprobed with a polyclonal
antibody, R49, against laminin 02. The laminin 02 levels were higher in the nuclei from

differentiated cells (lanes 2, 4, and 6) than in undifferentiated cells (lanes 1, 3, and 5). Total cell

lysate of S-C2 cells was used as a control (lane 7).
152

50000
] undifferentiated
I differentiated
co
<D

40000 -

>

<D
(N

s 30000
c
G

E

20000

<D

>

• r—*

<D

10000

0

T

I

I

wtC2

S-C2

I

1

I

1

1

RMo

Fig. 48b. Nuclear laminin P2 in undifferentiated vs. differentiated muscle cells. The results in Fig.

48a. were scanned with a densitometer. Generally, the nuclear laminin P2 levels in differentiated
muscle cells are higher than in undifferentiated cells.
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Discussion
I. The interaction of laminin p2, Eps8 and desmin
Since laminin P2 was identified as a component of the synaptic BL in 1989, much work

has gone into understanding the function of this molecule in the synaptogenesis of neuromuscular
junctions. Previous studies indicated that laminin P2 selectively adheres to motoneurons and
inhibits neurite outgrowth via a putative LRE receptor on the motoneuron membrane, but this

receptor has not been isolated yet (Hunter et al., 1989a, 1989b, 1991; Porter et al., 1995; Porter and
Sane 1995). Knocking out the laminin P2 gene from mice demonstrated that this protein plays an

important role in the formation of the glomerular filtration membrane in kidney and in the
synaptogenesis of the neuromuscular junction in skeletal muscle (Noakes et al., 1995a). Recent

studies also found that laminin p2 is related to some types of human congenital muscular
dystrophy (Wewer et al., 1995; Yamada et al., 1995). All of these studies indicate that laminin P2

has an important and unique biological function in mammalian animals and humans; however, the
mechanism with which laminin P2 works still is not known. In order to understand the function of

the laminin P2, this study takes an alternative approach, the use of the yeast two-hybrid assay
(Fields and Song, 1989), to investigate possible protein-protein interactions with laminin p2. Since

most proteins in cells carry on their functions by interacting with other proteins, identification of
proteins which interact with laminin P2 would provide important information for its function.
In all of the laminin subunits identified to date, the closest relative of laminin p2 is

laminin pi (Hunter et al., 1989a). Both laminin pi and P2 associate with both a laminin a and y

chain to form a heterotrimer. However, pi and P2 do not assemble into the same laminin trimer
(Green et al., 1992). In tissues, laminin pi and p2 are distributed into the different subtypes of BLs
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(Sanes et al., 1990; Sollberg et al., 1992; Wewer et al., 1992; Glukhova et al., 1993; Porter et al.,

1993; Wewer et al., 1994b). Evidently, pl and p2 chains have distinctive biological functions in
different tissues. The homology between pi and P2 is the least in the domain I. Another major

difference in this domain is the presence of the tripeptide Leucine-Arginine-Glutamate (LRE)

sequence in laminin p2 but not in laminin pi (Hunter et al., 1989a). The tripeptide LRE sequence

selectively appears in a number of proteins concentrated at the neuromuscular junctions
(McMahan and Wallace, 1989; Sanes et al., 1989 and 1990), and it defines a crucial determinant of
a motoneuron-selective adhesive site (Hunter et al., 1991; Porter et al., 1995). Besides the synaptic
BL of skeletal muscle, laminin P2 is also concentrated in the BL of glomeruli in the kidney and

plays an important role in the formation of glomerular filtration barrier (Sanes et at., 1990; Noakes
et al., 1995a, 1995b). It has been confirmed that the kidney cells are a rich source of laminin P2

(Hunter et al., 1989a, 1989b). Since a mouse kidney cDNA library was commercially available,
domain I of laminin P2 was utilized as a bait to screen this library using the yeast two-hybrid
assay. Four groups of candidate proteins which interacted with domain I of laminin P2 were

identified from partially sequenced DNAs from 15 positive clones (Table 1). For the reasons
already described earlier in the result part, this study focused on the interaction of laminin p2 with

Eps8 and the intermediate filament protein keratin 10 in this kidney cDNA library.
To determine if these proteins are important in the function of laminin p2 at the

neuromuscular junction, the interaction of laminin p2 with Eps8 and intermediate filament

proteins in skeletal muscle cells was investigated using independent methods based on the
information supplied by the two-hybrid screen of the mouse kidney cDNA library.
Immunoprecipitations (IPs) of laminin p2-transfected C2 muscle cells indicate that laminin p2
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does associate with Eps8 and desmin, the intermediate filament protein in C2 skeletal muscle cells
(Figs. 9 and 10). In wt RMo muscle cells, which do not make desmin (Fig. 12), the interaction of

laminin 02 and Eps8 could not be detected (Fig. 13), providing another line of evidence that

desmin is necessary for this interaction. IPs of wt and laminin p2-transfected C2 cells indicate that
the interaction between laminin P2 and Eps8 is chain specific, since Eps8 could be coprecipitated

with laminin p2 and yl, but not laminin pi (Figs. 19 and 20). Furthermore, no Eps8 could be

coprecipitated with laminin pl from desmin-transfected RMo cells (Fig. 16). It also appears that
phosphorylated Eps8 binds to laminin P2 in muscle cells (Figs. 9, 10 and 18). The discovery of

this interaction between laminin p2, Eps8 and desmin in skeletal muscle cells has opened a new

avenue for the study of the function of laminin p2.
In yeast two-hybrid assays, the domain I of laminin P2 interacts with Eps8. This
observation is supported by the data from IPs and immunocytochemistry of C2 mouse muscle

cells. However, the interaction between laminin p2 and Eps8 is not detectable in rat muscle RMo
cells which make both laminin P2 and Eps8. This indicates that laminin P2 does not directly

interact with Eps8. Several posibilities have been carefully considered. First, yeast two-hybrid
assay is an artificial system; the protein-protein interactions identified using the yeast two-hybrid

system do not necessarily indicate these proteins interact in the cells where the proteins are

normally synthesized. It seems not to be the case for the interaction between laminin P2 and Eps8,

since the IP results of wt and laminin p2-transfected C2 cells are consistent with the discovery
from the yeast two-hybrid assays (Fig. 9, 10, 11, and 25). Another possibility is that in the yeast
two-hybrid system, cotransfected yeast only synthesized domain I of laminin 02; this fragment of

laminin 02 may have some exposed “binding sites” which interact with Eps8. In the muscle cells,
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full-length laminin P2 forms a complex with laminin a and y chains. In this native protein
complex, those “Eps8-binding sites” of laminin p2 in RMo cells may not be available because of
the protein conformation. If this was true, the data from C2 muscle cells can not be explained

either, since laminin p2 also forms a complex with the same laminin chains in C2 cells. If the
“Eps8-binding sites” on laminin p2 are blocked by the protein conformation in RMo cells, it
should also happen in C2 cells, but laminin P2 can interact with Eps8 in C2 cells. Therefore, the

possibility that “Eps8-binding sites” in the native laminin P2 is covered up by the protein

conformation does not appear to be the case either. The only reasonable explanation is that the
interaction between laminin p2 and Eps8 is mediated by some unknown accessory proteins which

are made by yeasts and C2 muscle cells but missing from RMo cells. Therefore, the interaction of
laminin P2 with Eps8 could be detected in yeast two-hybrid system and C2 muscle cells but not in

RMo muscle cells. In addition to not making desmin, RMo cells are different from wt C2 and

laminin p2-transfected C2 (S-C2) muscle cells in at least three aspects. (1) wt C2 and S-C2 cells
make both the 97 and 68 kD forms of Eps8, whereas RMo cells only make the 97 kD component

of Eps8 (Fig.22a). (2) The ratio of phosphorylated to unphosphorylated Eps8 in RMo cells is lower

than that in wt C2 and S-C2 cells, based on the migration and intensity of the Eps8 signals on
Western blots (Fig. 22b). (3) C2 cells express high levels of both erbB2 and erbB3 receptors (Fig.

27 and 28), whereas RMo cells express only very low levels of erbB3 receptors (Fig. 32).
However, these differences are not the critical factors preventing the interaction of laminin P2 with

Eps8. Neither RMo nor 293 cells make the 68 kD Eps8. However, laminin p2 associates with Eps8

in laminin p2-transfected 293 cells (Fig. 17) but not in RMo cells (Fig. 13). Treating RMo cells
with recombinant neuregulin (NRG) can dramatically increase Eps8 levels and change the ratio of
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phosphorylated versus unphosphorylated Eps8 in RMo cells (Fig. 14), but it failed to facilitate the
detection of laminin p2-Eps8 interaction in the cells. Both S-C2 and RMo cells express very low

levels of erbB3 receptors, but laminin P2 only associates with Eps8 in S-C2 cells. Therefore,
desmin-deficiency is the important factor responsible for the failure of interaction between laminin
P2 and Eps8 in RMo cells. However, expression of desmin in RMo cells only led to the partial

recovery of the laminin P2-Eps8 association (Fig. 16), since only very weak laminin P2 signals
were detected in the precipitates with Eps8 and desmin antibodies. This suggests that some other
unknown protein(s) may also be involved in this interaction which is(are) missing from RMo cells.

These data demonstrated that desmin is necessary but not sufficient for the laminin P2-Eps8

interaction. Whether the candidate protein G9a and/or the product of a novel open reading frame
identified from the yeast two-hybrid assays contributes to this process is not known.
The IP results of laminin p2-transfected C2 cells using antibodies against phosphotyrosine

and laminin P2 show that phosphorylated Eps8 coprecipitates with laminin P2. Further proof for
this observation can be obtained by treating the cell lysates with protein phosphatase. A loss of

coprecipitation of laminin P2 and Eps8 by an antiphosphotyrosine antibody, following the removal
of phosphate groups from the tyrosine residues of Eps8, would indicate Eps8 has to be

phosphorylated for interaction to occur. Clarifying whether phosphorylated or unphosphorylated
Eps8 interacts with laminin P2 is important for further study of this protein-protein interaction in
muscle cells. Eps8 is a substrate of receptor tyrosine kinases (RTKs). This protein can be tyrosine-

phosphorylated by activating several RTKs including EGF receptors (Fazioli et al., 1993). Eps8
does not contain an SH2 domain which mediates the interactions between proteins and

phosphotyrosine residues of the RTKs (Koch et al., 1991). This protein can bind to the
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juxtamembrane region of EGFR, and the binding of Eps8 to EGFR is phosphotyrosine

independent (Castagnino et al., 1995). The mechanism with which Eps8 binds to EGFR is not
clear. It is known that reversible phosphorylation/dephosphorylation of some proteins is a common

mechanism used in RTK mediated signalling pathways in cells. For example, phospholipase C-y

binds by its SH2 domain to phosphorylated tyrosine residues in the RTKs and is tyrosinephosphorylated by RTKs (Alberts et al., 1994). Verifying if laminin 02 interacts with
phosphorylated or unphosphorylated Eps8 would help to determine whether laminin 02 plays a

role in regulating the interaction of Eps8 and RTKs or in regulating the function of phosphorylated
Eps8.
In RMo cells, laminin 02 does not associate with Eps8. So why, by reducing laminin 02

levels in the antisense laminin 02 RMo cells, would Eps8 levels be lower? Previous studies
indicate that animals bearing a non-functional laminin 02 gene showed obvious defects in the

structure and function of neuromuscular junctions, but the major cause of death in the

homozygote animals was massive amounts of protein present in the urine caused by the defect in
the glomerular filtration barrier. The heterozygotic animals appear normal (Noakes et al., 1995a).

This indicated that the laminin 02 knock out in muscle is not lethal. In order to maintain their
cellular function and survive, muscle cells may have some unknown mechanism to compensate for

the effect of reduced laminin 02. It has been found that kidney cells of laminin 02 knock out

animals make more laminin 01 to compensate for the reduced laminin 02 (Noakes et al., 1995b).

Whether mutant muscle cells also make more laminin 01 is not known. In antisense laminin 02
RMo cells, the situation is similar to the muscle cells of laminin 02 mutant animals. In these cells,

laminin 02 was reduced but not completely lost. The reduced laminin 02 may affect Eps8 level of
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the cells via this unknown compensation mechanism.

Consistent with the results of the IPs, the confocal images of double-immunostained cells
revealed that some laminin P2 and some Eps8 did colocalize in the cytoplasm of laminin p2-

transfected C2 cells (S-C2 cells), especially in the area close to the cell membrane (Fig. 25). In
Eps8-EGFP (green fluorescent protein) transiently transfected C2 muscle cells, a portion of the

labeled Eps8 also distributed to the regions underneath the cell membrane (Fig. 35). A new study
has demonstrated that Eps8 can be recruited to the cell membrane ruffles and at cell-cell junctions

in Swiss 3T3 fibroblasts upon the stimulation by serum (Provenzano et al., 1998). Activation of
the oncogene product v-Src, a non-receptor tyrosine kinase, has been shown to result in both
tyrosine-phosphorylation of Eps8 and cytoskeleton remodeling in v-Src-transfected quail

myoblasts. The subcellular distribution of Eps8 in these cells is similar to that in fibroblasts before
the activation of v-Src; and its distribution changes depending upon the structural rearrangement of
the cytoskeleton induced by v-Src (Gallo et al., 1997; Provenzano et al., 1998). Eps8 co-localized
with the cytoskeletal F-actin-binding protein cortactin in these cells. The localization of Eps8 at

the cell cortex region is independent of the binding to the receptor tyrosine kinase. When the
detergent-resistant fraction of cell lysates of the v-Src transfected NIH 3T3 fibroblast was

immunoprecipitated using anti-Eps8 antibody and then immunoblotted with antiphosphotyrosine
antibody, the result indicated that highly phosphorylated Eps8 associated with the cytoskeleton

(Provenzano et al., 1998). The fact that laminin P2 is concentrated in the neuromuscular junction
region in skeletal muscle has been very well documented (Hunter et al., 1989a). It also was found

that besides linking together adjacent myofibrils in skeletal muscle cells, desmin also was
concentrated at the neuromuscular junctional region (Askanas et al., 1990), especially around the
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junctional folds (Sealock et al., 1989). It is very possible that Eps8, as one component of the
laminin p2-Eps8-desmin complex, also is concentrated in the neuromuscular junction regions of

the muscle. Immunohistochemistry of skeletal muscle tissue using fluorochrome labeled abungarotoxin and Eps8 antibody should determine if this is occurring. It is known that laminin p2
plays an important role in the synaptogenesis of the neuromuscular junction. The role played by

laminin P2 in this process may be via a laminin P2-Eps8-desmin complex or laminin p2 may be
targeted to the neuromuscular junction through this protein complex.
Transient transfection of C2 cells with the EGFP-Eps8 construct showed that Eps8

distribution varied from cell to cell. Eps8 concentrated either at the membrane region or in the
perinuclear region in different cells. Since growth of the cultured cells was unsynchronized,

variations in localization of EGFP-labeled Eps8 may be due to the cells being in different stages of

the cell cycle. This suggests that Eps8 may have different functions at different stages of the cell
cycle, possibly by playing a role in regulating cell growth and differentiation. Gallo et al. (1997)

reported that Eps8 expression in fibroblasts responded to mitogenic or differentiation signals.
Resting fibroblasts express low levels of Eps8, but expression of Eps8 is strongly induced by

serum, phorbol esters and the v-src oncogene. They also reported that in terminally differentiated
murine myogenic cells, expression of Eps8 is virtually extinguished. Gallo et al. believe that Eps8

may be involved in determination of cell growth and differentiation. In this study the muscle cells
still make Eps8, even after differentiation, which is different from Gallo’s observation that

terminally differentiated myogenic cells stop making Eps8.
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II. Laminin P2-Eps8-desmin complex and erbB3 receptors
To investigate the physiological function of the laminin 02-Eps8 complex, several lines of
evidence led us to perform a series of experiments to detect the interrelationship between laminin
P2, Eps8 and NRG/ARIA. NRG/ARIA plays a very important role in the neuromuscular junction

formation process. These molecules activate AChR gene expression selectively in myofiber nuclei
located near synaptic sites (Harris, 1989). The function of NRG/ARIA is mediated by erbB2 and

erbB3 receptors (Harris et al., 1991; Jo et al., 1995). Eps8, as a substrate of receptor tyrosine

kinases, also can be tyrosine-phosphorylated in response to the activation of the erbB2 receptor
tyrosine kinase (Fazioli et al., 1993). Therefore, Eps8 may be a substrate of erbB receptors as well
as a substrate of EGF receptors in skeletal muscle. Eps8 levels of the muscle cells are directly

correlated with the laminin p2 levels of the cells (Figs. 21, 23 and 24). Both C2 and RMo cells

respond to the addition of recombinant NRG by increasing Eps8 along with decreasing laminin P2
(Figs. 14, 26 and 29). All the data listed above clearly indicate that the laminin P2 and NRG/ARIA

signaling pathways are linked together via Eps8. The data also show that overexpression of
laminin P2 results in a dramatic down-regulation of erbB3 receptor expression in the transfected

C2 muscle cells (Fig. 30 and 32) compared with wt C2 cells which express high levels of erbB3
(Fig. 27). Under the influence of recombinant NRG, expression of erbB2 receptors in laminin p2transfected C2 cells is dramatically upregulated both in the absence and presence of serum

compared with the control cells not treated with NRG (Fig. 31b, lane 3 and 7 versus 1 and 6). In

contrast, expression of erbB2 receptors in wt C2 cells was down-regulated by the treatment with

NRG in the absence of serum but is the same as that in the control cells in the presence of serum
(Fig. 28b, lane 3 and 7). It seems that the erbB2 receptors are regulated by NRG in a positive
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feedback manner in laminin 02-overexpressed C2 cells but in a negative feedback manner in wt

C2 cells. Ln addition, the influence of anti-erbB2 and erbB3 antibodies on NRG-treated wt C2 cells
is different from NRG-treated laminin P2-transfected C2 cells. In this study, the cells were also

treated with 3 nM NRG in the presence of a 15 nM mixture of anti-erbB2 and erbB3 antibodies.
Although the effect of NRG on erbB2 levels in both wt C2 and laminin p2-transfected C2 was

partially blocked by these antibodies, the antibodies had a stronger effect in laminin P2-transfected
C2 cells (Fig. 31, lanes 3, 4 and 7, 8) than in wt C2 cells (Fig. 28, lanes 3, 4 and 7, 8). It suggests

that the expression of erbB2 receptors in laminin p2-transfected C2 cells is potentiated and is more
sensitive to the treatment of NRG than in wt C2 cells. In the absence of the antibodies, the erbB2

receptor levels were much more greatly induced in laminin p2-transfected C2 cells than in wt C2

cells. In the presence of the antibodies, the up-regulation of erbB2 receptors by NRG treatmement
in these cells was also almost completely abolished (Fig. 31). The results of these experiments

suggest that laminin p2 may play a role in the regulation of erbB2 and erbB3 receptor levels and
further regulate the response of muscle cells to NRG at the neuromuscular junctions.

C2 muscle cells were also stably transfected with the Eps8; overexpression of Eps8
dramatically weakened the capability of the cells to adhere to culture plates. At the same time,

proliferation of Eps8-transfected C2 cells in the growth medium was extremely slow and a large
percentage of the cells died for unknown reasons. Overexpression of Eps8 also was correlated with
a large down-regulation of erbB3 receptors in the transfected cells. However, after passaging the

Eps8-transfected cells for several months, the behavior of the cells changed. Although they were
still G418-resistant, Eps8 levels in these cells gradually fell to a level only slightly higher than

those in wt C2 cells. The adhesion capability of the cells was almost completely recovered,
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proliferation of these cells was much faster than at the beginning when these cells were cloned,

and few cells died in growth medium. In these cells, the erbB3 receptor abundance also rose to a
level close to that in wt C2 cells (data not shown). An explanation for this phenotype change is

that after these Eps8-transfected C2 cells were passaged in growth medium for several months,
only those cells expressing lower levels of Eps8 survived. These cells exhibited characteristics

similar to wt C2 cells. This observation suggests that Eps8 in muscle cells may have multiple
functions. In addition to being involved in the regulation of cell-adhesion capability, inhibiting
cell-growth, and possibly inducing apoptosis of the muscle cells, Eps8 may also play a role in

regulating the expression of erbB3, one of two receptors of NRG/ARIA in skeletal muscle.
Compared with wt RMo cells, expression of desmin in transfected RMo cells led to a

decrease in Eps8 levels, an increase in erbB3 levels, and no change in erbB2 levels (Fig. 33).
ErbB4 receptors could not be detected in either wt or transfected RMo cells. This is consistent
with previous studies showing that skeletal muscle cells express few erbB4 receptors (Moscoso et
al., 1995).

A change in the expression of any component in the laminin P2, Eps8 and desmin complex

resulted in a change in erbB3 receptor abundance in C2 muscle cells. This suggests that at least
one function of the laminin p2-Eps8-desmin complex is to regulate the expression of erbB3
receptor in muscle cells. Both laminin P2 and Eps8 decrease, but desmin increases, the erbB3 level

of the cells. The opposite and coordinated actions of laminin P2, Eps8 and desmin may play a role

in maintaining homeostasis of erbB3 receptors in the cells. In normal muscle tissue, erbB2 and
erbB3 receptors are concentrated in the post synaptic membrane of the neuromuscular junctions

(Altiok et al., 1995; Carroll et al., 1997). These receptors mediate the function of NRG/ARIA to
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regulate the gene expression of AChR subunits in the muscle cells. How these receptors are
recruited to the neuromuscular junction is not clear, although some studies suggest that agrin,

which clusters AChRs in the post synaptic membrane of the neuromuscular junctions (Glass et al.,
1996), might do this (Burden et al., 1997). Localization of erbB2 and erbB3 receptors, laminin P2,
Eps8 and desmin to the neuromuscular junction, as well as the relationship among these protein

molecules in cells, suggest that the laminin p2-Eps8-desmin complex may play a role either in
recruiting erbB2 and erbB3 receptors to the post synaptic membrane of the neuromuscular junction

or maintaining an optimal density of erbB2 and erbB3 receptors at the neuromuscular junctions, or
both. By this mechanism, muscle cells might give a proper response to the nerve-derived
NRG/ARIA. It has been shown that NRG/ARIA regulates the expression of AChR genes through
activation of both the PIP2/IP3 and Ras/MAPK pathways (Marte et al., 1995; Tansey et al., 1996).

To understand how the laminin p2-Eps8-desmin complex regulates the expression of
erbB3 receptors in muscle cells, it is important to determine if this regulation is occurring at the

transcriptional or at the post-transcriptional level. The results of Northern blot analyses of erbB2
and erbB3 mRNA levels in wt and transfected muscle cells supports the hypothesis that the
laminin p2-Eps8-desmin complex regulates expression at the post-transcriptional level. Since there

is no significant difference between the erbB2 and erbB3 mRNA levels in wt and transfected

muscle cells, the complex is not accelerating the degradation of erbB mRNA. There is also no

evidence indicating that laminin P2, Eps8 or desmin has protease activity. Therefore, two

possibilities may be responsible for the lack of erbB3 protein. First, the laminin p2-Eps8-desmin
complex might be involved in the regulation of the translation of the erbB2 and erbB3 receptor
mRNAs by a negative translation control mechanism. This type of translation regulation is
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accomplished by a reversible mRNA/regulating protein interaction in the 5’ untranslated region of

the mRNA. A good example of this type of regulation in eucaryotic cells is the translation of the
mRNA encoding the intracellular iron storage protein ferritin. The translation of this mRNA is

blocked by an iron-sensitive translation repressor protein called aconitase, which binds to the 5’
untranslated region of the mRNA if the free iron concentration in the cytoplasm is low. When the

cells are exposed to iron and free iron concentration in the cytosol rises, iron can bind to aconitase
and dissociate it from the ferritin mRNA. After the block to translation is removed, the synthesis
of ferritin can be increased by as much as 100-fold (Melefors et al., 1993). Laminin P2 and Eps8

may inhibit the translation of erbB3 receptor mRNA while desmin may facilitate its translation.
Under the regulation of the laminin P2, Eps8 and desmin complex, the erbB3 receptor
concentrated in the post synaptic membrane region is maintained at the proper density. The

second possibility might be that overexpression of laminin P2 and Eps8 affects the post-

translational modification of erbB3 receptors and accelerates its degradation, whereas desmin
counterbalances the effect of laminin P2 and Eps8 on the erbB3 protein and stabilizes it.
Previous studies showed that the action of NRG/ARIA is mediated by the erbB2 and erbB3

receptors in skeletal muscle (Altiok et al., 1995; Carroll et al., 1997). Like other RTKs, erbB
receptors also form homodimers or heterodimers following the binding of ligands. The erbB3
receptors can directly bind to NRG. Since the intrinsic receptor tyrosine kinase activity of erbB3

has become attenuated relative to that of other erbB receptors during evolution (Guy et al., 1994),
it has to bind to erbB2 or other erbB receptors family members to form functional heterodimers
(Burden and Yarden, 1997). Although no ligand has been shown to directly bind to erbB2

receptors so far, erbB2 is required for cooperation with erbB3 receptors for high-affinity binding
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of NRG (Sliwkowski et al., 1994). Removal oferbB2 from the cell surface almost completely
abolished ligand binding by accelerating dissociation of both EGF and NRG (Karunagaran et al.,
1996). In laminin p2-transfected C2 muscle cells, overexpression of laminin p2 leads to a dramatic

down-regulation of erbB3 receptors (Fig. 30 and 32). After stimulation with NRG, the cells
express a high level of erbB2 receptors (Fig. 31). These cells still respond to the stimulation of

NRG by increasing the levels of Eps8. The mechanism through which laminin p2-transfected C2
cells respond to NRG is not clear. Since erbB2 is the preferred heterodimerization partner of all

erbB proteins (Graus-Porta et al., 1997), and erbB2 overexpression enhanced binding affinities to
both EGF and NDF through deceleration of ligand dissociation rates (Karunagaran et al., 1996), it
is possible that the action of NRG on these cells is mediated by erbB2 heterodimerizing with both
EGFR (erbBl) and erbB3 receptors.

III. Nuclear translocation of Eps8 and laminin P2

Several lines of evidence encouraged us to investigate the nuclear translocation of Eps8
and laminin P2. Eps8 bears a putative nuclear localization sequence. Overexpression of Eps8 in

fibroblasts and hematopoietic cells results in an increased mitogenic response to stimulation by

EGF (Fazioli et al., 1993). This suggests that Eps8 may play a role in gene regulation, but events
downstream of Eps8 phosphorylation in this signaling pathway are not known.

In an attempt of determine the role of Eps8 in muscle, an Eps8-EGFP fusion was expressed

in C2 cells. The confocal images of these cells showed a small amount of the protein translocated

into nuclei of C2 muscle cells. Although it has been reported that in the transfected cells, GFP
itself can be translocated into nuclei of the cells (Ogawa et al., 1995), it is impossible for Eps8-
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EGFP fusion protein to be translocated non-specifically into nuclei of the muscle cells because of
the size of this fusion protein (about 130 kD). Therefore, the appearance of green fluorescence in
nuclei of Eps8-EGFP transfected muscle cells is strong evidence that Eps8 can be translocated into

nuclei of the cells. Immunocytochemistry of laminin p2-transfected C2 cells supported the above
observations by showing Eps8 and laminin P2 staining in nuclei of the cells. Therefore, the nuclear

translocation of Eps8, laminin p2 and desmin in muscle cells was studied by a series of

experiments in which nuclei from muscle cells were isolated by three different biochemical
methods and analyzed by Western blots. The data strongly indicate that a small amount of Eps8

(Figs.37, 40 and 47) and laminin p2 (Figs. 38, 39, 40 and 48), but not desmin (Fig. 45), can be
translocated into the nuclei of the muscle cells. Also, the nuclear translocation of Eps8 and laminin

P2 is related to the cell differentiation (Figs. 47 and 48). Since laminin p2 is an ECM protein, it is

important to exclude the possibility that nuclear preparations were contaminated by proteins from
other cellular compartments. Therefore, the nuclear translocation of laminin P2 was carefully and

repeatedly investigated. There are six reasons to exclude the possibility that the nuclear laminin P2
and Eps8 resulted from protein contamination from other cellular compartments. 1) Collagen IV,
which is the most abundant molecule in BL and exclusively found in the BL (Ayad et al., 1994),

was not detected in nuclear preparations (Fig. 44). 2) Neither was the erbB2 receptor, a integral
cell membrane protein, detected (Fig. 41). 3) Actin, the most abundant cytoskeletal protein in

eukaryotic cells and constituting about 20% total protein in skeletal muscle cells (Kabsch et al.,
1992), could not be detected in nuclear preparations (Fig. 42). 4) The c-Fos, a transcription factor

expressed in very low levels in differentiated muscle cell (Tiainen et al., 1996), still could be
detected in the nuclei of the muscle cells. Moreover, c-Fos was enriched in the nuclear preparation
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isolated with sucrose density ultracentrifugation, compared to regular cell lysates (Fig. 46). 5)
Desmin, which complexes with laminin 02 and Eps8 in muscle cells, could not be detected in

nuclear preparations (Fig. 45). If nuclear translocation of laminin 02 and Eps8 simply was caused
by protein contamination from different compartments of the cells, desmin, as one of the
components of laminin 02-Eps8-desmin complex and one of the most abundant proteins in the

muscle cells, would have been detected in the nuclear preparations. 6) Nuclear laminin 02 and
Eps8 abundance was related to the differentiation of the cells (Fig. 47 and 48). The nuclei of wt

C2, laminin 02-transfected C2 and RMo cells were isolated with sucrose density

ultracentrifugation at about 50% confluence for undifferentiated (proliferating stage) and 100% of

confluence for differentiated (non-proliferating stage) cells. Western analysis of these nuclear
proteins indicated that the nuclear laminin 02 and Eps8 levels generally were much higher in

differentiated muscle cells than in undifferentiated cells, except for differentiated wt C2 cells, in
which the Eps8 level was lower than in undifferentiated C2 cells (Fig. 47 and 48) for unknown

reasons.

Since Eps8 contains a putative nuclear localization sequence, its translocation to the nuclei

of the cells seems understandable. The nuclear localization sequences of many nuclear proteins
have been precisely defined using recombinant DNA technology. It is known that the nuclear

localization sequences vary from protein to protein. Generally, the nuclear localization sequence
consists of a short peptide sequence, typically four to eight amino acids long. It is rich in the

positively charged amino acids lysine and arginine and usually contains proline. In many nuclear
proteins this short sequence is split into two arms of two to four amino acids each. This sequence

can be located anywhere in the peptide sequence of the proteins. Based on the defined nuclear
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localization sequences of some nuclear proteins published in recent years (Lin et al., 1995 and
1996; Fukuda et al., 1996; Moroianu et al., 1996; Efthymiadis et al., 1997 and 1998; Fukuda et al.,

1997; Subramaniam et al., 1999), a similarity search was performed for rat laminin p2. There are
no sequences in laminin p2 exactly matching any nuclear localization sequences used in the
search. However, the possiblity that laminin p2 contains a nuclear localization sequence can not be

excluded. During the similarity search, three short peptides in rat laminin P2 were found that were
similar to the consensus sequence “RR~ short variable sequence~RRR”, or “KK-10-12 aa

~KKK” which characterize the structures of the nuclear localization sequences of yeast
transcription factor SWI5 and human IL-5 (Jans et al., 1995; Efthymiadis et al., 1997). One of the
three sequences is KKCFLCDSRRP (at amino acids 89-99 in rat laminin P2). The second is
RRANASTFAIPSPVSNSADTRRR (amino acids 1348-1370). The third one is

RRAEQLLQDAQRARSR (aa 1584-1599). Whether these are true nuclear localization sequences
can be tested by attaching one of these sequences to a known cytoplasmic protein to see if the

protein can be translocated into nuclei of the transfected cells. If this is not the case, laminin p2
still could be translocated into nuclei of the muscle cells by another mechanism. It is known that
proteins can be delivered to different destinations, including the nucleus, by at least two different

types of sorting signals. One type is a signal peptide consisting of a stretch of specific amino acids,

such as the nuclear localization sequence of Eps8. This sequence is formed from a short cluster of

positively charged amino acids in the middle of the polypeptide chain. The other type of sorting
signal is called a “signal patch” (von Heijne et al., 1990). The amino acid residues in a signal patch
can be dispersed in different parts in the linear amino acid sequence and brought together by the
specific three-dimensional arrangement of amino acids in the protein (Garoff, 1985). Laminin p2

170

might be delivered to nucleus of muscle cell by this kind of mechanism. The “dragging” of

Laminin 02 into nuclei by binding to Eps8 does not seem to be the occurring. Laminin 02 does not
associate with Eps8 in RMo cells but it still can be detected in nuclei of RMo cells. Why desmin,

the third component of laminin-02-Eps8-desmin complex, was not detected in nuclei is not

understood. In most animal cells an extensive network of intermediate filaments surrounds the
nucleus and extends out to the cell periphery, where they interact with the plasma membrane

(Albers and Fuchs, 1992). If one assumes that desmin serves as a “controller or carrier” for
intracellular tracking of laminin 02 and Eps8 between nuclei and neuromuscular junctions, the

translocation of laminin 02 and Eps8 in wt C2 and S-C2 cells can fit into this model. For instance,
laminin 02 and Eps8 may be translocated along desmin either to the neuromuscular junctions or to
the nuclei under the influence of different intracellular and extracellular signals. However, it is

difficult to explain what is happening in RMo cells since these cells do not make desmin.
The function of nuclear Eps8 and laminin 02 is not clear at this time. Eps8 is a substrate for

receptor tyrosine kinases and plays an important role in the mitogenic signaling process. This

protein contains an SH3 domain. It is known that SH3-containing proteins are involved in signal
transduction by a number of growth factor receptors and in the organization of the cytoskeleton

(Gallo et al., 1997). The structural study of the Eps8 SH3 domain showed that two Eps8 molecules
can form a homodimer by binding to each other at their SH3 domains; it can also form multimers
in vivo (Kishan et al., 1997). An Eps8 SH3 domain binding protein, e3Bl, has recently been

identified. Overexpression of e3Bl inhibited the growth of NIH/EGFR fibroblasts (Biesova et al.,

1997). However, many aspects of Eps8 function are still not understood. So far there is no
information available about genes specifically regulated by Eps8. Overall, the significance of Eps8
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nuclear translocation remains unclear. In recent years more and more evidence has indicated that

extracellular matrix proteins and cell-cell adhesion molecules, such as classical laminin (Chen et
al., 1994; Blomme et al., 1998), cadherin and p-catenin (Rubinfeld et al., 1996; Giarre et al., 1998;
Soler et al., 1999), and the tight junction protein ZO-1 (Gottardi et al., 1996) also play important

roles in gene regulation. Both p-catenin and ZO-1 can be translocated into nuclei of the cells. In

vitro, laminin P2 inhibited growth and induced differentiation of neurites from the NSC-34
motoneuron-like cells. In vivo, laminin p2 knock-outs have aberrant differentiation of
neuromuscular junctions. Not only the differentiation of motor axons but also Schwann cells and
muscle cells are affected. These experiments suggest that laminin p2 might be involved in turning

on /off some growth/differentiation related genes in both motoneuron and skeletal muscle cells. At
this moment, the genes regulated by nuclear laminin are not known.
Although there is a lot of uncertainty, this study has shown that laminin p2 associates with

Eps8 and desmin to form a complex in skeletal muscle cells. This complex may be concentrated at
the neuromuscular junction region and involved in neuromuscular junction formation. At least one

function of this complex is to regulate the density of erbB3 receptors and/or maintain erbB2 and
erbB3 receptors concentrated at the postsynaptic membrane of the neuromuscular junctions. In
response to some unknown cell growth/differentiation signals, this complex also regulates the

nuclear translocation of laminin p2 and Eps8. The translocated Eps8 and laminin p2 may then

regulate gene expression in muscle nuclei.

!
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CONCLUSION

1. Laminin P2 interacts with Eps8 and the intermediate filament protein desmin in the mouse

skeletal muscle cells.
2. Eps8 specifically associates with laminin P2 and does not associate with laminin pi.
3. The laminin p2-Eps8-desmin complex may play a role in regulating the expression of erbB3

receptors at the neuromuscular junctions and in regulating the response of muscle cells to
neuregulins.

4. Laminin p2 and Eps8 can be translocated into the nuclei of muscle cells.
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Interaction of Laminin 02 with Eps8 and Desmin in Muscle Cells

ABSTRACT
Laminin 02 is localized to the synaptic basal lamina (BL) in muscle and glomerular BL in

kidney. To find interacting proteins, a mouse kidney cDNA library was screened with domain I of
rat laminin 02 using the yeast two-hybrid system. Fifteen positive clones were found. The DNA

sequence of three each of these clones corresponded to the phosphoprotein Eps8 (epidermal

growth factor receptor pathway substrate clone 8, which is tyrosine phosphorylated after EGF
stimulation) and the intermediate filament (IF) protein keratin. To determine if this interaction

occurred in muscle cells, C2 cells transfected with the rat laminin 02 cDNA (S-C2 cells) were
immunoprecipitated with antibodies to either laminin 02, Eps8, or desmin (the IF protein found in

skeletal muscle). When the precipitates were immunoblotted with the same antibodies, both Eps8
and desmin were found to be complexed with laminin 02. Based on migration on SDS-PAGE and
detection of laminin 02 in an anti-phosphotyrosine precipitate, the hyperphosphorylated form of
Eps8 interacts with laminin 02 and desmin. These results suggest that a complex is formed in

muscle cells between laminin 02, hyperphosphorylated Eps8, and desmin. Confocal microscopy of

Eps8-EGFP (green fluorescen protein ) transfected C2 cells and immunocytochemistry of S-C2

cells demonstrated not only that a portion of laminin 02 and Eps8 co-localized underneath the
muscle cell membrane, but also that a part of laminin 02 and Eps8 was translocated into nuclei of
the cells. The nuclear translocation of laminin 02 and Eps8 was carefully verified with three

different biochemical methods. The nuclear translocation of Eps8 and laminin 02 is related to the
differentiation of muscle cells since more of these proteins were found in differentiated nuclei.
ErbB2 and erbB3 receptors, which are related to the epidermal growth factor receptor (EGFR),
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mediate the neuregulin (NRG)/acetylcholine receptor inducing activity (ARIA) signaling-pathway

at the neuromuscular junction. Western analyses of laminin p2-transfected C2 cell lysates using

antibodies against erbB receptors revealed that overexpression of laminin p2 in C2 muscle cells
results in dramatic down-regulation of erbB3 receptors from these cells. When desmin was

expressed in RMo rat muscle cells, it resulted in an up-regulation of erbB3 receptors. The erbB3
mRNA levels of transfectd C2 and RMo cells were not affected, suggesting that laminin p2-Eps8desmin complex may be involved in the regulation of expression of erbB3 receptors on the post-

translational level. The data support the hypothesis that laminin P2, Eps8, and desmin play a role
in NRG/ARIA-erbB signaling pathway at the neuromuscular junctions and are involved in the

gene regulation of muscle cell differentiation.
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